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The discovery and subsequent introduction of the first antibiotic drugs into the clinic are considered 
as major medical breakthroughs of the 20th century. Especially when penicillin became available 
for treatment of the general public, this new drug was believed to represent the beginning of 
the end of bacterial infections. Before the introduction of antibiotics, bacterial infections were 
commonly considered as untreatable, and severe invasive infections often resulted in the death of 
patients. The new antibiotics offered an effective treatment of bacterial infections, which became 
suddenly relatively easy to cure. This of course had a major impact on the overall quality of 
public health. However, soon after the start of the large-scale use of antibiotics, the first resistant 
bacterial strains emerged. For example in the case of penicillin, Abraham and Chain reported 
already in 1940 the identification of penicillin-resistant bacteria (1). Disturbingly, over the years, 
and without exception, each introduction of a novel antibiotic drug was quickly followed by 
the emergence of resistant phenotypes. In contrast, the development of novel antibiotics is a 
time-consuming and costly process, and it is therefore easily outcompeted by the fast incline of 
resistance (Figure 1). As a consequence of this imbalance, some bacterial infections are again 
becoming increasingly difficult to treat. Thus, the recent rise of Multidrug resistant (MDR) or 
even totally drug resistant (TDR) bacteria might announce the beginning of a post-antibiotic era. 
Origin and development of antibiotic resistance
The development of antibiotic resistance has historically always been linked to the first clinical 
use of antimicrobial compounds. However, ever since microorganisms started to reign this 
world, they had to compete with other microorganisms for their biological niche. This constant 
battle for nutrients is seen as the origin of natural product antibiotics, which are thought to have 
Figure 1. Timeline of the introduction of new antibiotics and the emergence of resistance against them. Figure 
adapted from (2).
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evolved 2 billion to 40 million years ago (3, 4). As a consequence of this continuous biochemical 
warfare, a large variety of different antimicrobial compounds have evolved, targeting different 
pathways essential for bacterial life (Figure 2). In fact, many of the antibiotic therapies that 
are used in today’s clinical setting originate from these naturally occurring antimicrobial 
compounds. The evolution of these antimicrobials went hand in hand with the evolution of a 
scale of different microbial strategies to counteract their toxic effects. Several of the respective 
molecular mechanisms that confer resistance to antibiotics will be discussed later on in this 
chapter. 
On the one hand, some of the microbial counter measures against antibiotics are essential to 
provide the producing microorganisms with the needed resistance towards the effects of their own 
antibiotic compound. On the other hand, resistance towards the products of hostile organisms is 
an efficient strategy for microorganisms to improve their competitive success and fitness. Proof 
that resistance is indeed an ancient phenomenon that predates the clinical use of antibiotics 
was provided by the identification of a highly diverse collection of antibiotic resistance genes 
in 30,000-year old permafrost samples (6). These genes encoded for resistance to β-lactam, 
tetracycline and glycopeptide antibiotics, and were functional in conferring resistance towards 
Figure 2. Illustration of the bacterial targets for the different antibiotic classes. Figure adapted from (5).
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antibiotics that are still used in the clinic today. The study thus advocates the idea that the 
introduction of new antibiotics will most likely select for pre-existing resistance determinants 
that are already circulating in the natural microbial genome pool. The start of large-scale use, 
or abuse, of antibiotics in both clinical, industrial and veterinary settings provided the selective 
pressure needed for the development of highly resistant phenotypes, thereby triggering the 
current antibiotic resistance problem in the treatment of infectious diseases. 
Molecular mechanisms of antibiotic resistance
The mechanisms that confer antibiotic resistance to bacteria can either relate to the intrinsic traits 
of particular species, or they may be acquired via mutations or horizontal gene transfer. Intrinsic 
resistance to a specific antibiotic is caused by inherent functional or structural properties of 
bacteria. For example, the composition of the cytoplasmic membrane of Gram-negative bacteria 
provides them with an intrinsic resistance towards the antibiotic drug daptomycin (7). Using high-
throughput screening and random transposon mutagenesis to investigate the origin of intrinsic 
resistance, a multitude of genes were identified that can confer inherent resistance phenotypes 
to clinically relevant bacterial species, such as Staphylococcus aureus, Escherichia coli and 
Pseudomonas aeruginosa (8, 9, 10). In addition to having an intrinsic resistance towards an 
antibiotic, bacteria can acquire traits that can efficiently confer resistance. Acquired resistance 
can be achieved by three main mechanisms; (1) inactivation of the antibiotic by hydrolysis 
or modification; (2) modification of the antibiotic target; or (3) decreasing the intracellular 
concentration of the drug by altering the drug’s influx or efflux (Figure 3) (10).
The intracellular antibiotic concentration can be lowered by changing the permeability of the 
membrane. Due to the presence of an outer membrane, Gram-negative bacteria are less permeable 
for hydrophilic antibiotics. Efficient diffusion of hydrophilic antibiotics across the lipidic outer 
membrane layer is therefore dependent on non-specific membrane channels called porins. The 
selective pressure applied by antibiotics, promotes mutations that either affect porin expression or 
change porin selectivity. These mutations can result in reduced influx of an antibiotic compound, 
making it more difficult to fight the bacterial pathogens that employ this strategy.  
An alternative way to decrease the intracellular concentration of an antibiotic compound is by 
expelling it out of the cell through the use of efflux pumps. Some of these drug-efflux transport 
systems are highly dedicated to the transport of a specific substrate, while others are capable 
of transporting a multitude of different structurally unrelated substrates. The latter systems 
are therefore referred to as multidrug resistance (MDR) pumps. Expression of MDR pumps 
allows bacteria to acquire resistance to multiple antibiotic compounds, making infections caused 
by these bacteria nearly impossible to treat. Bacterial MDR-transporters can be grouped into 
five distinct families, namely the major facilitator superfamily (MFS), the small multidrug 
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resistance (SMR) family, the resistance nodulation division (RND) family, the multidrug and 
toxic compound extrusion (MATE) family, and the ATP-binding cassette (ABC) superfamily. 
The MDR transporters of the ABC family are referred to as primary active transporters, as these 
transporters directly utilize the energy released from the hydrolysis of ATP for extrusion of the 
antibiotic substrate (12). All other MDR transporters belong to the group of secondary active 
transporters as they employ antiport mechanisms, wherein the export of the antibiotic drug is 
driven by either the proton-motive force (PMF) or the sodium-motive force (SMF) (Figure 4)
(13). 
The vast majority of known bacterial MDR transporters belong to the group of secondary 
transporters, of which some have a profound role in conferring resistance in clinically relevant 
bacteria. For example, in S. aureus the MFS transporter NorA provides resistance towards 
chloramphenicol and the fluoroquinolone ciprofloxacin (14, 15, 16). The expression of MdfA 
confers resistance in E.coli to a wide spectrum of antibiotics, including aminoglucosides, 
chloramphenicol, fluoroquinolones, macrolides and tertracylcine (17). A set of RND efflux 
systems in P. aeruginosa, namely MexAB-OprM, MexXY-OprM, MexCD-OprJ and MexEF-
OprN, are all capable of exporting several types of antibiotics, including chloramphenicol, 
Figure 3. Mechanisms that confer antibiotic resistance in bacteria. A, Inactivation of the antibiotics by either 
hydrolysis or modification. B, Modification of the antibiotic target. C, Decrease of the intracellular antibiotic 
concentration by changing drug permeability. D, Decrease of the intracellular antibiotic concentration by expression 
of antibiotic efflux transporters. The bacterial cell envelope is represented by a large ring. Antibiotics are represented 
by the skull and crossbones symbol, antibiotic targets by hearts, pores that allow membrane passage of antibiotics 
by rings, and antibiotic efflux systems by membrane channels filled with a large arrows. Figure adapted from (11). 
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fluoroquinolones and tetracyline (18). PmrA, a MFS pump expressed by Streptococcus 
pneumoniae, is responsible for the efflux of the fluoroquinolones ciprofloxacin and norfloxacin 
(19). Of note, these examples are only a limited representation of the vast range of different 
secondary MDR transporters that contribute to the current antibiotic resistance problem. More 
complete lists of  bacterial MDR transporters can be found in several  excellent review articles 
(11, 13, 20, 21).
In contrast to the secondary MDR transporters, there are only a limited number of ABC transporters 
associated with a role in MDR. This is surprising since ABC transporters are highly represented 
in bacteria and are notorious for their role in MDR in mamallian species (21). To date, several 
bacterial ABC-type MDR pumps have been characterized, one of which is Sav1866 of S. aureus. 
Notably, Sav1866  is probably one of the best-chacterized bacterial MDR ABC transporters. Due 
to its homology to the mammalian MDR ABC transporter Pgp-1, Sav1866 has been extensively 
used in structeral studies investigating the moleculair mechanism of ABC transporter-mediated 
drug efflux (22, 23). Although these studies have provided valuable insights into the inner 
workings of MDR ABC transporters, there is so far no definitive in vivo proof that Sav1866 
Figure 4. Drug-resistance efflux pumps. Schematic representation of the five families of drug efflux pumps in 
Gram-negative and Gram-positive bacteria: The ATP-binding cassette (ABC) superfamily, the major facilitator 
superfamily (MFS), the multidrug and toxic compound extrusion (MATE) family, the small multidrug resistance 
(SMR) family, and the resistance nodulation division (RND) family. Figure adapted from (13). 
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confers resistance towards clinically relevant antibiotics. LmrCD is a homologue of Sav1866 
in Lactococcus lactis. This ABC transporter functions as a heterodimeric transporter being 
composed of the two half-transporters LmrC and LmrD. Expression of the lmrC and lmrD genes 
is strongly upregulated by a variety of different chemicals, including daunomycin, Hoechst and 
cholate (24, 25). In Bacillus subtilis a homologue of the LmrCD ABC transporter was recently 
identified as a multidrug transporter. Based on the similarity to its counterpart in L. lactis, the B. 
subtilis transporter was named BmrCD (26, 27). Expression of the bmrC and bmrD genes was 
shown to be induced in response to antibiotics that inhibit the protein synthesis machinery (26, 
28)(Chapter 2 of this thesis). Further characterization demonstrated that BmrCD can mediate 
the transport of several known MDR pump substrates. However, despite these characteristic 
MDR features, an in vivo role for BmrCD in drug resistance has not yet been identified.  
For several other known bacterial ABC transporters, there is sufficient evidence that demonstrates 
their role in antibiotic resistance. In E. coli the ABC-transporter MacAB provides, in complex 
with the outer membrane channel TolC, resistance to macrolides (29). In S. pneumoniae the 
ABC transporter system PatAB has been associated with the fluoroquinolone resistance in 
clinical isolates (30). Recently, multiple new ABC-type resistance genes have been identified in 
several Gram-positive bacteria, including S. aureus and Enterococcus faecium. These atypical 
ABC transporters consist of two nucleotide-binding domains (NBD) and apparently lack the 
hydrophobic transmembrane component. Nevertheless, they efficiently confer resistance to 
streptogramin A, lincosamides and pleuromutilins (31, 32).
In addition to the expression of dedicated resistance proteins, bacteria can increase their tolerance 
to antibiotics by adjusting their lifestyle. By changing from a planktonic lifestyle, characterized by 
free-swimming bacteria, to growth in a so-called biofilm, bacteria can increase their antimicrobial 
tolerance by 100- to 1000-fold (33). A bacterial biofilm consists of a multitude of bacteria, 
which are often encased in a polysaccharide matrix made from so-called extracellular polymeric 
substances (34, 35). In addition, biofilm formation can be promoted by cell surface-associated 
proteins (36). Biofilms are often attached to solid surfaces and have a complex multicellular 
structure containing macro-colonies and liquid-filled channels (33) (Figure 5). Biofilms are 
notorious in, for instance, staphylococcal implant infections, urinary tract infections, periodontal 
diseases and airway infections in cystic fibrosis patients. Due to the high tolerance towards 
antimicrobials, these biofilm infections are very difficult to treat. The mechanisms causing the 
high antibiotic tolerance of bacteria in biofilms are still not completely clear, but there are most 
likely multiple factors involved. These seem to include the inability of antibiotics to penetrate 
into biofilms, slow bacterial growth rates, an altered bacterial metabolism, the presence of an 
oxygen gradient, chemical and physical properties of the extracellular biofilm matrix, and the 
presence of so-called persister cells (33, 37). 
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A clinically relevant trait of many bacterial populations is the presence of persister cells, 
which form a subpopulation of slow-growing, dormant and non-dividing cells that exhibit high 
resistance to antibiotics (Figure 6) (38, 39). Although this subpopulation consists of cells with an 
identical genetic background as the rest of the population, their low growth rate or dormant state 
protects them from the lethal action of antibiotics (40). This relates to the fact that bacteria are 
usually killed by the corruptive effects of bactericidal antibiotics on the function of key cellular 
processes. Such corruptive effects can result in the formation of toxic products or weakened cell 
walls, or they may initiate pathways that eventually result in the death of the cell. For example, 
aminoglycoside antibiotics, such as streptomycin, kanamycin, and gentamycin interfere with 
translation, which results in the production of toxic misfolded peptides (41).  Accordingly, to 
allow bactericidal antibiotics to exert their toxic effects, the targeted cellular processes have 
to be active. In dormant persister cells, the antibiotics do interact with their designated target, 
but the highly restricted metabolic state of these cells prevents the toxic effects following this 
interaction to unfold (40). 
The mechanisms controlling the formation of persister cells are presently not completely 
understood. There are studies that showed that persister cells display an increased expression 
of toxin/antitoxin (TA) modules (42, 43). The toxin encoded by a TA module inhibits essential 
cellular functions, but it can also form an inactive complex with the antitoxin component. 
The toxin is relatively stable, whereas the antitoxin is prone to proteolysis. Accordingly, the 
antitoxin needs to be expressed continuously to prevent activity of the toxin. TA modules are 
often encoded by plasmids, where they ensure plasmid maintenance. However, such modules are 
Figure 5. Schematic representation of the formation of a bacterial biofilm. Planktonic bacteria (blue) change to a biofilm-forming 
phenotype (green). The developing biofilm is often attached to a solid surface (grey), but this is not strictly necessary. Eventually, 
the biofilm-forming bacteria develop a multi-cellular structure that is incased by a self-produced extracellular matrix consisting 
of DNA, proteins, and polysaccharides. Certain bacteria in a biofilm structure demonstrate a highly increased tolerance to 
antibiotics (yellow).
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also commonly encoded by the bacterial core genomes. The roles of these genome-encoded TA 
modules are still largely unknown, but several have been implicated in persister cell formation 
(44). In E. coli, persister cell formation as a result of the SOS response is largely dependent 
on the TA module named TisAB. Induction of the SOS response upon DNA damage results in 
increased expression of the toxin TisB, which is targeted to the cell membrane. The toxin induces 
a decrease in the PMF and intracellular ATP levels, resulting in the shutdown of key cellular 
functions and thus in the formation of persister cells (45). The subpopulation of persister cells is 
generally very small, consisting of ~0.001% of the overall population during early exponential 
growth (40). The formation of persister cells is likely to be regulated by a stochastic process. 
Small cell to cell fluctuations in the concentration of dedicated proteins controlling persister cell 
formation steer the formation of this dormant sub-population. In general, the number of persister 
cells increases dramatically during late exponential and stationary growth, reaching levels of 
up to 1% of the total population. This suggests that there is, next to a stochastic process, a more 
deterministic component that is controlling persister cell formation, such as the afore-mentioned 
SOS response. Lastly, there is increasing evidence that persister cells play an important role 
in chronic infections (40). Therefore, more knowledge about the formation and characteristics 
of persister cells is key in understanding antibiotic tolerance and resistance in difficult to treat 
bacterial infections.
Figure 6. Persister cells. A fraction of a bacterial population consists of slow-growing, dormant and non-dividing 
cells. These persister cells (red) are genetically identical to the bulk of the population, but their phenotypic traits 
render them highly resistant to antibiotics. When challenged with antibiotics these persisters have a better chance of 
survival. After the antibiotic stress is relieved the persister cells can propagate to form a new population. 
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Acquired antibiotic resistance through horizontal gene transfer
Bacteria can acquire antibiotic resistance by modification of particular genes through point 
mutations or gene amplifications. The former is probably best exemplified by mutations in 
the gyrA gene, which cause resistance to fluoroquinolones, such as ciprofloxacin. The latter 
is underscored by the fact that many resistance genes are located on multi-copy plasmids(46). 
A very effective strategy for bacteria to acquire antibiotic resistance is based on the uptake 
of foreign DNA. The exchange of DNA between different bacterial strains or even different 
species of bacteria is referred to as horizontal gene transfer (HGT). This HGT is in fact an 
important feature in the development of antibiotic resistance. HGT can facilitate the acquisition 
of individual genes. However, it often involves the uptake of multiple genes by the transfer of 
mobile genetic elements (MGE’s). In fact, the MGE’s often mediate the mobility of DNA within 
genomes or between different bacterial cells. Between bacteria, the transfer of DNA can occur 
via three distinct mechanisms, namely conjugation, transduction or transformation. 
Conjugation is facilitated by conjugative plasmids or chromosomally integrated conjugative 
elements. These DNA elements encode several transfer proteins that trigger and facilitate DNA 
transfer from the donor cell to a recipient cell (47). Consequently, also antibiotic resistance 
genes can be directly transferred from one cell to another by conjugation. In the case of 
transduction, the intercellular exchange of DNA is facilitated by bacterial viruses, also known as 
bacteriophages or phages. Such phages can infect bacteria not only with phage DNA, but they 
can also transfer other DNA elements, such as chromosomal DNA segments or plasmids (47). 
Hence, chromosomal and plasmid-borne antibiotic resistance genes are often transferred between 
cells via transduction. During natural transformation, bacterial cells, which are competent for 
DNA binding and internalization (i.e. ‘competent cells’), actively take up DNA from their 
environment and incorporate this exogenous material into their own genome (48). Notably, in 
most cases, the DNA taken up from the environment will be used by the bacteria as a source of 
deoxyribonucleotides, which are essential for the replication of their own genome. However, if 
a plasmid is taken up by a competent bacterial cell, this plasmid may start to replicate in this 
cell. Moreover, if the internalized foreign DNA contains sequences that resemble parts of the 
recipient cell’s own genome, the foreign DNA can be integrated into the recipient’s genome via 
homologous recombination. This allows bacteria to acquire DNA fragments that provide them 
with an evolutionary selective advantage, which is the case when antibiotic resistance genes 
are taken up by pathogens. Many bacteria are considered to be naturally competent, including 
several notorious pathogens, such as Haemophilus influenzae, Helicobacter pylori, Legionella 
pneumophila, S. pneumoniae and S. aureus (49, 50, 51, 52, 53).
The DNA uptake system of Bacillus subtilis, a soil bacterium that is often used as a Gram-
positive model organism, has been studied particularly well. DNA uptake involves the expression 
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of at least five different loci of so-called com genes (54). Expression of these competence loci 
is regulated by the specialized competence transcription factor ComK (55). DNA uptake is 
facilitated by pilus-like structures composed of different proteins encoded by the comG operon. 
Processing of the ComG proteins by the signal peptidase ComC is needed for proper assembly 
of the ComG pilus structure (56). Once the extracellular DNA is bound, it is internalized through 
a membrane pore that is formed by the polytopic transmembrane protein ComEC. During this 
translocation event, the external DNA is processed by the membrane-localized nuclease NucA, 
resulting in linear fragments of up to 20 kb, which are taken up as single-stranded DNA (57). 
While one strand is degraded into single nucleotides, the other strand can be integrated into 
the cell’s genome by a dedicated DNA recombination machinery if homologous sequences 
are present (58). Interestingly, while the competence system of B. subtilis is relatively well 
understood, the function of a homologous competence system in S. aureus has still remained 
largely uncharacterized. Although, the genes encoding for most Com proteins have been 
identified in sequenced S. aureus strains (59) and natural competence has been reported (54, 60), 
the details of the DNA uptake mechanism in S. aureus are still elusive. More knowledge about 
competence development in S. aureus could provide novel insights into the fast evolution of this 
important human pathogen.
Novel strategies to combat the antibiotic resistance problem
As mentioned earlier in this Introduction, the antibiotic resistance problem is mainly due to 
over-usage of existing antibiotics, and the slow development of new antibiotics that is easily 
outcompeted by the development of antibiotic resistance. This has been an incentive to search 
for alternative strategies to tackle the antibiotic resistance problem. One of these is the use 
of combination therapies, wherein cocktails of different antibiotics are used to treat bacterial 
infections. It has been demonstrated that this approach is more effective in combating MDR 
bacterial infections than the extended use of individual antibiotics (61, 62). In addition, the 
combined use of antibiotics has shown to prolong the effective life-time of individual drugs 
(63). Combinations can consist of antibiotics that target different pathways, different targets of 
the same pathway, or the same target through different molecular mechanisms (64). Intriguingly, 
a recent study suggests that very potent novel antibiotics can also be identified by mining the 
genomes of so far non-cultured bacteria, as was exemplified by the identification of the antibiotic 
teixobactin, which inhibits cell wall synthesis (65). A completely different approach involves 
the therapeutic use of quorum sensing inhibitors. These molecules effectively block the bacterial 
communication pathways, thereby preventing clinically relevant bacterial behavior, such as 
the formation of persister cells and virulence (66). Another alternative approach to the use of 
traditional antibiotics is the use of antimicrobial peptides (AMPs). AMPs are produced by a 
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large range of different organism, including humans, and they provide their host with an innate 
immunity towards bacteria. These natural AMPs are 12 to 50 amino acids in length, have a broad 
antibacterial spectrum and can be directed to different cellular targets (67, 68, 69). In addition 
to these naturally occurring AMPs, it is possible to design synthetic molecules that mimic their 
shape and function, thereby extending the potential AMP pool (70). However, the downside of 
AMPs is that they are, thus far, relatively expensive to produce and that they can be antigenic. 
Despite these disadvantages several AMPs have been positively evaluated by the FDA (64). Yet 
another alternative for antibiotics can be found in the development of novel immunotherapies. 
Vaccination has proven to be a highly successful strategy against many dangerous bacterial 
infections, including diphtheria, pertussis (whooping cough), tetanus and pneumonia (71, 
72). Accordingly, the increasing incidence of infections with methicillin resistant S. aureus 
(MRSA) lineages that are difficult to treat with the available arsenal of antibiotics has become 
an incentive for studies towards the development of efficient immunotherapies to prevent (active 
immunization) or treat (passive immunization) severe invasive S. aureus infections (73). Such 
immunotherapeutic agents should target at least one, but preferably more, key component(s) 
that are of importance for bacteria during the infectious process. Ideally they should prevent 
adherence to host tissue, promote phagocyte-mediated killing, neutralize secreted toxic proteins 
and prevent quorum sensing. Target selection is therefore one of the most critical as well as 
one of the most challenging steps in the development of an efficient immunotherapeutic agent. 
In the recent period, several different attempts have been made to develop vaccines targeting 
toxins, quorum sensing, capsule, and a few cell wall-associated or secreted proteins of S. 
aureus. However, despite intense efforts, so far none of these approaches provided sufficient 
protection in clinical trials (73, 74, 75, 76). More recently, the focus has been shifted towards 
immunodominant epitopes present on the surface of S. aureus, which has led to the identification 
of several potential new vaccine targets. Time will tell which immunotherapeutic approach will 
lead to the development of an effective vaccine against S. aureus. An effective immunotherapy 
would be of significant importance in combating the rise of MDR S. aureus infections. 
Interestingly, one of the most effective approaches in the battle against MDR pathogens is 
the implementation of strict infection prevention measures in hospital settings. Hospitalized 
patients are especially vulnerable for bacterial infections due to the underlying illness that may 
render them frail and/or immunocompromised. In addition, surgical wounds represent breaches 
of the skin barrier that normally protects individuals against invasive bacteria. The increasing 
incidence of MDR bacteria makes effective treatments of hospital-acquired (HA) infections 
increasingly difficult and this problem is seriously exacerbated by the emergence of MDR 
bacteria in the general community and livestock (77, 78, 79). Due to the continuously applied 
antibiotic pressure, nosocomial and veterinary settings have become major incubators for the 
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evolution and selection of MDR bacteria. Importantly, a large fraction of the HA infections are 
directly related to contacts between patients and healthcare workers (80). Accordingly, effective 
infection prevention measures and especially hygiene protocols will diminish the incidence of 
bacterial infections in general and, thus, the spread of MDR bacteria. Notably, the most effective 
infection prevention measure is still the systematic decontamination of the hands of physicians 
and other healthcare workers in between their contacts with different patients and each other 
(80, 81). Quite clearly, the success of this and other infection prevention strategies is intimately 
related to the compliance of all healthcare workers with the established hygiene protocols. 
Scope of this thesis
This thesis addresses different aspects of the antibiotic resistance problem, which were briefly 
introduced in Chapter 1. 
In Chapter 2, the regulatory mechanism controlling the expression of bmrCD, an ABC-type MDR 
transporter of B. subtilis, is described. The expression of this ABC transporter system was found 
to be induced by several ribosome-targeted antibiotics. Intriguingly, this antibiotic-inducible 
expression of bmrCD was restricted to the late-exponential and stationary growth stages. This 
was shown to be due to regulation of bmrCD expression by the transition state regulator AbrB. 
Furthermore, this study showed that the antibiotic-induced expression of bmrCD is regulated 
via a transcriptional attenuation mechanism. Specifically, a transcriptional terminator in bmrB, 
a small gene that is co-transcribed with bmrC and bmrD, controls the transcription of these 
ABC transporter genes. In addition, the antibiotic-induced expression of bmrCD requires the 
translation of BmrB, which implies that BmrB serves as regulatory leader peptide. Altogether, 
this study represents the first example of a leader peptide-based transcriptional attenuation 
mechanism in B. subtilis controlling the expression of a multidrug ABC transporter.  
Chapter 3 describes the role of a small regulatory (s)RNA molecule named RnaC/S1022 in the 
expression of the transition state regulator AbrB of B. subtilis. In this study, it was demonstrated 
that the interaction between RnaC/S1022 and the abrB mRNA results in increased cell-to-
cell variation of the AbrB protein levels. This RnaC/S1022-induced variability in AbrB levels 
was then shown to trigger growth rate heterogeneity during exponential growth. The resulting 
establishment of distinct subpopulations of fast- and slow-growing cells seems to represent 
a bacterial survival strategy that may have important implications for the emergence of drug 
resistant persister cells. 
Chapter 4 describes a large multi-condition transcriptome study on S. aureus. A previously 
developed high-density tiling array approach was applied for the comprehensive mapping of 
transcription units, including both coding and non-coding RNAs, and other features of the 
transcriptional regulatory network of S. aureus. Most relevant for the present PhD research on 
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antibiotic resistance was the challenging of S. aureus with sub-inhibitory concentrations of the 
clinically relevant antibiotics ciprofloxacin, clindamycin, erythromycin, flucloxacillin, linezolid, 
trimethoprim (TMP) - sulfamethoxazole (SMX), and vancomycin. Generally, the effects of these 
antibiotics on the S. aureus transcriptome were very minor at sub-inhibitory concentrations. The 
most eminent response was observed for the fluoroquinolone ciprofloxacin, which induced the 
transcription of prophage genes. This is in line with the view that ciprofloxacin may trigger HGT 
events through prophage induction. Altogether, the tiling array study described in Chapter 4 
provides novel insights into the rearrangements that will occur in the transcriptional network of 
S. aureus under a range of different conditions.     
In Chapter 5 the processing pathway of the S. aureus pseudopilin ComGC is described. The 
results show that ComGC is likely to form a pilus-like structure that is localized to the cytoplasmic 
membrane and cell wall of S. aureus. The stability of the ComGC protein is dependent on the thiol-
disulphide oxidoreductase DsbA, indicating that the ComGC pseudopilin contains a disulphide 
bond, similar to what was previously described for its B. subtilis homologue. In addition, it 
was demonstrated that optimal cell surface exposure of ComGC relies on the expression of 
the pseudopilin-specific signal peptidase ComC. Altogether, the results described in Chapter 5 
provide novel insights into the biogenesis of the Com system of S. aureus, which is likely to be 
of relevance in the acquisition of antibiotic resistance genes by this important human pathogen. 
Chapter 6 describes a study aimed at thoroughly profiling the cell surface-exposed staphylococcal 
proteome by using different trypsin-based surface shaving approaches combined with gel-free 
mass spectrometry (MS). A selection of cell wall-attached proteins that were identified using 
this approach, were screened for their immunogenicity using immunoglobulin G samples from 
epidermolysis bullosa patients, who are heavily colonized with S. aureus. This resulted in the 
identification of immunodomintant epitopes from several surface-exposed proteins. These 
epitopes could prove to be useful targets for the development of an effective anti-staphylococcal 
vaccine. 
The proof-of-principle study described in Chapter 7 investigated the feasibility of a polymer-
based antimicrobial hand rub that might serve as an alternative for the alcohol-based sanitizers 
currently used in hand disinfection by health care workers. The most suitable polymer formulation 
was selected from a collection of different polymer formulations. It consists of a co-polymer 
of Polyvinylpyrrolidone (PVP), an excipient widely used in the pharmaceutical industry, and 
derivatized maleate, which was supplemented with 0.9% benzalkonium chloride (BKC). The 
study demonstrates that the application of this polymer formulation provides protection against 
newly acquired microbial contaminants for a period of at least three hours. After use, the hand 
rub is readily removed by hand washing and, thus, it does not interfere with established hygiene 
regimens. It is anticipated that the successful development and implementation of disinfecting 
General Introduction and Scope
23
hand sanitizers with a so-called ‘microglove function’ will lead to further improvements in 
infection prevention, especially in nosocomial settings.
Finally, Chapter 8 summarizes the results described in this thesis, and their implications in 
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The multidrug ABC transporter BmrC/BmrD of 
Bacillus subtilis is regulated via a ribosome-mediated 
transcriptional attenuation mechanism







Expression of particular drug transporters in response to antibiotic pressure is a critical element 
in the development of bacterial multidrug resistance, and represents a serious concern for human 
health. To obtain a better understanding of underlying regulatory mechanisms, we have dissected 
the transcriptional activation of the ATP-binding cassette (ABC) transporter BmrC/BmrD of 
the Gram-positive model bacterium Bacillus subtilis. By using promoter-GFP fusions and Live 
Cell Array technology, we demonstrate a temporally controlled transcriptional activation of 
the bmrCD genes in response to antibiotics that target protein synthesis. Intriguingly, bmrCD 
expression only occurs during the late-exponential and stationary growth stages, irrespective of 
the timing of the antibiotic challenge. We show that this is due to tight transcriptional control 
by the transition state regulator AbrB. Moreover, our results show that the bmrCD genes are 
co-transcribed with bmrB (yheJ), a small open reading frame immediately upstream of bmrC 
that harbors three alternative stem-loop structures. These stem-loops are apparently crucial for 
antibiotic-induced bmrCD transcription. Importantly, the antibiotic-induced bmrCD expression 
requires translation of bmrB, which implies that BmrB serves as a regulatory leader peptide. 
Altogether, we demonstrate for the first time that a ribosome-mediated transcriptional attenuation 
mechanism can control the expression of a multidrug ABC transporter.
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Introduction
Since the clinical introduction of antibiotics, bacteria have evolved efficient mechanisms to 
counteract their effects. This has resulted in the emergence of multidrug resistant (MDR) bacterial 
pathogens, which is a serious threat to public health as the treatment of infections caused by these 
pathogens is becoming increasingly difficult (1). An effective strategy for bacteria to achieve 
resistance to a multitude of antibiotics is the expression of efflux pumps, such as ATP-binding 
cassette (ABC) transporters, that can actively excrete harmful substances from the cell (1, 2). 
The model bacterium Bacillus subtilis, a close relative of notoriously drug-resistant Gram-
positive bacteria such as Staphylococcus aureus, is equipped with an extensive repertoire of 
genes that encode for potential drug efflux transporters (3). These include a significant number 
of ABC transporters (4). Eight of the 78 ABC transport systems that are encoded by the genome 
of B. subtilis have been classified as potential MDR-like transporters (4). Among these eight 
is the heterodimeric ABC transporter YheI/YheH, which was renamed BmrC/BmrD (in short 
BmrCD) due to its homology to the LmrC/LmrD ABC transporter of Lactococcus lactis (5). 
BmrCD was the first multidrug ABC transporter in B. subtilis that was shown to function as a 
heterodimer. Torres et al. (6) used inside-out membrane vesicles to demonstrate that BmrCD can 
mediate efflux of several fluorescent substrates of MDR-ABC transporters, including Hoechst 
33342, doxorubicin and mitoxantrone. In addition, they investigated the transcriptional response 
of B. subtilis to sub-inhibitory concentrations of 46 different antibiotics. Eleven of these 
antibiotics, most of which act as inhibitors of protein synthesis, were shown to significantly 
increase the transcription of the bmrCD operon (6). These included ribosome-targeted antibiotics, 
such as chloramphenicol, erythromycin and gentamycin, which was consistent with an earlier 
study on antibiotic-induced gene expression in B. subtilis (7). 
In the present study, we have dissected the transcriptional regulation of the bmrCD genes in 
response to ribosome-targeted antibiotics to obtain a better understanding of the underlying 
regulatory mechanisms. The results show that induction of bmrCD is controlled at two levels. 
Firstly, this process is tightly restricted to the transition- and stationary growth phases by the 
main transition state regulator AbrB. Secondly, we show that antibiotic-induced expression of 
bmrCD is regulated via a dedicated ribosome-mediated transcriptional attenuation mechanism 
that requires the yheJ-encoded leader peptide. In view of the location of yheJ immediately 
upstream of bmrC, and the intimate relationship between yheJ translation and the expression of 




Plasmids, bacterial strains and growth condition
The plasmids and bacterial strains used in this study are listed in Supplementary Table S1, 
and the primers used for plasmid constructions in Supplementary Table S2. B. subtilis 168 
and Escherichia coli TG1 were grown with vigorous agitation in Lysogeny broth (LB; Difco 
laboratories) at 37°C. Where appropriate, the growth medium was supplemented with antibiotics: 
ampicillin 100 μg/mL, spectinomycin 100 μg/mL, chloramphenicol 5 μg/mL (B. subtilis) or 10 
μg/mL (E. coli). 
Construction of chromosomally integrated transcriptional 5’-gfp fusions
Transcriptional gfp fusions were constructed using the integrative pBaSysBioII plasmid, as 
described previously (8). The 5’ upstream regions of bmrB or bmrC were amplified by PCR 
with the Phusion® Hot Start High-Fidelity DNA Polymerase (Finnzymes, NEB), and then 
joined with the pBaSysBioII plasmid by Ligation-Independent Cloning (LIC). The resulting 
plasmids were used to transform B. subtilis 168 as described by Kunst and Rapoport (9). Since 
pBaSysBioII cannot replicate in B. subtilis, its derivatives carrying the cloned 5' upstream 
regions of bmrB or bmrC integrated at the respective loci via single cross-over recombination. 
This placed the respective gfp fusion in single copy on the chromosome at the original locus and, 
at the same time the sequence cloned in pBaSysBioII was duplicated (for details see 8).  For 
each transcriptional-GFP fusion, three independent clones were selected and used for further 
experiments. In addition, genomic DNA isolated from one of these clones was used as a template 
to PCR-amplify the complete or a truncated version of the respective transcriptional GFP fusion. 
The resulting PCR-amplified fragments were cloned into pRMC, a LIC-adapted derivative of the 
pXTC plasmid (10) that allows the incorporation of genes via double cross-over recombination 
into the chromosomal amyE gene. Importantly, the xylose-inducible promoter of pXTC was 
removed from pRMC, making this plasmid suitable for driving GFP expression exclusively 
from inserted promoter- and regulatory sequences. Integration of the different transcriptional 
GFP fusions into the amyE locus was confirmed by growing transformants on starch-containing 
plates and testing the absence of α-amylase secretion by staining of the plates with iodine as 
described previously (10). 
Construction of plasmid-borne transcriptional bmrB-gfp fusions
Plasmid pRM3 was constructed by combining the backbone of plasmid pHB201 (11) with the 
xylose-inducible promoter from pXTC (10) using circular polymerase extension cloning and 
primers listed in Table S2 (12). In this manner, the AscI LIC site was introduced into pRM3 by 
primer overlap. Two different fragments of bmrB including the 5’UTR and coding sequence, 
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either with or without the terminator region, were amplified by PCR. The resulting DNA 
fragments were fused by overlap-PCR with gfpmut3, including an optimal ribosome-binding site 
(RBS) (8). The resulting overlapped PCR-products were gel-extracted and cloned into plasmid 
pRM3 via LIC (13) resulting in plasmids pRM3-bmrB162 and pRM3-bmrB109. Mutations in 
pRM3-bmrB∆Term were introduced by site-directed mutagenesis using the bmrB-gfp fusion 
of pRM3-bmrB162 as a template. For this purpose, bmrB-gfp was amplified by PCR in two 
separate fragments, one of which included the required mutations. Subsequently, these PCR 
fragments were joined by overlap-PCR, gel-extracted and cloned into plasmid pRM3 via LIC. 
The sequences required for pRM3-bmrB∆start and pRM3-bmrB−CodonOpt, were commercially 
synthesized by Integrated DNA Technologies (http://eu.idtdna.com/). PCR fragments of these 
synthesized sequences, consisting of the front part of bmrB, were fused to the terminator region 
and GFP by overlap-PCR.  
Live cell array analyses
Live cell array (LCA) analyses with B. subtilis were performed as described previously (8, 14, 
15). All strains used for LCA analysis were grown overnight in LB, diluted 1000-fold and grown 
in 100 µl cultures in 96-well flat bottom microtiter plates (Greiner Bio-One). Cultures were 
grown for 14 h in a Biotek synergy 2 plate reader, monitoring both growth by optical density 
readings at 600 nm (OD600nm) and GFP fluorescence (excitation 485/20 nm, emission 528/20 
nm) at 5- or 10-min intervals. The promoter-GFP strains were either exposed to sub-inhibitory 
concentrations of antibiotics or mock-treated during early exponential growth (OD600nm corrected 
for 1 cm path length = ~0.5). Background fluorescence from the isogenic wild-type control strain 
not expressing GFP was subtracted. Arbitrary transcriptional activity units (TAU) represent the 
increase in GFP expression levels during each 5- or 10-min interval and were calculated using 
the equation: (GFPt-GFPt-1)/OD600
t (where t represents a given time point at which fluorescence 
was measured, and t-1 the preceding time point at which fluorescence was measured). 
Expression of the transcriptional-GFP fusions on pRM3 was induced in exponentially growing 
cells (OD600nm ~0.18) by the addition of xylose (0.1% final concentration) either with or without 
supplementation of lincomycin (0.75 µg/mL). For the experiments with strains containing 
pRM3-borne gfp fusions, the final GFP activity levels were corrected by subtracting the GFP 
activity levels measured for non-induced cultures. The xylose-induced GFP activity levels thus 
obtained were expressed in arbitrary units (AU). Data depicted in the LCA Figures were derived 
from one of three representative experiments. 
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RNA extraction, reverse transcription and real-time PCR
B. subtilis 168 was inoculated from an overnight culture into 150 mL LB medium to an OD600 
of 0.05. During exponential growth (OD600 ~0.6) the cells were either mock-treated or exposed 
to lincomycin (0.5 µg/mL) for 150 min. Next, total RNA was extracted according to the method 
described by Eymann et al. (16). The RNA was reverse transcribed into cDNA using Taqman 
RT-PCR reagents (Applied Biosystems®, LifeTechnologies) according to the manufacturers 
protocol. The resulting cDNA was used as a PCR template to confirm the structure of the bmrB/
bmrC/bmrD operon (in short bmrBCD) with Taq polymerase (Life Technologies) and the qPCR 
primers bmrB-foward and bmrC-reverse (Table S2). Real-time quantitative PCR (GoTaq® 
qPCR Master Mix, Promega) was performed according to the manufacturers protocol using an 
Applied Biosystems® 7500 Real-time PCR system and the primer sets specified in Table S2. The 
recF and ssrA genes were included as reference genes. Data analysis was carried out using the 
accompanying Applied Biosystems® software package (v.2.0.5).
Results
Transition phase-dependent induction of bmrCD by ribosome-targeted antibiotics
The BmrCD ABC transporter was previously shown to be regulated by exposure to several 
ribosome-targeted antibiotics (6, 7). To gain further insights into the mechanisms involved in this 
regulation, the genomic environment of the bmrCD genes was carefully mapped using data from a 
recent high-resolution transcriptional analysis of B. subtilis grown under 104 different conditions 
(17). Based on these data, which are schematically represented in Supplementary Figure S1A, 
we postulated that the bmrC and bmrD genes are co-transcribed with bmrB (previously known 
as yheJ), a small and as yet uncharacterized gene of 162 bp that ends 119 bp upstream from the 
start codon of bmrC (Figure 1, A and B). This view was confirmed by a reverse transcription 
PCR analysis (Figure S1B). It thus seems that the bmrBCD operon is transcribed from a conjoint 
promoter which, according to the B. subtilis Expression Data Browser (http://genome.jouy.inra.
fr/seb), is located ~70 bp upstream of bmrB (Figure 1B). 
To gain further insight into the mechanisms involved in bmrCD expression, we transcriptionally 
fused the 600-bp region upstream from the -18 position of bmrC to gfp and integrated one 
copy of this fusion by single cross-over recombination into the native bmrC locus of the B. 
subtilis chromosome (Figure 1A). The resulting strain 168 BSBII-5’bmrC-gfp was then used to 
monitor the antibiotic-induced expression of bmrCD in ‘real-time’ following the Live Cell Array 
approach as detailed in the Materials and Methods. To determine the base-line gfp expression 
in B. subtilis 168 BSBII-5’bmrC-gfp, this strain was cultured in LB without antibiotics. As 
shown in Figure 2A, relatively little transcriptional activity (~500 TAU) was detectable during 
exponential growth, but the activity increased during the late transition- and early stationary 
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growth phases to ~1950 TAU. Next, exponentially growing cells (OD600nm ~0.5) carrying the 
5’bmrC-gfp fusion were exposed to sub-inhibitory concentrations of the ribosome-targeted 
antibiotics chloramphenicol (0.2 μg/mL), erythromycin (0.02 μg/mL), lincomycin (0.2 μg/
mL), kanamycin (0.2 μg/mL), or gentamycin (0.2 μg/mL). The addition of chloramphenicol or 
erythromycin resulted in a slight reduction in the growth rate and a slight drop in the maximum 
OD600nm that was reached (Figure 2A). Following addition of either of these two antibiotics, 
the transcriptional activity of the 5’bmrC-gfp fusion remained unaltered at baseline levels for 
~75 min and then increased during a period of ~50 to 200 min to a maximum (~4350 to 5900 
TAU, respectively) after which it gradually returned to baseline levels. Interestingly, while the 
presence of 0.2 μg/mL lincomycin had no inhibitory effect on growth, it triggered the strongest 
Figure 1. Genomic context of the bmrCD locus and transcriptional GFP fusions. (A) The top line depicts the 
genomic context of the ABC transporter genes bmrC and bmrD, which are preceded by the small open reading 
frame bmrB. The two lines below represent the relative positions of the two regions selected for construction of the 
transcriptional 5’bmrC-gfp and 5’bmrB-gfp fusions. (B) Detailed representation of the regulatory region upstream 
of bmrC, including the segment of bmrB (nucleotides 60-162) in which predicted terminator, anti-terminator, 
and anti-anti-terminator structures are encoded. These three putative structures are assigned with their nucleotide 
positions relative to the first nucleotide of bmrB. The black arrowhead marks nucleotide 109 after which bmrB was 
truncated in pRM3-bmrB109. In addition, the 5’UTR upstream of bmrB and the intergenic region between bmrB 
and bmrC are indicated. (C) Structures of the putative anti-anti-terminator, anti-terminator and terminator, with 
their respective sizes and Gibbs free energy (ΔG) values, as predicted by RibEx: Riboswitch Explorer. The overlap 
in the terminator and anti-terminator structures is marked in bold, and the overlap in the anti-terminator and anti-
anti-terminator structures is marked by underlining.
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Figure 2. Live cell array real-time analysis of bmrCD transcription. (A) Growth of B. subtilis BSBII-5’bmrC-
gfp (OD600nm; grey line) and bmrC transcriptional activity (solid black line) in response to the ribosome-targeted 
antibiotics chloramphenicol, erythromycin, lincomycin, kanamycin or gentamycin. Arrows indicate the time points 
at which antibiotics or an equivalent volume of water (‘no antibiotics’) were added. (B) Dose-dependent response 
of 5’bmrC-gfp transcription to increasing concentrations of lincomycin. Bold lines indicate transcriptional activity 
and thin lines indicate bacterial growth. The arrow indicates the time point at which lincomycin was added. (C) 
Transcriptional response of B. subtilis BSBII-5’bmrC-gfp to an early exposure to lincomycin. The bold line indicates 
transcriptional activity and the dashed line indicates bacterial growth. Lincomycin (final concentration: 0.02 µg/
mL) was added at the start of the culture, as indicated by the arrow. Cultures entered the transition phase between 
exponential and post-exponential growth at OD600 of ~1.
induction of the 5’bmrC-gfp fusion (Figure 2A). After a ~75-min delay, lincomycin induced the 
transcriptional activity of the 5’bmrC-gfp fusion to a maximum of ~11800 TAU and this level 
was sustained for ~90 min before returning to baseline. In contrast, the antibiotics kanamycin 
and gentamycin did not induce the 5’bmrC-gfp fusion. The latter observation was unexpected as 
earlier studies had suggested that gentamycin would induce bmrCD expression (6), a finding that 
we were unable to reproduce. In fact, the gfp transcription even seemed to decrease in response 
to these antibiotics. In this respect it is noteworthy that the latter two antibiotics target the 30S 
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ribosomal subunit, while the bmrCD-activating antibiotics chloramphenicol, erythromycin and 
lincomycin are specific for the 50S subunit. 
We subsequently verified the dose-dependence of the response to the most potent inducer of 
bmrCD transcription, lincomycin, by subjecting B. subtilis 168 BSBII-5’bmrC-gfp to increasing 
concentrations of lincomycin. This showed that the transcriptional response towards lincomycin 
was indeed dose-dependent (Figure 2B). The lowest concentration of lincomycin, (0.02 μg/mL) 
induced the 5’bmrC-gfp fusion to a maximum of ~5800 TAU. By increasing the lincomycin 
concentration 10-fold (0.2 μg/mL), the transcriptional activity was doubled, and a further 10-
fold increase (2 μg/mL) induced the bmrC promoter activity to ~17800 TAU. This relatively 
high concentration of lincomycin slightly affected growth of the 168 BSBII-5’bmrC-gfp strain 
(Figure 2B). 
Intriguingly, the transcription of bmrCD was highly growth phase-dependent as evidenced by the 
~75-min delay between the administration of chloramphenicol, erythromycin or lincomycin and 
the induction of promoter activity. Specifically, this delayed promoter activation coincided with 
the late transition stage in growth. To further investigate the apparent growth phase-dependent 
transcriptional activation of bmrCD, lincomycin (0.02 μg/mL) was administered to the culture 
at the start of the experiment (T0; Figure 2C). Also in this case, the 5’bmrC-gfp fusion remained 
largely silent until the ~300 min time point after which its activity increased to a peak of ~9100 
TAU. The GFP activity remained constant for ~200 min before returning to basal level. Thus, 
transcriptional activation of bmrCD followed exactly the same pattern as observed when the 
antibiotic was added after 200 min of growth. This shows that bmrCD expression as reflected by 
the 5’bmrC-gfp fusion is tightly regulated in a growth-phase dependent manner.
To exclude the possibility that the delayed transcriptional response of the 5’bmrC-gfp fusion 
was caused by a direct effect of the antibiotics on GFP expression levels, a strain with an IPTG-
inducible transcriptional 5’-GFP fusion, B. subtilis 168 BSBII spac-gfp, was included in the 
experiments (Supplementary Figure S2). A final concentration of 0.1 mM IPTG was added 
to exponentially growing bacteria, which, as expected, resulted in an immediate and strong 
induction of the spac-gfp fusion. Importantly, the addition of lincomycin (2.0 μg/mL) had no 
detectable effect on the IPTG-induced GFP production, excluding a direct inhibitory effect 
of this antibiotic on the production of active GFP. Taken together, these observations imply 
that bmrCD expression is induced by a sub-set of ribosome-targeted antibiotics, and that this 
induction is limited to the late transition- and early stationary growth phases.
 
The bmrBCD promoter determines growth phase-controlled bmrCD expression
Notably, the 5’bmrC-gfp fusion was constructed to monitor bmrCD transcription and, for this 
purpose, the 600-bp region directly upstream of bmrC was cloned into pBaSysBioII. As a 
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consequence, transcription of the 5’bmrC-gfp fusion was not only subject to control by the 
upstream bmrBCD promoter region, but also to possible regulatory sequences within bmrB 
(Figure 1A). To establish whether the antibiotic-induced and temporally-controlled transcription 
of bmrCD could be entirely attributed to the bmrBCD promoter, a second pBaSysBioII-based 
GFP reporter fusion was constructed using the 600-bp region directly upstream of bmrB (Figure 
1A). One copy of the resulting transcriptional 5’bmrB-gfp fusion was introduced by single cross-
over recombination into the bmrB locus of the B. subtilis chromosome. Next, the resulting strain 
BSBII-5’bmrB-gfp was grown under the same antibiotic stress conditions as described above. 
As shown in Figure 3 (A and B), the 5’bmrB-gfp fusion displayed a growth phase-dependent 
expression profile, similar to the 5’bmrC-gfp fusion. In all tested conditions, the 5’bmrB-gfp 
fusion was activated during the transition from exponential to stationary growth (Figure 3, A and 
B), matching the time point of the antibiotic-induced activation observed in the BSBII-5’bmrC-
gfp strain (Figure 2). However, the BSBII-5’bmrB-gfp strain did not respond to the antibiotics 
chloramphenicol, erythromycin and lincomycin (Figure 3A), which induced the transcription 
of bmrCD. This led to the hypothesis that particular features within the upstream region of 
bmrCD could be responsible for antibiotic-induced transcription of the two ABC transporter 
genes. Subsequent in silico analysis of the region upstream of bmrC revealed a perfect intrinsic 
terminator-like structure within the coding region of bmrB, together with alternative anti-
terminator and anti-anti-terminator structures as defined by the RibEx: Riboswitch Explorer 
algorithm (18) (Figure 1, B and C). 
Conceivably, the terminator structure within bmrB could play a role in the antibiotic-induced 
activation of the 5’bmrC-gfp construct while, as indicated above, expression of the complete 
bmrBCD operon is most likely directed from the promoter located upstream of bmrB. Expression 
of the bmrCD transporter genes however, would rely on the decision of the RNA polymerase 
to either stop transcription at the terminator site or continue transcription of bmrCD. As a first 
approach to test this idea, the BSBII-5’bmrC-gfp and BSBII-5’bmrB-gfp strains were monitored 
in parallel and lincomycin was added to the BSBII-5’bmrC-gfp strain directly after the first 
fluorescence signal from BSBII-5’bmrB-gfp strain was detectable (Figure 3C). The addition of 
lincomycin at this point resulted in an immediate transcriptional response in the BSBII-5’bmrC-
gfp strain (Figure 3, C and D). This showed that the onset of transcription of bmrB coincides 
with the onset of antibiotic-induced transcription of bmrCD, and it was in agreement with our 
hypothesis that the putative terminator in bmrB controls the antibiotic-induced transcription 
of bmrCD. To provide additional evidence for lincomycin induction of the bmrCD genes, we 
isolated RNA from B. subtilis 168 cultures that were either treated with 0.5 μg/mL lincomycin 
or mock-treated. Real-time quantitative PCR demonstrated that the relative expression level 
of bmrB was stable in these conditions, whereas transcription of bmrC was increased 5- to 
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Figure 3. Live cell array real-time analysis of bmrB transcription. (A) Growth of B. subtilis BSBII-5’bmrB-gfp 
(OD600nm; grey line) and bmrB transcriptional activity (solid black line) in response to chloramphenicol, lincomycin, 
or erythromycin. Arrows indicate the time points at which antibiotics or an equivalent volume of water (‘no 
antibiotics’) were added. Cultures entered the transition phase between exponential and post-exponential growth at 
OD600 of ~1. (B) Graphs from raw GFP values as recorded with the Biotek synergy 2 plate reader. These raw values 
were used to calculate the transcriptional activity units (TAU) in panel A. Note that details of the transcriptional 
activity profiles in panel A are partly obscured by background noise. (C and D) Lincomycin-induced transcription 
of the 5’bmrC-gfp fusion coincides with the time point at which transcription of the bmrB-gfp fusion starts to 
increase. Strains carrying the 5’bmrB-gfp fusion or the 5’bmrC-gfp fusion were grown in parallel; lincomycin was 
added to the BSBII-5’bmrC-gfp strain once GFP fluorescence in the BSBII-5’bmrB-gfp strain started to increase. 
Note that panel C shows the raw GFP expression levels while panel D shows transcriptional activity units. (E) 
Quantitative real-time PCR analysis on RNA isolated from B. subtilis 168 during transition-phase growth, either in 
the presence or absence of lincomycin (0.5 µg/mL).
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7-fold in lincomycin-treated cells (Figure 3E). This was in full agreement with the data obtained 
from the experiments with the promoter GFP fusions. Furthermore , we verified that there is no 
alternative promoter within bmrB that controls the antibiotic-induced transcription of bmrCD 
by removing the bmrB promoter region from the 5'bmrC-gfp fusion. Both the truncated and 
complete 5'bmrC-gfp fusions were cloned into pRMC and were integrated into the amyE locus. 
The complete 5'bmrC-gfp fusion was inducible by lincomycin, whereas the truncated 5'bmrC-gfp 
fusion lacking the bmrB promoter region was not inducible and displayed only baseline levels 
of GFP (Supplementary Figure S3). Together these findings verified that transcription of the 
bmrBCD operon is indeed initiated from a promoter upstream of bmrB. This conjoint promoter 
is activated during the transition- and early-stationary growth stages and is not responsive to 
ribosome-targeted antibiotics such as lincomycin. 
The transition state regulator AbrB represses transcription of the bmrBCD operon during 
exponential growth
Since expression of the bmrBCD operon was strictly retained to the transition and early-stationary 
growth stages, we investigated whether this could be attributed to the transition state regulator 
AbrB. Supporting this idea, a potential AbrB-binding site upstream of bmrB was previously 
identified in a genome-wide AbrB-binding study (19). In addition, Chumsakul et al. showed 
that transcription of bmrBCD was elevated in an abrB deletion mutant, where bmrB and bmrCD 
mRNA levels increased by four- and two-fold, respectively. To verify that AbrB represses the 
early transcriptional activation of the bmrBCD operon, we introduced the 5’bmrC-gfp fusion 
into a ∆abrB background. Indeed, the abrB deletion resulted in derepression, precluding the 
growth phase-dependent expression of the 5'bmrC-gfp fusion (Figure 4, lower panel). When 
exponentially growing ∆abrB cells with the 5’bmrC-gfp fusion were subjected to lincomycin (0.2 
g/mL), this resulted in a strong expression of GFP. However, in contrast to the abrB-proficient 
strain, which displayed the reported delay, the transcriptional activation of the 5’bmrC-gfp 
fusion in response to lincomycin was considerably faster in the ∆abrB strain (Figure 4, upper 
panel). Transcriptional activation occurred within 20 min after the addition of lincomycin. We 
therefore conclude that transcription of the bmrBCD operon is restrained to the transition and 
early-stationary growth stages via repression by the global transition-state regulator AbrB.
The intrinsic terminator within the bmrB-coding region controls the expression of bmrCD 
As demonstrated in our LCA experiments, the promoter controlling the expression of the 
bmrBCD operon itself proved to be unresponsive towards the tested antibiotics. Therefore, we 
next determined whether the antibiotic-induced expression of bmrCD could be regulated via 
the putative intrinsic terminator located within the bmrB sequence. To test this hypothesis, we 
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constructed two transcriptional GFP fusions consisting of either a complete (1-162 bp) or a 
truncated version (1-109 bp) of the bmrB-coding sequence, the latter lacking the terminator 
region. In addition, the 5’ untranslated region (UTR), assigned according to the B. subtilis 
Expression Data Browser (17), was included in the design (Figures 5A and S1). The two 
resulting transcriptional GFP fusions were cloned into pRM3, a plasmid for xylose-inducible 
gene expression in B. subtilis. Specifically, the resulting plasmid pRM3-bmrB162 carried the 
complete bmrB sequence, while pRM3-bmrB109 carried the truncated version of bmrB (Figure 
5A). Strains expressing these transcriptional fusions upon induction with 0.1% xylose (final 
concentration; w/v) were monitored for growth and GFP production in the presence or absence 
of 0.75 μg/mL lincomycin.
When pRM3-bmrB162 was induced with xylose, GFP fluorescence increased gradually to a 
maximum of ~22 AU (Figure 5B). The fact that we observed expression of GFP was an indication 
that the gfp gene was transcribed and translated. In addition, this observation demonstrated that 
although the bmrB terminator is present in pRM3-bmrB162, it was not able to prevent transcription 
of gfp completely. By co-induction with xylose and lincomycin, the GFP fluorescence from 
Figure 4. AbrB determines the growth phase-dependent transcription of bmrCD. The upper panel shows the 
transcriptional activity (TAU) of the 5’bmrC-gfp fusion in the parental strain B. subtilis 168 (thick grey line) and 
in an abrB deletion mutant (thick black line) upon lincomycin induction. The thin lines depict growth of the abrB-
proficient (grey) and abrB-deficient (black) strains carrying the 5’bmrC-gfp fusion. Lincomycin was added to the 
cells during exponential growth as indicated with an arrow. The lower panel shows the transcriptional activity 
(TAU) of the 5’bmrC-gfp fusion in the parental strain 168 (thick grey line) and the abrB deletion mutant (thick 
black line) grown in the absence of lincomycin. Note that the patterns of the expression profiles for strain 168 are 
qualitatively similar to those shown in Figures 2 and 3D, but that the arbitrary TAU are quantitatively different due 
to the use of plate readers with different detector sensitivity.
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pRM3-bmrB162 was more than doubled, reaching ~53 AU. Lincomycin alone did not induce 
expression of GFP. This indicates that lincomycin has no influence on transcription initiation, 
but rather enhances the transcriptional elongation of bmrB. 
To assess whether the bmrB terminator was involved in the lincomycin-mediated control, we 
used pRM3-bmrB109. In the strain carrying this plasmid, xylose-induced GFP levels reached 
a maximum of ~33 AU (Figure 5C), which is a slightly higher level than that observed for the 
strain carrying pRM3-bmrB162 (Figure 5B). However, by removing the terminator sequence, 
the lincomycin-mediated control of the xylose-induced GFP expression was completely lost. B. 
subtilis pRM3-bmrB109 induced with xylose and lincomycin, produced fluorescence levels of 
~31 AU, which were similar to those of the xylose-induced strain without lincomycin (Figure 
5C). The latter shows that the region containing the bmrB terminator sequence is essential for the 
lincomycin-mediated control observed for pRM3-bmrB162. To verify the role of the terminator 
Figure 5. The 3’ end of bmrB is required for lincomycin-induced bmrCD transcription. (A) Schematic representation 
of a part of plasmids pRM3-bmrB162 and pRM3-bmrB109. pRM3-bmrB162 was constructed by fusing the complete 
sequence of bmrB and its 5’-UTR to the gfp gene. pRM3-bmrB109 was constructed by fusing a truncated version 
of bmrB, consisting of this gene’s first 109 nucleotides to gfp. Accordingly, pRM3-bmrB109 lacks the predicted 
terminator within bmrB and part of the predicted anti-terminator. Panels B and C show the GFP fluorescence of 
B. subtilis carrying pRM3-bmrB162 (B) or pRM3-bmrB109 (C) in response to xylose, lincomycin (0.75 µg/mL), 
or a combination of xylose and lincomycin added at the time-points indicated by arrows. Xylose-induced GFP 
fluorescence, given in arbitrary units (AU), was used as measure for the level of gfp expression.
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structure in controlling the lincomycin-induced transcription of bmrCD, we constructed pRM3-
bmrB∆Term (Figure 6A). In this reporter construct the formation of the terminator is precluded, 
according to a RibEx: Riboswitch Explorer (18) prediction, due to the introduction of two C to G 
point mutations at positions 136 and 140 (Figure 6, A and B). In B. subtilis pRM3-bmrB∆Term, 
the induction with xylose alone was already sufficient to reach maximum GFP levels of ~109 
AU, which corresponded to a ~5-fold increase compared to xylose-induced expression of the 
bmrB162-gfp fusion (Figure 6C). Importantly, lincomycin-mediated control of GFP expression 
was completely absent in the strain carrying pRM3-bmrB∆Term. Induction with xylose and 
lincomycin resulted in an average GFP level of ~115 AU, which was comparable to that observed 
in the xylose-induced cultures without lincomycin (Figure 6C). Firstly, these observations 
imply that formation of the terminator structure is essential for lincomycin-mediated control 
of bmrCD expression. Secondly, the elevated GFP expression due to the two point mutations 
in the bmrB∆Term-gfp fusion indicates that the predicted terminator does indeed set a limit to 
the expression of bmrCD. Finally, the findings presented in Figure 6C show that lincomycin can 
significantly enhance GFP expression in strains containing the bmrB162-gfp fusion, but that this 
Figure 6. The terminator in bmrB is required for lincomycin-induced bmrCD transcription. (A) Schematic 
representation of a part of plasmid pRM3-bmrB∆Term. Nucleotides 79-162 of the intact bmrB gene and its 
bmrB∆Term derivative are shown; C to G point mutations at positions 136 and 140 are marked with an asterisk 
(*). The predicted terminator sequence is underscored. (B) Predicted structure of the terminator sequence with 
the position of the C to G point mutations marked in bold and with an asterisk (*) (C) Maximum GFP expression 
levels measured for B. subtilis strains carrying pRM3-bmrB162 (marked bmrB162) or pRM3-bmrB∆Term (marked 
bmrB∆Term) upon induction with xylose (white bars) or xylose and 0.75 µg/mL lincomcyin (black bars).
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antibiotic cannot completely prevent the termination event, at least at the applied lincomycin 
concentration. It thus seems that antibiotic-induced transcription of bmrCD is at least partly 
controlled via the intrinsic terminator within bmrB. Noteworthy was the observed discrepancy 
between the GFP expression levels directed from pRM3-bmrB109 (Figure 5C) and pRM3-
bmrB∆Term (Figure 6C). This observation suggests that the removal of 53 bp of the 3’end of 
brmB, including the terminator plus a part of the putative anti-terminator structure (Figures 1B 
and 5A), has a negative influence on the GFP expression levels. In this respect, the use of point 
mutations, as applied in pRM3-bmrB∆Term, represents a more commendable strategy.
Transcription of bmrCD is controlled via a ribosome-mediated attenuation mechanism
With the aid of pRM3-bmrB109 and pRM3-bmrB∆Term, we demonstrated that the terminator 
within the coding region of bmrB is able to regulate the expression of the downstream bmrCD 
genes via a transcriptional attenuation mechanism, which seems responsive to several ribosome-
targeted antibiotics. We therefore aimed to further characterize the molecular details of this 
antibiotic-mediated regulatory mechanism. Although their precise mechanism of action varies, 
all ribosome-targeted antibiotics interfere with protein synthesis. Since bmrB contains a 53 
amino acid ORF, we wondered whether bmrB could encode a potential leader peptide involved 
in the regulation of transcriptional read-through via its translation. 
To determine whether bmrB is translated and could thus function as a regulatory leader peptide, we 
constructed a translational BmrB-GFP fusion, using the pMUTIN-GFP chromosomal integration 
plasmid (20). In this case, gfp was fused in-frame with the predicted bmrB-coding sequence at 
the bmrB locus (Supplementary Figure S4A). However, cells containing this construct showed 
no detectable GFP fluorescence. To test whether this was due to low-level expression of BmrB-
GFP from the single-copy gene fusion on the chromosome, the in-frame bmrB-gfp fusion was 
PCR-amplified and cloned in plasmid pRM3. Upon induction with xylose, cells containing the 
resulting construct (pRM3-bmrB-gfpInframe) were fluorescent, which showed that the bmrB 
open reading frame is translated and, therefore, has the intrinsic potential to act as a regulatory 
leader peptide (Supplementary Figure S4). 
To test the hypothesis that bmrB could function as a leader peptide, we constructed the 
transcriptional pRM3-bmrB∆start-gfp fusion in which we prevented the translation of bmrB. 
This was done by mutating the annotated GTG start codon to GTC, the insertion of a TAG 
stop codon downstream of the mutated start codon, and four point mutations in the 5’-UTR 
that either remove alternative start codons or potential ribosome-binding sites (Figure 7A). As 
shown in Figure 7B, cells carrying the resulting plasmid pRM3-bmrB∆start produced ~15 AU 
of GFP upon xylose induction. This was substantially lower than the GFP expression observed 
for xylose-induced cells carrying pRM3-bmrB162 (Figure 7B), which suggested that impaired 
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translation of bmrB increases the efficiency of the transcriptional terminator within the bmrB 
coding sequence. More importantly, expression of the bmrB∆start-gfp fusion was not inducible 
with lincomycin (Figure 7B). Together, these results imply that translation of bmrB is required 
for efficient and lincomycin-inducible transcription of bmrCD, supporting our hypothesis that 
BmrB could function as a sensory leader peptide in a transcriptional attenuation mechanism.
In a leader peptide-based transcriptional attenuation mechanism for bmrCD, the ribosome could 
conceivably act as a sensory component for the presence of antibiotics which, in turn, would 
affect the rate of translation of bmrB. If so, transcription downstream of the bmrB terminator 
would depend on the effect that lincomycin exerts on the ribosome. To obtain experimental 
evidence for an involvement of the ribosome-lincomycin interaction in the translation-mediated 
transcriptional read-through of the bmrB terminator, we took advantage of the ermC selection 
marker on pRM3. The encoded erythromycin ribosomal methylase provides resistance to 
macrolides, lincosamides and streptogramins (MLS) by methylating a single adenine residue 
of the 23S rRNA (the rRNA component of the 50S subunit), thereby preventing binding of 
the antibiotic compound. While ermC provides cross-resistance to several ribosome-targeted 
antibiotics including lincomycin, expression of ermC can only be induced by erythromycin (21). 
Figure 7. Translation of bmrB is essential for efficient and lincomycin-induced transcription of bmrCD. (A) 
Schematic representation of plasmid pRM3-bmrB∆start with the sequences of the first 15 nucleotides of bmrB and 
bmrB∆start, and 70 nucleotides of the 5’-UTR. The mutations that were introduced to preclude translation of bmrB 
are marked with an asterisk (*). (B) Maximum GFP expression values (AU) obtained from B. subtilis carrying 
pRM3-bmrB162 or pRM3-bmrB∆start in response to xylose induction, either with or without lincomycin (0.75 µg/
mL). (C) ErmC-mediated methylation of the lincomycin-binding site on the ribosome prevents lincomycin-induced 
expression of bmrB-gfp. B. subtilis cells carrying pRM3-bmrB162 were pre-cultured in medium with or without 
erythromycin (0.5 µg/mL) and maximum GFP expression values were measured upon xylose induction, either with 
or without lincomycin (0.75 µg/mL). Culturing of cells in the presence of erythromycin induces expression of the 
ermC gene located on pRM3.
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To induce methylation of the ribosomes, the strain containing pRM3-bmrB162 was cultured 
in LB with a sub-inhibitory concentration of 0.5 µg/mL erythromycin. As a result of this, the 
lincomycin-mediated control on the expression of GFP was completely lost. Specifically, the 
induction with xylose alone resulted in GFP levels similar to those of cells grown in LB with 
xylose and lincomycin (~25 AU) (Figure 7C). The fact that ribosome methylation prevented the 
antibiotic-controlled regulation of bmrCD underpins the importance of the antibiotic-ribosome 
interaction, which is apparently required for read-through transcription beyond the bmrB 
terminator-like sequences. 
Taken together, these observations show that the antibiotic-mediated regulation of transcriptional 
termination occurs during the translation of bmrB. The BmrB peptide would then serve as a 
regulatory leader peptide. In this system, the ribosomes translating the BmrB leader peptide 
would act as a sensor for the presence of ribosome-targeted antibiotics. By inhibiting protein 
synthesis, these antibiotics will interfere with the efficient translation of bmrB. In turn, this would 
promote the formation of the anti-termination structure, thereby stimulating the transcription of 
the downstream bmrCD genes.
Rare codons in bmrB affect the transcriptional attenuation decision
The importance of the translation of bmrB for controlling the transcription of bmrCD led us to 
ask the question whether the codon composition of bmrB could be important for its function as 
a regulatory leader peptide. This question was relevant since we have identified five rare codons 
within the bmrB coding sequence upstream of the regulatory terminator region (Figure 8A). 
The rare codons were manually assigned based on the previously determined codon usage in B. 
subtilis (22) and this was verified using the online codon optimization tool JCat (http://www.
jcat.de/)(23). Rare codons are known to slow down the speed of translation (24, 25, 26, 27), 
and therefore, the presence of these rare codons within bmrB could affect the transcriptional 
termination decision. To investigate this idea, a codon-optimized bmrB sequence was designed 
using the JCat tool and subsequently synthesized. This codon-optimized bmrB sequence was 
transcriptionally fused to gfp and cloned into pRM3, which resulted in plasmid pRM3-bmrBCopt 
(Figure 8A). Next the GFP expression by cells containing pRM3-bmrBCopt was compared to 
that of cells containing pRM3-bmrB162. Interestingly, the xylose-induced GFP expression from 
pRM3-bmrBCopt reached a level of ~6.3 AU, which was much lower than the xylose-induced 
GFP expression of ~40 AU from pRM3-bmrB162 (Figure 8B). Furthermore, co-induction of the 
bmrBCopt-gfp fusion with xylose and lincomycin doubled the GFP expression levels to ~13 AU, 
and this 2-fold increase was comparable to the increase observed for the bmrB162-gfp fusion 
induced with xylose and lincomycin, which reached ~82 AU. Thus, although the lincomycin-
mediated regulation was not affected by the codon optimization, the total GFP expression 
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levels directed from pRM3-bmrBCopt were considerably lower compared to those directed 
from pRM3-bmrB162. This suggests that the codon-optimized bmrB sequence results in more 
efficient termination of the bmrB-gfp transcript, without affecting the regulatory capacity of the 
terminator region. It therefore seems that the rare codons in bmrB slow down the rate by which 
the corresponding mRNA is translated, and this might provide sufficient time for the predicted 
anti-terminator to form. In contrast, codon optimization of the bmrB sequence increases the rate 
of translation, allowing less time for the anti-terminator structure to form, and thereby favors 
transcriptional termination. The latter will result in the lower GFP levels as documented in Figure 
8B. Altogether, our observations suggest that the rare codons in bmrB do not play a major role in 
the lincomycin-mediated control, because the regulatory capacity of the codon optimized bmrB 
Figure 8. Codon optimization in bmrB leads to reduced transcription of bmrCD. (A) Sequences of the bmrB 
(marked bmrB162) and bmrBCopt genes. The five rare codons that were mutated in bmrBCopt are marked with 
an asterisk (*). (B) Maximum GFP expression values (AU) obtained from B. subtilis carrying pRM3-bmrB162 or 
pRM3-bmrBCopt in response to xylose induction, either with or without lincomycin (0.75 µg/mL).
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sequence remained apparently unaffected. Instead these rare codons seem to enhance the basal 
level of transcriptional read-through. In addition, these results emphasize the importance of the 
rate of translation in the regulation of read-through transcription beyond bmrB. 
Discussion
In the present study, we have employed promoter-GFP fusions to monitor the expression 
dynamics of the genes encoding the MDR-ABC transporter BmrCD upon exposure to antibiotics. 
This real-time approach revealed that the antibiotic-induced expression profile of bmrCD is 
constrained to the transition and stationary growth phases due to a tight control by the transition 
state regulator AbrB. In addition, we have demonstrated that antibiotic-induced expression of 
bmrCD is regulated via a ribosome-mediated transcription termination mechanism, a regulatory 
mechanism that has not been previously described for MDR-ABC transporters.
Our study shows that the promoter controlling transcription of the bmrBCD operon is regulated 
via the transcriptional regulator AbrB, which is known to repress stationary phase-specific genes 
during exponential growth of B. subtilis (28), and that this regulation determines the timing 
of antibiotic-induced bmrCD expression. Nevertheless, although the AbrB-regulated promoter 
upstream of bmrB controls the growth phase-dependent expression of bmrCD, this promoter is 
unresponsive to the antibiotics that induce bmrCD expression. By constructing several different 
transcriptional-fusions, we have now demonstrated that the antibiotic-induced expression of 
these two MDR-transporter genes is regulated via the transcriptional terminator located within 
the coding sequence of bmrB. In the absence of antibiotics, such as lincomycin, transcription of 
the bmrBCD operon will be terminated at this terminator site, thereby minimizing expression 
of bmrCD. In contrast, when the cells are challenged with translational inhibitors, such as 
lincomycin, erythromycin or chloramphenicol, transcriptional termination is prevented and the 
bmrCD transporter genes are transcribed. Moreover, our study shows that translation of bmrB 
is essential for the antibiotic-controlled transcription of bmrCD. From these observations we 
conclude that BmrB acts as a regulatory leader peptide, and that the extent of bmrCD transcription 
is related to the efficiency of bmrB translation. Intriguingly, kanamycin and gentamycin, both 
targeting the 30S ribosomal subunit, were unable to induce the 5’bmrC-gfp fusion, whereas 
chloramphenicol, erythromycin and lincomycin, which target the 50S subunit, did induce the 
5’bmrC-gfp fusion. This difference between antibiotics that target the 50S and 30S ribosomal 
subunits could relate to their exact binding sites on the ribosome and/or mechanisms of action 
in relation to bmrB translation, but this is presently highly speculative and further research is 
needed to explain this observation.
While we have identified the first leader peptide-based transcriptional control system for the 
expression of an MDR transporter, it should be noted that leader peptide-based regulatory 
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mechanisms have previously been reported to control various other processes in bacteria. These 
mechanisms rely on the fact that bacterial transcription and translation are coupled. The best-
known example of leader peptide control involving transcriptional termination is the operon 
responsible for tryptophan synthesis in E. coli (29, 30). In this case, the Trp leader peptide 
contains two adjacent tryptophan residues involved in the sensing of tryptophan shortage, which 
will result in stalling of the translating ribosome at the adjacent Trp codons (31). This ribosome 
stalling promotes the formation of an anti-terminator structure and thereby prevents premature 
termination of the transcript (32). The regulation of the B. subtilis bmrBCD operon, as described 
here, differs from that of the E. coli trp operon in that ribosome stalling is caused by the 
inhibitory effect of the ribosome-targeted antibiotics on protein synthesis instead of a tryptophan 
shortage. However, as described for the trp operon, it seems likely that the ribosome translational 
stalling will allow structural organization of the anti-terminator in bmrB, thereby promoting the 
transcription of bmrCD as schematically represented in Figure 9. In this way, the ribosome 
plays a regulatory role in transcriptional regulation by acting as a sensor for compounds like 
lincomycin that hinder efficient translation. Indeed, our results show that the interaction between 
the ribosome and the antibiotic is crucial for the anti-termination process, especially since the 
lincomycin-induced bmrB transcription was completely lost upon methylation of the ribosome 
by ErmC (Figure 7C). The function of the predicted anti-anti-terminator (Figure 1C) within our 
proposed transcriptional attenuation model remains unclear. If functional, it is conceivable that 
formation of the anti-anti-terminator structure promotes the formation of the terminator, and 
thus, acts as an inhibiting factor for bmrCD transcription.
Transcriptional termination has previously been reported as a regulatory mechanism in the 
expression of several resistance genes, including the B. subtilis vmlR ABC transporter gene, 
which is involved in resistance to lincomycin and virginiamycin M (33, 34). These ribosome-
targeted antibiotics also promote transcriptional read-through and thus expression of vmlR 
(34). However, the 5’UTR of vmlR lacks an ORF, indicating that the expression of this gene 
is not regulated via ribosome-mediated transcriptional termination. In addition, vmlR lacks the 
typical anti-terminator structure that is normally required for such transcriptional attenuation 
mechanisms, and the precise mechanism regulating vmlR expression remains to be determined 
(34). Furthermore, expression of ermC, encoding the erythromycin ribosomal methylase C, is 
regulated via another class of leader peptide-based systems. Under non-inducing conditions 
efficient translation of the leader peptide of ermC promotes formation of a stem-loop structure 
that protects the RBS so that translation of ermC is prevented (21). The presence of erythromycin 
causes stalling of the ribosome that is translating the ermC leader peptide, giving time for the 
formation of an alternative stem-loop structure (35). As a result, the RBS becomes accessible, 
and ribosomes can efficiently translate ermC (36). The regulatory control mechanism of ermC 
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encourages the theory that translational leader peptides can act as efficient sensors for ribosome-
targeted antibiotics. This is further supported by the translation-mediated attenuation mechanism 
controlling transcription of cat-86, a plasmid-borne chloramphenicol resistance gene in B. 
subtilis. Expression of cat-86 is induced when the ribosome, while translating the leader peptide, 
is stalled by chloramphenicol (37). Despite some overlap with the regulatory mechanisms of 
vmlR, ermC and cat-86, the bmrCD genes are, to the best of our knowledge, the first MDR-ABC 
transporter genes to be regulated via ribosome-mediated transcriptional attenuation. In fact, the 
termination system controlling the expression of bmrCD is the first documented transcriptional 
Figure 9. Model for antibiotic-induced bmrCD expression. Due to transcriptional and translational coupling, the 
RNA polymerase transcribing the bmrB gene is closely followed by the respective ribosome-mRNA-BmrB nascent 
chain complex. (A) In the absence of ribosome-targeted antibiotics, the ribosome can translate the bmrB transcript 
without impediments. When bmrB is efficiently translated the formation of an anti-terminator structure, which is 
energetically less favorable than the terminator structure (Figure 1C), is prevented. Consequently, this will result in 
formation of the terminator structure (T), which will, by destabilizing the transcriptional elongation complex, result 
in transcriptional termination. (B) The presence of antibiotics, such as lincomycin (indicated as stars), which target 
the bacterial ribosome, will reduce the translation rate of bmrB. This will allow formation of the anti-terminator 
(AT) structure and, thereby, preclude formation of the transcriptional terminator. In turn, this will allow the RNA 
polymerase to continue transcription of bmrCD.
BmrC/BmrD is regulated via a ribosome-mediated transcriptional attenuation mechanism 
53
attenuation mechanism encoded in the B. subtilis genome that is controlled by a leader peptide. 
However, it should be noted that other transcriptional attenuation systems have previously been 
characterized in B. subtilis. One example is the tryptophan synthesis operon, which is dependent 
on an RNA-binding protein to control expression of downstream genes (38). Additionally, B. 
subtilis has several transcriptional systems that are controlled by riboswitches (39). These RNA 
elements control transcription of downstream genes by changing their structure in response to 
temperature shifts, or direct interaction with cellular components (e.g. tRNAs) or small molecules 
(e.g. amino acids, metals)(40).
The biological relevance for the observed strictly growth phase-dependent bmrCD expression 
is presently elusive. Fast and efficient detoxification of the cellular interior is essential when 
bacteria are exposed to antibiotics. Therefore, most drug efflux systems show an immediate 
transcriptional response towards the toxic compounds they expel. However, as a soil bacterium, 
B. subtilis can be confronted with a large variety of different antimicrobial compounds and this 
is probably the reason why it possesses a multitude of efflux pumps (3). Consequently, it seems 
most likely that there is overlap in the substrate specificities of the different MDR transporters 
of B. subtilis. The transcriptional response of bmrCD is strongest upon exposure to lincomycin, 
an antibiotic produced by Streptomyces lincolnensis, which is also a soil-dwelling bacterium 
(41). Interestingly, the lincomcyin-induced expression of vmlR occurs during the early- and 
mid-exponential growth phases and declines in the late exponential growth phase (34). It thus 
partially overlaps with the lincomycin-induced bmrCD expression during the late-exponential 
and stationary growth stages. In addition, lmrB, encoding an additional lincomycin exporter, 
follows a similar expression profile as vmlR (42, 43). Since both vmlR and lmrB seem to be 
transcribed predominantly in the exponential growth phase, it appears that expression of bmrCD 
would be redundant during this point in growth and more effective during later growth stages. An 
alternative explanation for the strictly growth phase-dependent expression profile of bmrCD is 
a potential role of the respective transporter in sporulation. Transcript levels of bmrCD increase 
during sporulation (17), and the overexpression of bmrCD was shown to significantly reduce 
spore formation in a kinB mutant B. subtilis strain (42). Kumano et al. subsequently demonstrated 
that BmrD interacts with KinA, one of the key regulators of the sporulation process, and they 
postulated that this interaction might inhibit the activation of KinA by trapping it to the inner 
surface of the cytoplasmic membrane. 
In conclusion, the regulatory mechanism controlling the transcription of the bmrCD genes as 
uncovered in the present study points towards a role of BmrCD in antibiotic efflux during the post-
exponential stages of growth. This mechanism is apparently tailored for the optimal extrusion 
of ribosome-targeted antibiotics and represents the first ribosome-mediated transcriptional 
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Isogenic bacterial populations can consist of cells displaying heterogeneous physiological traits. 
Small regulatory RNAs (sRNAs) could affect this heterogeneity since they act by fine-tuning 
mRNA or protein levels to coordinate the appropriate cellular behavior. Here we show that the 
sRNA RnaC/S1022 from the Gram-positive bacterium Bacillus subtilis can suppress exponential 
growth by modulation of the transcriptional regulator AbrB. Specifically, the post-transcriptional 
abrB-RnaC/S1022 interaction allows B. subtilis to increase the cell-to-cell variation in AbrB 
protein levels, despite strong negative autoregulation of the abrB promoter. This behavior is 
consistent with existing mathematical models of sRNA action, thus suggesting that induction 
of protein expression noise could be a new general aspect of sRNA regulation. Importantly, 
we show that the sRNA-induced diversity in AbrB levels generates heterogeneity in growth 
rates during the exponential growth phase. Based on these findings, we hypothesize that the 
resulting subpopulations of fast- and slow-growing B. subtilis cells reflect a bet-hedging strategy 
for enhanced survival of unfavorable conditions.
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Introduction
In their natural habitats, bacteria constantly adapt to changing environmental conditions while 
simultaneously anticipating further disturbances. To efficiently cope with these changes, intricate 
interlinked metabolic and genetic regulation has evolved (1). This complex regulatory network 
includes the action of small regulatory RNAs (sRNAs) (2). sRNAs are a widespread means for 
bacterial cells to coordinate (stress) responses by fine-tuning levels of mRNAs or proteins, and 
they have been studied in great detail in Gram-negative bacteria (3). Regulation by some sRNAs 
takes place by short complementary base pairing to their target mRNA molecules, for instance in 
the region of the ribosome-binding site (RBS) to inhibit translation or trigger mRNA degradation. 
In Gram-negative bacteria many of these sRNA-mRNA interactions are mediated by the RNA 
chaperone Hfq (4). However, the Hfq homologue in the Gram-positive model bacterium Bacillus 
subtilis has no effect on the regulation of the eight sRNA targets reported in this species so far 
(5-7). Owing to the complexity of sRNA regulation, only a relatively small number of studies 
have focused specifically on the physiological necessity of sRNA-target interactions. This is 
again particularly true for Gram-positive bacteria, such as B. subtilis, despite the fact that many 
potential sRNAs have been identified (8, 9). 
Within a bacterial population, genes and proteins can be expressed with a large variability, 
with high expression levels in some cells and low expression levels in others (10). Examples 
of expression heterogeneity in B. subtilis are the extensively studied development of natural 
competence for DNA binding and uptake and the differentiation into spores (11-13). In both 
cases, expression heterogeneity is generated by positive feedback loops, and results in bistable 
or ON-OFF expression of crucial regulators (14). Distinctly from bistability, proteins can also 
be expressed with large cell-to-cell variability. This variation in expression levels, or noise, can 
originate from intrinsic or extrinsic sources (15, 16). Extrinsic noise is related to cell-to-cell 
fluctuations in numbers of RNA polymerase, numbers of genome copies, or numbers of free 
ribosomes. Conversely, intrinsic noise is caused by factors directly involved in the transcription 
or translation of the respective gene or protein. Interestingly, particularly noisy genes are often 
found to be regulators of development and bacterial persistence (12, 17, 18). Because of the 
importance of noise in protein expression, cells have evolved mechanisms to regulate the noise 
levels of at least some proteins (10). Reducing noise levels has been suggested as an important 
explanation why many transcriptional regulators in bacteria (40% in E. coli (19)) autorepress the 
transcription of their own promoter (i.e. negative autoregulation (NAR)).
AbrB is a global transcriptional regulator in Gram-positive bacteria, including the important 
human pathogens Bacillus anthracis and Listeria monocytogenes (20, 21). B. subtilis AbrB 
positively regulates some genes when carbon catabolite repression (CCR) is relieved (22), and 
negatively regulates the expression of over two hundred genes in the exponential growth phase 
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(23). Transcription of abrB is negatively autoregulated by binding of AbrB tetramers to the 
abrB promoter (24, 25). Upon entry into stationary phase, abrB transcription is repressed via 
increasing levels of Spo0A-P and AbrB is inactivated by AbbA (26, 27). The resulting AbrB 
depletion is consequently followed by activation of AbrB repressed genes, which are often 
important for stationary phase processes. Notably, because of its role in the elaborate sporulation 
and competence decision making network (26, 27), AbrB has mainly been studied in the context 
of entry into stationary phase while much less is known about its exact role in the exponential 
growth phase.
We selected putative sRNAs from a rich tiling array dataset of 1583 potentially regulatory RNAs 
(9). This selection was made for evolutionary conserved putative sRNAs with a high expression 
level on defined minimal medium. Deletion strains of these putative B. subtilis sRNAs were 
subsequently tested for growth phenotypes. One sRNA - RnaC/S1022 - stood out since the 
mutant strain displayed a strongly increased final optical density on minimal medium with 
sucrose as the sole carbon source. The present study was therefore aimed at determining how 
RnaC/S1022 influences the growth of B. subtilis. Inspection of consistently observed predicted 
RnaC/S1022 targets indicated that the aberrant growth phenotype could relate to elevated AbrB 
levels. Here we show that, under certain conditions, B. subtilis employs RnaC/S1022 to post-
transcriptionally modulate AbrB protein expression noise. The observed noise in AbrB protein 
levels is remarkable, because the abrB gene displays low transcriptional noise consistent with 
its NAR. Importantly, the sRNA-induced noise in the AbrB protein levels generates growth rate 
heterogeneity in the exponential phase. 
Results 
RnaC/S1022 deletion enhances growth on minimal medium
RnaC/S1022 was first identified in a systematic screening of B. subtilis intergenic regions 
with an oligonucleotide microarray (28). RnaC/S1022 is located in between yrhK, a gene of 
unknown function, and cypB, encoding cytochrome P450 NADPH-cytochrome P450 reductase 
(also known as yrhJ). We tested the conservation of the B. subtilis RnaC/S1022 sequence with 
BLAST analysis against a set of 62 Bacillus genomes, and found evolutionary conservation 
in a clade of the phylogenetic tree including 19 B. subtilis, Bacillus atrophaeus, and Bacillus 
amyloliquefaciens genomes (Fig 1A and S1 Fig for extensive alignments). Within these 19 
genomes, the 5’ and 3’ ends of the RnaC/S1022 sequence are conserved, but the core sequence 
is disrupted in all 9 B. amyloliquefaciens genomes (S1 Fig). Notably, the RnaC/S1022 from B. 
atropheus 1942 seems to represent an in-between form of RnaC/S1022 that mostly resembles 
the RnaC/S1022 sequences from the B. amyloliquefaciens sp. genomes. Therefore, an alignment 
of only the RnaC/S1022 sequences from the 9 remaining B. subtilis genomes was used to predict 
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the RnaC/S1022 secondary structure using the LocARNA tool (29) (Fig 1B, S1 Fig). These 
analyses predict RnaC/S1022 to fold into a stable structure with a Gibbs free energy for the 
sequence shown in Fig 1B of -38.5 kcal/mol, as calculated with RNAfold (30).
RnaC/S1022 was recently included in a screen for possible functions of conserved putative 
sRNAs identified by Nicolas et al. (9) that are highly expressed on M9 minimal medium 
supplemented with different carbon sources. Here, the RnaC/S1022 mutant stood out, because 
it consistently grew to a higher optical density (OD) in M9 minimal medium supplemented with 
sucrose (M9S) than the parental strain (Fig 1C). To distinguish effects on the growth rate and 
growth yield, lin-log plots of these growth profiles are presented in S2 Fig, which show that the 
growth rate was only slightly influenced by the RnaC/S1022 deletion while the growth yield 
was strongly increased. Compared to M9S, the growth phenotype was less pronounced in M9 
with glucose (M9G). Since transcription of RnaC/S1022 is exclusively regulated by SigD (28), 
we also tested a sigD mutant for growth under these conditions. Interestingly, the ∆sigD mutant 
displayed similar growth characteristics as the ∆RnaC/S1022 mutant (Fig 1C). Differential 
growth and increased competitiveness were previously reported for a sigD mutant (31), and our 
observations suggest that in some conditions the increased final OD of the ∆sigD strain is partly 
due to deregulation of RnaC/S1022.
AbrB is a consistently predicted target of RnaC/S1022
We wondered whether deregulation of an sRNA target was responsible for the remarkable 
growth phenotype observed for the ∆RnaC/S1022 mutant and decided to perform exploratory 
target predictions using TargetRNA (32). Predicting sRNA targets can be successful, but target 
verification is complicated by the large number of false-positively predicted targets. We argued 
that additional information about the likelihood of a true target could be obtained by determining 
whether the predicted interaction is conserved over evolutionary time. To identify predicted 
RnaC/S1022-target interactions that are conserved, a bioinformatics pipeline was established 
that predicts sRNA targets in genomes in which the RnaC/S1022 sequence is conserved. Since 
we were interested in finding true B. subtilis sRNA targets, we only considered targets also 
predicted in B. subtilis, and these are listed in S1 Table. This analysis reduced the number of 
considered RnaC/S1022 targets to 47 (from 147 predicted targets for TargetRNA_v1 predictions 
with P value ≤ 0.01 on the B. subtilis 168 genome). These 47 predicted targets included seven 
sporulation-related genes (phrA, spoVAD, spoIIM, spoIIIAG, cotO, sspG, spsI). The sigma factor 
sigM was also consistently predicted but, since a sigM mutant strain only displays a growth 
phenotype under conditions of high salinity (33), this seemed unrelated to the observed growth 
phenotype of the ∆RnaC/S1022 mutant on M9 medium. In addition, two consistently predicted 
targets are involved in cell division (racA and ftsW), but we observed no specific cell-division 
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Figure 1. The RnaC/S1022 growth phenotype is linked to the evolutionary target prediction of abrB. 
(A) Phylogenetic tree of Bacillus genomes. The tree was constructed based on an alignment of rpoB (present in 
60 of the 62 genomes; except for two Bacillus coagulans genomes for which no significant rpoB nBLAST hits 
were found). The outer (black) box indicates 19 genomes in which RnaC/S1022 is present. The inner (red) box 
indicates 10 genomes in which the predicted RnaC/S1022-abrB interaction is consistently observed. A significant 
nBLAST hit for AbrB was not obtained for the species shaded in grey. (B) LocARNA structural conservation 
alignment of RnaC/S1022 based on the sequence published by Schmalisch et al. [28]. The alignment includes 
RnaC/S1022 sequences from genomes in which the RnaC/S1022-abrB interaction is consistently observed (marked 
in the red box in panel A), except the RnaC/S1022 from B. atrophaeus (see also S1 Fig). Numbers indicate the 
coordinates of S1022 defined by Nicolas et al. [9]. The arrow highlights the uracil base that is required for the 
interaction with abrB. (C) Growth curves of parental strain 168trp+, ∆RnaC/S1022, ∆sigD, and the ∆RnaC/S1022 
amyE::RnaC/S1022 complemented strain grown on LB, M9G or M9S. Each experiment was repeated at least 
three times in 96-well plates and shake flasks. Averages from triplicates from a representative 96-well plate 
experiment are shown. The OD600 was monitored every 10 min. One in two time-points were plotted. (D) Overview 
of the predicted RnaC/S1022-abrB interaction. “Genome”, name of the bacterium in which the interaction was 
predicted. “Conservation start”, the base of the RnaC/S1022 sequence as defined by Nicolas et al. [9] where the 
significant nBLAST hit starts. “Conservation end”, end coordinate of the significant nBLAST hit. “Identity”, 
fraction of identity of the conserved RnaC/S1022 sequence compared to RnaC/S1022 of B. subtilis 168. “Target 
Rank” the ranking of the abrB target in the predicted RnaC/S1022 targets for the respective genome. “TargetRNA 
P value” TargetRNA_v1 prediction P-value. “sRNA_start”, start coordinate of RnaC/S1022 homologue in the 
predicted target interaction. “sRNA_stop”, end coordinate of RnaC/S1022 homologue in the predicted target 
interaction. “abrB mRNA_start”, start coordinate of abrB in the predicted target interaction relative to its start 
codon. “abrB mRNA_stop”, end coordinate of abrB in the predicted target interaction relative to its start codon.
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abnormalities of the ∆RnaC/S1022 strain by live-imaging microscopy. Furthermore, the TCA 
cycle genes citB and citZ were predicted targets and tested by Western blot analysis, but no 
deregulation was observed. The last consistently predicted target of initial interest was the gene 
for the transition state regulator AbrB (Fig 1D). Reviewing the literature on abrB pointed us to 
an interesting observation where a spo0A mutant was reported to display increased growth rates 
on media similar to our M9 medium (22). Furthermore, it had been reported that AbrB has an 
additional role in modulating the expression of some genes during slow growth in suboptimal 
environments (34), which we argued could also be relevant to the M9S growth condition. Since 
abrB is a consistently predicted target of RnaC/S1022 (Fig 1D), we checked whether the presence 
of this sRNA coincides with the presence of the abrB gene. Indeed, abrB is conserved in 53 out 
of 62 available Bacillus genomes, and RnaC/S1022 is present in 19 of these 53 genomes (Fig 
1A). In addition, we identified no genomes that contain RnaC/1022 but lack the abrB gene (Fig 
1A). Accordingly, we hypothesized that RnaC/S1022 might be a regulator of AbrB.
AbrB levels are elevated in an RnaC/S1022 mutant
The combined clues from bioinformatics analyses and literature suggested that the growth 
phenotype of the ∆RnaC/S1022 mutant could relate to elevated AbrB levels. To test whether 
AbrB levels are indeed altered in this mutant, we performed Western blot and Northern blot 
analyses. This indeed revealed a strong trend towards higher AbrB protein and mRNA levels 
in the RnaC/S1022 mutant and for cells grown in M9G or M9S this effect was statistically 
significant (Fig 2). Importantly, the growth phenotype as well as AbrB protein and mRNA levels 
returned to wild-type (wt) by ectopic expression of RnaC/S1022 under control of its native 
promoter from the amyE locus (Fig 1C and 2). We also tested the effects of a ∆spo0A mutation 
by Western and Northern blot analyses. Interestingly, the combined deletion of RnaC/S1022 and 
spoOA seemed to lead to a further increase in the AbrB protein and mRNA levels compared to 
the already elevated levels in the spo0A mutant background. Lastly, we observed a three-fold 
reduced natural competence of the ∆RnaC/S1022 mutant, which is expected when the AbrB 
levels are elevated (35) (S3 Fig).
To test whether the AbrB levels were directly dependent on RnaC/S1022 levels, we placed the 
RnaC/S1022 complementation cassette in the amyE locus of the parental strain and used Western 
and Northern blotting to measure AbrB protein and mRNA levels. These analyses showed a trend 
towards reduction of both the AbrB protein and mRNA levels in cells grown on M9G and M9S, 
which would be consistent with elevated RnaC/S1022 expression and increased abrB regulation 
(Fig 2). Since the amount of AbrB was apparently correlated to the amount of RnaC/S1022, this 
suggested a stoichiometric relationship between these two molecules.
Before testing whether there could be a direct interaction between RnaC/S1022 and the abrB 
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mRNA, we decided to investigate the fate of the abrB mRNA in the presence or absence of 
RnaC/S1022. For this purpose, we assayed the levels of the abrB mRNA at different time 
points after blocking transcription initiation with rifampicin in the RnaC/S1022 mutant strain 
and in the strain with two chromosomal copies of RnaC/S1022. This analysis showed that the 
abrB mRNA level decreased significantly faster in the presence of RnaC/S1022 than in its 
absence (S4 Fig). In case of a direct interaction between RnaC/S1022 and the abrB mRNA, the 
observed difference could relate to an RnaC/S1022-triggered degradation of the abrB mRNA. 
Alternatively, this difference could be due to an RnaC/S1022-precluded protection of the abrB 
mRNA by elongating ribosomes (36).
Figure 2. AbrB levels are dependent on the presence of RnaC/S1022. (A) AbrB Western blot analysis. The position 
of AbrB is indicated. The bar diagrams show the relative AbrB levels, with the level in the parental strain (wt) set 
at 100%. All AbrB levels were corrected for the internal control protein BdbD. Error bars represent the standard 
deviation between triplicate experiments. The effect of RnaC/S1022 absence is most pronounced in cells grown 
on M9G and M9S, which corresponds to higher expression levels under these growth conditions. Statistical data 
analyis was performed with a one-sided Welch two-sample t-test (H1: AbrB/abrB levels in ∆RnaC/S1022 > than in the parental strain and the RnaC/S1022 complementation strain). The respective p-values are either indicated, or marked with asterisks (* p-value <0.05; ** p-value <0.01). (B) abrB Northern blot analysis. Equal 
amounts of RNA were loaded in each lane. The bar diagrams show the relative abrB mRNA levels, with the level 
in the parental strain (wt) set at 100%. Quantifications are based on minimally two independent experiments. Error 
bars represent the standard deviation between experiments. Data was analyzed for significance as in A.
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The RnaC/S1022 sRNA regulates AbrB by a direct sRNA-mRNA interaction
The apparently stoichiometric relationship between AbrB and the sRNA RnaC/S1022 is 
suggestive of a direct sRNA – target interaction. The predicted interaction region in B. subtilis 
168 spans a region from the RBS of abrB  (-10) until 19 bp after the start of the abrB ORF of 
which the strongest consecutive stretch of predicted base-pair interactions are present from +7 
bp till +19 bp (left top panel in Fig 3). In addition, only this region within the abrB-encoding 
sequence is part of the conserved predicted interaction region in B. atrophaeus and B. subtilis 
spizinenzii (Fig 1D). It has been reported that loop-exposed bases of sRNAs are more often 
responsible for regulation than bases in stems (37). Two predicted loop regions of RnaC/S1022 
are complementary with the predicted abrB interaction region (one of two basepairs and one 
of seven basepairs; bases 51-52 and 57-63 in Fig 1B and 3). We therefore decided to introduce 
a point-mutation by a U to A substitution in the predicted 7-bp loop of RnaC/S1022 encoded 
by plasmid pRM3 and a compensatory mutation in a plasmid pRM15-borne truncated abrB-
gfp reporter construct (abrBtrunc-gfp). Strains containing different combinations of the respective 
plasmids were grown on M9G and assayed by Flow Cytometry (FC) in the exponential growth 
phase. Cells containing one of the abrBtrunc-gfp constructs in combination with the empty pRM3 
plasmid displayed a unimodal distribution in GFP levels (Fig 3, lower panels). However, when 
the wt abrBtrunc-gfp was assayed in combination with the wt RnaC/S1022, a bimodal distribution 
in AbrBtrunc-GFP levels was observed, including a new peak of lowered fluorescence intensity 
(Fig 3, top left). Interestingly, a unimodal fluorescence distribution was found when the wt 
abrBtrunc-gfp construct was combined with point-mutated RnaC/S1022* (Fig 3, middle left) or 
the mutated abrB*trunc-gfp with the wt RnaC/S1022 (Fig 3, top right). In the case of the point-
mutated abrB*-gfp construct, however, a bimodal fluorescence distribution was only observed 
when this construct was combined with the mutated RnaC/S1022* (Fig 3, middle right). This 
implies that a direct mRNA-sRNA interaction takes place between abrB and RnaC/S1022. 
RnaC/S1022 sRNA is condition-dependently expressed
Studying the condition-dependency of sRNA expression can give clues to its function and 
targets. To obtain high-resolution expression profiles, we constructed an integrative RnaC/
S1022 promoter-gfp fusion (38). As expected, the presence of this PRnaC/S1022-gfp fusion caused 
GFP fluorescence in wild-type cells, but not in cells with a sigD mutation (Fig 4D). Next, a 
live cell array approach was used to compare the PRnaC/S1022-gfp activity with that of another 
SigD-dependent promoter, Phag, which drives flagellin expression. These promoter fusion strains 
revealed that the expression of hag was consistently ~4 fold higher than that of RnaC/S1022 
(Fig 4), which is in agreement with previously published expression data (9). On LB medium, 
the expression of both RnaC/S1022 and hag peaked in the late exponential and transition phase, 
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Figure 3. RnaC/S1022 regulates abrB by a direct mRNA-sRNA interaction. Wild-type and base pair-substituted (marked with 
asterix *) abrBtrunc-gfp constructs were expressed from plasmid pRM15 and combined with one of three variants of the pRM3 
plasmid (pRM3+RnaC/S1022, pRM3+RnaC/S1022*, pRM3 empty). All combinations of these constructs were assayed by FC 
and one representative histogram per combination is shown. Base-pairs high-lighted in identical color indicate the possibility 
for regulation due to base-pairing, while bases highlighted in two different colors indicate an inability for regulating due to 
the absence of base-pairing. Boxed regions in the abrB mRNA indicate the coding sequence, and boxed regions in the sRNA 
(RnaC/S1022) indicate predicted exposed bases in the structure shown in Fig 1B. The base pair found to be essential for sRNA 
regulation corresponds to U59 in a predicted RnaC/S1022 loop region (RnaC/S1022* U59A) and the 11th base in the abrB-
encoding region (abrB*A11U).
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while on both tested minimal media the peak in expression occurred in early exponential phase 
(Fig 4). This higher RnaC/S1022 expression level in the exponential phase on M9 relative to that 
in LB is in concordance with the stronger effect of ∆RnaC/S1022 on AbrB levels, as indicated 
by the Northern and Western blot analyses.
The RnaC/S1022 sRNA modulates protein expression noise of AbrB-GFP
Experimental methods that measure average protein levels in a population obscure possible 
cell-to-cell variation. To further study the cell-to-cell variation of AbrB-GFP in the exponential 
growth phase (as observed in Fig 3), we therefore employed a full-length translational abrB-
gfpmut3 fusion that was integrated into the chromosome via single cross-over (Campbell-type) 
recombination. Specifically, this integration resulted in a duplication of abrB where one full-
length copy of abrB was expressed from its own promoter and fused in-frame to gfp, while the 
downstream abrB copy was truncated lacking the start codon required for translation (39). In 
this AbrB-GFP strain all AbrB monomers have a C-terminally attached GFP molecule. While 
AbrB-GFP still localized to the nucleoid (S5 Fig), this AbrB-GFP strain displayed a somewhat 
Figure 4. RnaC/S1022 is condition-dependently expressed. Promoter activity of the PRnaC/S1022-gfp and Phag-gfp 
fusions in cells grown on LB (A), M9G (B), and M9S (C). Promoter activities were computed by subtraction of 
GFP level from the previous time-point as described by Botella et al. [38]. The experiment was performed three 
times in triplicate. Average data from triplicate measurements of one representative experiment are shown. The 
grey line indicates mean data and the black line a smoothed version of this mean. One in two time-points were 
plotted for the growth curve as open circles for the Phag-gfp strain and closed circles for the PRnaC/S1022-gfp strain. (D) 
Representative FC results for PRnaC/S1022-gfp expression in mid-exponentially growing cells with or without a sigD 
deletion. The cells were grown in M9G. Wt, B. subtilis 168 not expressing GFP.
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reduced growth rate on media where AbrB is required for rapid growth. Since the translational 
abrB-gfp fusion is chromosomally integrated at the abrB locus, this system is insensitive to 
fluctuations in noise levels by plasmid copy number variation and its chromosomal location in 
the division cycle.
We first used the AbrB-GFP fusion to test whether B. subtilis Hfq might have an effect of the 
RnaC/1022-abrB interaction. Consistent with previous studies on other sRNA targets of B. 
subtilis (5-7), the direct RnaC/S1022-abrB regulation was found to be independent of Hfq since 
comparable FC profiles for AbrB-GFP expression were obtained for the parental strain and the 
hfq deletion mutant (S6 Fig).
Next, we analyzed all AbrB-GFP strains by FC in the exponential phase on both LB and M9G. 
Noise measurements were not performed on M9S because of the strong growth difference 
between the parental and ∆RnaC/S1022 strains on this medium (Fig 1C). We observed that 
the difference between cells expressing AbrB-GFP at the highest level and those at the lowest 
level was large (Fig 5A). This means that AbrB-GFP is expressed with high noise (quantified as 
the coefficient of variation; CV%). Interestingly, we observed lower AbrB-GFP noise in strains 
lacking RnaC/S1022 and, crucially, the presence of an additional genomic RnaC/S1022 copy 
further increased AbrB-GFP noise. Remarkably, increased RnaC/S1022 levels only reduced 
the minimal expression level of the distribution while not affecting the maximum AbrB-
GFP expression level (Fig 5A), which is consistent with the data presented in Fig 3. There 
was a statistically significant positive linear correlation between RnaC/S1022 levels (0, 1 or 2 
genomic copies) and AbrB-GFP noise (on LB for pooled data points from ∆spo0A and parental 
backgrounds R2 0.48, P-value <0.001, and M9G R2 0.43, P-value <0.001) (Fig 5B). Direct 
statistical comparisons between AbrB-GFP noise levels at different sRNA levels also revealed 
significant changes (Fig 5). The noise increase therefore seems correlated to the level of RnaC/
S1022. Notably, this relation was also observed for noise measurements in a spo0A deletion 
background, even though the mean AbrB-GFP expression was between 1.37 and 2.32 fold (for 
LB and M9G respectively, µ=1.79) higher in ∆spo0A strains. This suggests that RnaC/S1022 has 
a specific role in noise modulation of AbrB-GFP. 
RnaC/S1022 has no indirect effect on the abrB promoter and is expressed homogeneously
After observing that RnaC/S1022 specifically increases AbrB-GFP expression noise, we aimed 
to elucidate the origin of this AbrB-GFP noise. Three possibilities for noise generation by an 
sRNA are conceivable. Firstly RnaC/S1022 could have an additional indirect effect on abrB 
expression, leading to noisy expression from the abrB promoter and subsequent propagation 
of this noise to the AbrB protein level. Secondly, RnaC/S1022 may itself be expressed either in 
bimodal fashion or with high noise. The third possibility would be an AbrB-dependent repression 
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Figure 5. RnaC/S1022 induces protein expression noise of AbrB-GFP.  (A) Representative FC data for the 
translational AbrB-GFP fusion expressed from a single copy of the respective gene fusion integrated into the B. 
subtilis chromosome. All strains were grown on M9G. The left panel shows histograms for, from left to right, the 
AbrB-GFP-producing strain with two chromosomal RnaC/S1022 copies, the AbrB-GFP-producing parental strain 
with one chromosomal RnaC/S1022 copy, and the AbrB-GFP-producing strain with the ∆RnaC/S1022 mutation. 
The right panel shows data for the same strains with an additional ∆spo0A mutation. Please note the increase in 
the width of the distribution with increasing RnaC/S1022 gene dosage. (B) Quantification of AbrB-GFP noise 
(left panel) and mean expression data (right panel) from three independent experiments with cells grown on M9G. 
Shaded areas indicate the noise increase (∆CV%) from 0 to 2 sRNA copies in the spo0A-proficient background (wt) 
and the ∆spo0A mutant background. Statistical significance of the comparisons of data obtained for spo0A-proficient 
or -deficient strains containing 0 to 2 sRNA copies are indicated with asterisks in the legend (* p-value <0.05; ** 
p-value <0.01; ANOVA with Tukey HSD test). Error bars represent the standard deviation. (C) Quantification of 
PabrB-gfp noise (left panel) and mean PabrB-gfp activity data (right panel) from three independent experiments with 
cells grown on M9G. Statistical significance of the comparisons of data obtained for spo0A-proficient or -deficient 
strains containing 0 to 2 sRNA copies are indicated with asterisks in the legend (* p-value <0.05; n.s. means not 
significant; ANOVA with Tukey HSD test). Error bars represent the standard deviation.
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of the RnaC/S1022 promoter and subsequent repression of AbrB protein levels by RnaC/S1022. 
This double negative repression would correspond to positive feedback on the AbrB protein 
level, and positive feedback is a known source of expression heterogeneity (40).
To study the distribution of the abrB promoter, we integrated the pBaSysBioII plasmid (38) 
directly behind the Spo0A binding site in the promoter region of abrB (41), resulting in a single-
copy promoter fusion at the native genomic locus (PabrB ; -41bp of the abrB start codon). This 
location was selected to include the effect of AbrB autorepression and Spo0A(-P) repression, 
while excluding RnaC/S1022 regulation. We observed no bimodal or particularly noisy 
expression of this abrB promoter fusion, showing that transcription from the abrB promoter is 
homogeneous in the exponential phase (Fig 5C). Of note, bimodal or noisy expression of PabrB 
would have been surprising since transcription of abrB is autorepressed and it is generally found 
that this NAR reduces the noise of promoter expression (42, 43). Interestingly, the expression 
from the abrB promoter rises with increasing levels of RnaC/S1022. This observation can be 
explained by AbrB autorepression and noise. There are more cells with low AbrB levels when 
the levels of RnaC/S1022 are increased. On average, this will lead to lowered repression of 
the abrB promoter, leading to a higher level of expression (but not more noise) from the abrB 
promoter (Fig 5C). This higher expression from the abrB promoter is apparently compensated 
for at the protein level by the elevated regulation of RnaC/S1022 (Fig 2 and 5B). Since we 
observed only a slight increase in abrB promoter noise specific to RnaC/S1022 (Fig 5C), the 
hypothesis that AbrB-GFP noise promotion originates from an additional effect of RnaC/S1022 
on the abrB promoter can be rejected.
A second possibility of noise promotion by RnaC/S1022 is that it is itself expressed with large 
noise similar to the SigD-dependent hag gene (44). In this case, large cell-to-cell variation in 
sRNA levels would only lead to regulation in cells that have above-threshold sRNA levels, and 
this could generate the variation in AbrB-GFP levels. We tested this at the promoter level by 
FC analysis of the integrative RnaC/S1022 promoter-gfp fusion (PRnaC/S1022; Fig 4) and found 
this promoter fusion to be homogenously expressed with a tight distribution of GFP levels 
(CV% of 64% for the M9G condition; Fig 4D). Furthermore, we argued that the relatively 
low expression of PRnaC/S1022 could result in threshold-level regulation where the sRNA is only 
involved in regulating abrB in cells with above-threshold levels of RnaC/S1022. However, this 
is not consistent with the observation of further increased noise levels in cells with two genomic 
copies of RnaC/S1022 (Fig 5B). We therefore consider the possibility of AbrB noise promotion 
via heterogeneous expression of RnaC/S1022 unlikely. It cannot be excluded, however, that 
variation in the levels of RnaC/S1022 might be introduced further downstream, for instance via 
mRNA degradation, or via regulation by a dedicated RNA chaperone.
The third option would be a double-negative feedback loop consisting of sRNA repression of 
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AbrB levels and AbrB repression of sRNA levels, which would ultimately lead to an increase 
in AbrB protein expression noise. This would thus depend on repression of the RnaC/S1022 
promoter by AbrB, in addition to the confirmed negative regulation of abrB by RnaC/S1022. 
Together this would lead to a decrease in AbrB protein levels in cells that start with below-
threshold AbrB levels. First of all, we found no indication for AbrB binding sites in the region 
upstream of RnaC/S1022 in the dataset of Chumsakul et al., where the binding sites of AbrB 
were mapped genome-wide (24). To test whether the RnaC/S1022 promoter is indeed not 
directly controlled by AbrB, or possibly under indirect control of AbrB, we deleted the abrB 
gene from the above-mentioned PRnaC/S1022 promoter fusion strain. As expected, the RnaC/S1022 
promoter activity levels were not detectably affected by the abrB deletion (S7 Fig), showing that 
it is unlikely that there is a negative feedback loop consisting of AbrB-dependent RnaC/S1022 
repression and RnaC/S1022-dependent abrB repression.
sRNA-induced protein expression noise is consistent with mathematical models of sRNA 
regulation
Since the experimental data presented above pointed to a direct role of the RnaC/S1022 sRNA 
in AbrB protein noise promotion, we wondered whether this possibility is consistent with 
mathematical models of sRNA regulation. To verify this, we considered a simple model of RNA 
regulation with two independently transcribed RNA species (sRNA and mRNA) (45-47). In this 
model, these molecules are synthesized with constant transcription rates αs and αm, respectively. 
Translation of mRNA into protein Q, and the degradation of sRNA, mRNA, and protein 
molecules were modeled as linear processes that occur with rates δ. βs, βm, and γ, respectively. 
The sRNA-mRNA duplex formation was assumed to be an irreversible second-order process 
that occurs with a rate κ. In the model, molecules in the sRNA-mRNA duplex were removed 
from the dynamical system. A summary of all reactions and the master equation used in the 
model can be found in Fig 6. 
We first implemented model parameters used in an earlier sRNA modeling study by Jia et al. (47) 
(Set I; Fig 6A and D). Of note, these parameters were essentially the same as those of Levine et 
al. (45). In all cases the sRNA transcription rate (αs) was a free variable to capture the effect of 0, 
1, or 2 genomic copies of RnaC/S1022. In addition, for each set of parameters we included two 
possible αm values to model the effect in the Spo0A deletion strain where the abrB transcription 
rate (αm) is approximately two-fold higher than in the parental strain (as determined with PabrB-
gfp). Varying extrinsic noise in the abrB transcription rate had no effect on the general modeling 
outcome (S8 Fig) and the intermediate αm CV% level of 40% was selected for plots in the main 
text. After running the model with parameters from Set I, we observed that model-predicted 
protein noise strongly increased with increasing αs. This trend of increasing protein noise with 
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increasing sRNA transcription rates was similar to what we observed for the genomic AbrB-GFP 
fusion (Fig 5A and B). Importantly, doubling αm (two-fold higher mRNA transcription rate) 
resulted in a more gradual noise increase with increasing s, just as was observed in the spo0A 
mutant with the AbrB-GFP fusion (Fig 5).
We next sought to determine the effect of changing modeling parameters on the modeling 
outcome, because the selected mRNA half-life of ~35 min (βm 0.02) in parameter Set I would 
only be relevant for a subset of mRNA molecules as shown experimentally by Hambraeus et 
al. (48) (with a relation between these of mean lifetime from Fig 6A * ln 2 = half-life). We 
therefore constructed a second set of modeling parameters (Set II), which gave the mRNA and 
sRNA species a half-life of ~3.5 min (βm and βs  0.20) while keeping protein half-life at ~35 min. 
Figure 6. sRNA regulation increases protein expression noise in a stochastic simulation model. (A) Noise-generating 
dynamics of sRNA regulation were simulated in a stochastic simulation model for two sets of parameters with two 
mRNA transcription rates and the sRNA transcription rate as a free parameter. (B) Reactions considered in the 
model. (C) Master equation used for the model. (D) Modeling outcome for parameter Set I. E) Modeling outcome 
for parameter Set II. Note that modeling with both parameter sets predicts increased protein expression noise with 
increased sRNA transcription rates. In both cases this effect is buffered by a higher mRNA transcription rate as was 
observed for the ∆spo0A mutant background (see Fig 5B).
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In addition, αm was increased from 2 transcripts per minute to 4 per minute, and δ was doubled 
to 2 synthesized proteins per minute. Although the maximum noise level from these Set II 
simulations was markedly different, it again clearly showed the trend of increasing protein noise 
with increasing sRNA transcription rates. We can therefore conclude that the modeling results 
robustly support the idea that sRNA regulation can generate noise at the protein level. This 
noise would be induced locally at the level of mRNA degradation or translation initiation, and 
the corresponding fluctuations would subsequently be propagated to the protein level. Recently, 
the theoretical background of this concept was also reported by Jost et al., who stated that such 
behavior is especially expected when the levels of the srRNA and the mRNA are approximately 
equal (49). Altogether, our experimental data and the modeling approach are consistent with the 
view that RnaC/S1022 is an intrinsic noise generator for AbrB-GFP at the post-transcriptional 
level.
RnaC/S1022-induced AbrB expression noise generates diversity in growth speeds in the 
exponential phase
After defining the experimental and theoretical framework for noise promotion by the RnaC/
S1022 sRNA, we wondered what the physiological relevance of this regulation might be. Since 
we and others (Fig 1A; (22)) have reported an effect of AbrB levels on the growth of B. subtilis, 
a growth-related function seemed obvious. We therefore tested whether AbrB levels are a direct 
determinant of growth rate and yield under the relevant conditions. To do this, we placed the abrB 
gene under control of an isopropyl ß-D-1-thiogalactopyranoside (IPTG)-inducible promoter in 
the amyE locus using plasmid pDR111 (50), and subsequently deleted the abrB gene from its 
native locus in this strain. We first verified the IPTG-dependent expression of AbrB from this 
construct by growing the parental strain, the ∆abrB strain, and the ∆abrB amyE::abrB strain on 
LB medium and, in the case of the ∆abrB amyE::abrB strain, the medium was supplemented 
with increasing IPTG concentrations. Subsequently, AbrB production was assessed by Western 
blot analysis (Fig 7A), which showed that AbrB production in the ∆abrB amyE::abrB strain was 
indeed IPTG-dependent. Notably, the abrB mutant strain displays a growth phenotype on LB 
medium, but this is only apparent in the late exponential growth phase (51). To analyze the effect 
of differing AbrB levels on growth under conditions that are more relevant for the RnaC/S1022 
– abrB interaction, we grew the same strains on M9G, which was supplemented with differing 
amounts of IPTG for the ∆abrB amyE::abrB strain. As shown in Fig 7B, the abrB deletion 
mutant did not grow in this medium. Importantly however, IPTG-induced expression of abrB 
in this mutant repaired the growth phenotype in a dose-dependent manner. This shows that the 
AbrB levels determine the growth rate and yield when cells are cultured on M9G.
We next aimed to unravel the effect of sRNA-induced AbrB heterogeneity on growth. This 
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requires the tracking of cells with low and high AbrB-GFP levels over time. To do this, we 
performed a live imaging experiment with the ∆spo0A AbrB-GFP strain either containing zero 
sRNA copies due to the ∆RnaC/S1022 mutation, or two genomic copies due to the insertion of 
an additional RnaC/S1022 copy in amyE. The ∆spo0A background was used to elevate AbrB-
GFP levels and thereby to facilitate fluorescence measurements. Cells were pre-cultured in M9G 
as was done for the FC measurements and applied to agarose pads (at OD600 ~0.15) essentially 
as was described by Piersma et al. (52). From these experiments, and consistent with FC data in 
Fig 5, it was apparent that there was a larger variation in AbrB-GFP levels in the strain with two 
genomic RnaC/S1022 copies, compared to the strain lacking RnaC/S1022 (Fig 8B; S1 Movie). 
In addition, this variation in AbrB-GFP levels was correlated to the variation in growth rates 
(quantified as the specific cell length increase) observed during the first 20 min of each live 
imaging run (Fig 8A). We excluded the possibility that this growth rate difference was dependent 
on the position on, or quality of the slide. Instead, it was solely linked to the cellular level of 
AbrB-GFP (Fig 8C; S1 Movie). 
Figure 7. AbrB levels determine the growth rate and growth yield on M9 minimal medium. (A) Representative 
Western blot data for AbrB production by the indicated strains grown on LB medium as a test for IPTG-dependent 
AbrB production from the amyE::abrB construct. At the lowest level of IPTG induction (0.01 mM), the AbrB 
production remained below the detection level. BdbD was used as a loading control. AbrB and BdbD were 
visualized with specific antibodies. (B) Growth profiles on M9G determined for the strains from panel A. The abrB 
mutant is unable to grow on this medium, but its growth defect is rescued by IPTG-induced AbrB expression from 
the amyE::abrB construct. Averages of triplicate measurements from one representative 96-well plate experiment 
are shown.
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Notably, in the two example cells from Fig 8C (S1 Movie) AbrB-GFP levels gradually increase 
in the cell with a low start level (i.e. high level of sRNA repression), which would be consistent 
with a gradual reduction in RnaC/S1022 expression on this solid agarose medium (S9 Fig). 
However, our experimental setting determines the effect of AbrB-GFP on growth before this 
reduction in RnaC/S1022 becomes relevant (e.g. the first 5 pictures, or 20 min) (Fig 8A). Beyond 
this, the increase in AbrB-GFP levels observed later (>150 min) in the live imaging experiment 
seems coupled to a concomitant increase in growth rate (S9 Fig). This is again consistent with 
the positive correlation of AbrB-GFP levels with growth rate. Interestingly, while we observed 
a few cells switching their AbrB-GFP expression state from high to low, the AbrB-GFP levels 
Figure 8. RnaC/S1022-induced variation in AbrB-GFP levels leads to heterogeneity in growth rates. (A) Tracing 
of growth and AbrB-GFP levels of 71 individual micro-colonies from ∆spo0A AbrB-GFP strains with either zero 
or two chromosomal copies of RnaC/S1022. Data originates from three independent experiments. Cell growth is 
expressed as the cell length (Feret’s diameter) increase per hour as determined in the first 20 min after spotting 
of the cells onto agarose slides. The plotted AbrB-GFP level is the average of fluorescence in the first and second 
picture. (B) Distribution of AbrB-GFP start levels for both strains. Note that two genomic RnaC/S1022 copies lead 
to a wider distribution of AbrB-GFP levels. (C) Montage of the two adjacent dividing cells from the S1 Movie. The 
white outline marks the contours of the cell. The positions of these cells in panel A are marked with an O. Individual 
cells were cropped for illustration purposes only.
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were generally stable throughout a cell’s lineage. Combined, these analyses show that the RnaC/
S1022-induced heterogeneity in the AbrB-GFP expression levels generates diversity in growth 
rates within the exponential phase of growth.
Discussion
In this study we show that B. subtilis employs the RnaC/S1022 sRNA to post-transcriptionally 
regulate AbrB and that this regulation results in increased heterogeneity in growth rates during 
the exponential phase of growth. RnaC/S1022 is the third sRNA in B. subtilis for which a direct 
target has been reported and this study reveals the value of evolutionary target predictions to 
identify true sRNA targets for this species.
The observed growth rate heterogeneity induced by RnaC/S1022 is conceivably of physiological 
relevance since slowly growing bacterial cells are generally less susceptible to antibiotics and 
other environmental insults than fast growing cells (53-55). Specifically, it was noted for hip 
strains of E. coli that slowly growing cells within a population will develop into persister cells 
when challenged with ampicillin (17). Notably, in this system, the initial heterogeneity in growth 
rates was reported to be dependent on the HipAB toxin-antitoxin module (56). Analogously, it 
is conceivable that a B. subtilis toxin-antitoxin module under negative AbrB control could be 
responsible for the heterogeneity observed in the present study. Another perhaps more likely 
possibility is that low AbrB levels cause the premature activation of transition- or stationary 
phase genes, thereby slowing down growth and causing premature stationary phase entry. AbrB 
has also been implicated in the activation of some genes when CCR is relieved (22, 23), and 
this could be related to the stronger growth phenotype observed on M9S compared to M9G. 
However, the AbrB level also determines growth rates on M9G (this study; (22)), when CCR is 
active and AbrB is not known to have an activating role (22). 
The initially observed growth phenotype of the ∆RnaC/S1022 mutant can be explained by the 
present observation that AbrB is an important determinant for growth on M9 medium, and that 
RnaC/S1022 regulation of AbrB is specifically linked to increasing AbrB noise. Specifically, the 
absence of RnaC/S1022 will reduce the number of cells expressing AbrB at a low level. Growth 
of the ∆RnaC/S1022 population will therefore be more homogeneous and, when inspected as 
an average, the population will enter stationary phase later than the parental strain. Beyond the 
mechanism of AbrB-mediated growth regulation, we show that noisy regulation of a growth 
regulator can also cause heterogeneity in growth rates. This suggests that the AbrB noise level 
has been fine-tuned in evolution, possibly as a bet-hedging strategy to deal with environmental 
insults.
Two other questions addressed by this study are the origin of AbrB expression noise, and the 
likely reason why this noise is generated at the post-transcriptional level. The origin of AbrB 
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expression noise via triggering of abrB mRNA degradation and/or inhibition of abrB translation 
fits the definition of an intrinsic noise source where the absence of RnaC/S1022 reduces the 
number of sources for intrinsic noise by one, and therefore results in lower protein expression 
noise. This specific noise-generating capacity of sRNA regulation might be due to the specific 
kinetics of the RnaC/S1022- abrB mRNA interaction. It is currently unclear whether this 
feature of sRNA-mediated regulation can be extended to other sRNA-mRNA pairs. Specifically, 
subtle consequences of sRNA regulation, such as noise generation, may have been overlooked 
in previous studies due to the use of plasmid-encoded translational fusions with fluorescent 
proteins expressed from strong non-native promoters as reporters. We therefore expressed all 
RnaC/S1022 and AbrB-GFP constructs from their native genomic location, from their native 
promoters, and assayed the effects in the relevant growth phase.
NAR of AbrB seems to be the answer to the second question why noise is generated post-
transcriptionally and not at the promoter level. AbrB’s NAR is important for its functioning 
in the stationary phase sporulation network (26, 27) and is therefore likely a constraint for 
evolutionary optimization of AbrB expression in the exponential phase, which is the growth 
phase addressed in this study. In turn, NAR is a clear constraint on noise generation since it is 
generally believed to dampen noise (42, 43). Consistent with this view, we observed only a slight 
increase in PabrB promoter noise upon increasing AbrB protein noise, suggesting that AbrB NAR 
is responsible for minimizing promoter noise. Besides reducing noise, NAR has been implicated 
in decreasing the response time of a genetic circuit, linearizing the dose response of an inducer, 
and increasing the input dynamic range of a transcriptional circuit (19). Individually, and in 
combination, these mechanistic aspects of NAR could explain why NAR is such a widespread 
phenomenon in transcriptional regulation. Besides this, the idea that AbrB and AbrB NAR are 
more widely conserved than RnaC/S1022 would be in line with the idea that AbrB expression in 
B. subtilis 168 has become fine-tuned by an additional regulator, which has evolved later in time. 
Lastly, on a more general note, the inconsistency between the abrB promoter and AbrB protein 
noise measurements make it clear that it is premature to draw conclusions about homogeneity or 
heterogeneity of protein expression when only data is gathered at the promoter level, especially 
for genes under a NAR regime. 
In conclusion, we have identified a novel direct sRNA target in the important B. subtilis 
transcriptional regulator abrB. Specifically, we provide functionally and physiologically relevant 
explanations for the evolution of the noise-generation aspects of this regulation in generating 
heterogeneity in growth rates. This noise is induced at the post-transcriptional level due to AbrB 
NAR. Based on our present observations, we hypothesize that the resulting subpopulations of 






E. coli and B. subtilis strains and plasmids used in this study are listed in S2 Table and 
oligonucleotides in S3 Table. E. coli TG1 was used for all cloning procedures. All B. subtilis 
strains were based on the trpC2-proficient parental strain 168 (1). B. subtilis transformations 
were performed as described previously (57). The isogenic RnaC/S1022 mutant was constructed 
according to the method described by Tanaka et al. (58). pRMC was derived from pXTC (59) by 
Circular Polymerase Extension Cloning (CPEC) (60) with primers ORM0054 and ORM0055 
using pXTC as PCR template and ORM0056 to circularize this PCR fragment in the final CPEC 
reaction. In this manner, the xylose-inducible promoter of pXTC was replaced with the AscI 
Ligation Independent Cloning (LIC; (61)) site from pMUTIN-GFP (39). As a consequence, 
pRMC carries a cassette that can be integrated into the amyE locus via double cross-over 
recombination, allowing ectopic expression of genes in single copy from their native promoter. 
RnaC/S1022 was cloned in pRMC under control of its native promoter as identified by Schmalisch 
et al. (28), and the subsequent integration of RnaC/S1022 into the amyE locus via double cross-
over recombination was confirmed by verifying the absence of α-amylase activity on starch 
plates. The LIC plasmid pRM3+Pwt RnaC/S1022, which is a derivative of plasmid pHB201 
(51), was used to express RnaC/S1022 under control of its native promoter. For IPTG-inducible 
expression of abrB, the abrB gene was cloned into pDR111 (50), and subsequently placed in the 
amyE locus via homologous recombination. Deletion alleles were introduced into this and other 
strains by transformation with chromosomal DNA containing the respective mutations. The 
RnaC/S1022, hag and abrB promoter gfp fusions were constructed at the native chromosomal 
locus by single cross-over integration of the pBaSysBioII plasmid (38). A minimum of three 
clones were checked to exclude possible multi-copy integration of the plasmid. 
Media and growth conditions
Lysogeny Broth (LB) consisted of 1% tryptone, 0.5% yeast extract and 1% NaCl, pH 7.4. M9 
medium supplemented with either 0.3% glucose (M9G) or 0.3% sucrose (M9S) was freshly 
prepared from separate stock solutions on the day of the experiment as previously described 
(9). For live cell imaging experiments, the M9 medium was filtered through a 0.2 µm Whatman 
filter (GE Healthcare). Strains were grown with vigorous agitation at 37 ºC in either Luria LB 
or M9 medium using an orbital shaker or a Biotek Synergy 2 plate reader at maximal shaking. 
Growth was recorded by optical density readings at 600 nm (OD600). For all growth experiments, 
overnight B. subtilis cultures in LB with antibiotics were diluted >1:50 in fresh prewarmed 
LB medium and grown for approximately 2.5 hours. This served as the pre-culture for all 
experiments with cells grown on LB medium. For experiments with cells grown on M9 medium, 
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the LB pre-culture was subsequently diluted 1:20 in pre-warmed M9 medium and incubated for 
approximately 2.5 hours, which corresponds to mid- or early exponential growth. This culture 
then served as the pre-culture for experiments with cells grown on M9 medium. When required, 
media for E. coli were supplemented with ampicillin (100 µg ml-1) or chloramphenicol (10 µg 
ml-1); media for B. subtilis were supplemented with phleomycin (4 µg ml-1), kanamycin (20 
µg ml-1), tetracyclin (5 µg ml-1), chloramphenicol (10 µg ml-1), erythromycin (2 µg ml-1), and 
spectinomycin (100 µg ml-1) or combinations thereof.
 
Evolutionary conservation analysis of RnaC/S1022 targets
In order to find predicted targets co-conserved with RnaC/S1022, we used the 62 Bacillus 
genomes available in Genbank (as of January 31, 2013). On each of these genomes a BLAST 
search (Blastn v2.2.26 with default parameters) was conducted with the B. subtilis 168 RnaC/
S1022 sequence as identified in Nicolas et al. (9). Genomes where a homologue of RnaC/
S1022 (E-value < 0.001) was found were then subjected to TargetRNA_v1 search with extended 
settings around the 5’UTR (-75 bp; +50 bp around the start codon and additional command line 
arguments “-z 250 -y 2 -l 6”) using as query the sequence of the first high-scoring-pair of the first 
BLAST hit in that particular genome. A bidirectional best hit criterion (based on Blastp v2.2.26 
with default parameters and E-value cut-off 0.001) was used to compare the predicted targets 
in each genome with the predicted targets in the reference B. subtilis 168 genome (Genbank: 
AL009126-3). The data was tabulated and subsetted for B. subtilis 168 genes predicted for RnaC/
S1022 in 8 or more genomes. 
The Bacillaceae phylogenetic tree was computed based on an alignment of the rpoB gene 
BLAST result from the same set of genomes mentioned above. RpoB was reported to be a better 
determinant of evolutionary relatedness for Bacillus species than 16S rRNA (62). 
Western blot, RNA isolation and Northern blot
Cultures grown on LB, M9G, or M9S were sampled in mid-exponential growth phase (OD600 
0.4 – 0.6) and were directly harvested in killing buffer and processed as previously described (9). 
Northern blot analysis was carried out as described previously (63). The digoxigenin-labeled 
RNA probe was synthesized by in vitro transcription with T7 RNA polymerase and an abrB 
specific PCR product as template. 5 µg of total RNA per lane was separated on 1.2% agarose 
gels. Chemiluminescence signals were detected using a ChemoCam Imager (Intas Science Image 
Instruments GmbH, Göttingen, Germany).
Western blot analysis was performed as described (64) using crude whole cell lysates. To 
prepare lysates, cell pellets were resuspended in LDS-sample buffer with reducing agent (Life 
technologies), and disrupted with glass beads in a bead beater (3 x 30 sec at 6500 rpm with 30 
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sec intermittences). Before loading on Novex nuPAGE 10% Bis-Tris gels (Life technologies), 
samples were boiled for 10 min and centrifuged to pellet the glass beads and cell debris. Equal 
OD units were loaded on gel and the intensity of the AbrB band was corrected with the intensity 
for the unrelated BdbD control.
Data from Northern blots and Western blots were quantified ImageJ software (available via 
http://rsbweb.nih.gov/ij/).
Analysis of mRNA decay
Rifampicin (Sigma Aldrich) was added to 100 ml of exponentially growing M9G culture to a 
final concentration of 150 µg/ml from a 100x stock solution in methanol stored at -20°C. Just 
before the rifampicin addition and at 1, 2, 4, 6, 8 and 10 min after rifampicin addition, 10 ml of 
cells were harvested in killing buffer as described previously (9). Cell pellets were washed once 
with 1 ml killing buffer and frozen in liquid nitrogen. RNA was extracted according to the hot 
phenol method as described previously (63). Quantitative PCR was performed as described by 
Reilman et al. (51). The Ct value corresponds to the PCR cycle at which the signal came above 
background.
We analyzed the four mRNA decay time-series (two strains and two replicates) with a non-linear 
model of mRNA concentration described in (65) that aims at capturing initial exponential decay 
followed by a plateau. The rate of the initial decay is supposed to correspond to the physiological 
degradation of the mRNA. In contrast, the final plateau can be contributed by several factors, 
such as background noise in measurement, a stable subpopulation of molecules, or a higher 
stability of the mRNAs at the end of the dynamic. In our context, we assumed that the mRNA 
concentration is proportional to 2-Ct and thus we fitted (with the nls function of the R package 
stats) the model
-Ct(ti)=log2(A*(α1exp(-γ1ti)+α2)) + εi, for i=1…7 (ti = 0, 1, 2, 4, 6, 8, 10 min) with A>0, α1>0, 
α2>0, γ1>0,α1+α2=0 and εi a Gaussian white noise. The estimates of the γ1 parameters of the first 
model were compared between the two genetic backgrounds (0 genomic copies vs. 2 copies of 
RnaC/S1022) with a student t-test after a log-transformation to stabilize the variance. For the 
2-copy background, we also examined a second model that involves two exponential decay 
terms as would for instance arise when two sub-populations of mRNAs with distinct degradation 
rates coexist. It writes -Ct(ti)=log2(A*(α1exp(-γ1ti)+α2exp(-γ2ti)+α3)) + εi 
with A>0, α1>0, α2>0, α3>0, γ1>γ2>0, and α1+α2+α3=0. For each pair of background and model, 
we plotted a “consensus” line whose parameters were obtained from the geometric mean between 
the two replicate experiments.
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Computation of promoter activity
Promoter activity was monitored every 10 min from cells grown in 96-well plates in a Biotek 
Synergy 2 plate reader. Promoter activity was computed by subtracting the fluorescence of the 
previous time-point from that of the measured time-point (as in Botella et al. (38)). Moving 
average filtering (filter function in R with filter=rep(1/5, 5) was applied for smoothing of the 
promoter activity plots.
Flow cytometry and noise measurements
Cultures grown on LB, M9G, or M9S were sampled in mid-exponential growth phase OD600 0.4 
– 0.5 and were directly analyzed in an Accuri C6 flow cytometer. The number of recorded events 
within a gate set with growth medium was 15,000. The coefficient of variation (i.e. relative 
standard deviation) (CV%; standard deviation / mean * 100%) was used as a measure of the 
width of the distribution, or protein/promoter expression noise. 
Microscopy and live imaging
To inspect co-localization of AbrB-GFP with the nucleoid, cells were cultured until the exponential 
growth phase, pelleted by centrifugation, resuspended in 400µl phosphate-buffered saline (PBS) 
containing 1µl 500 ng/µl 4',6-diamidino-2-phenylindole (DAPI), and incubated for 10 min on 
ice. After this, the cells were washed once with PBS and slides were prepared for microscopy.
Live imaging analysis was conducted on aerated agarose cover slips as described previously 
(52). Segmentation, calculation of Feret diameter, and auto-fluorescence correction for every 
microcolony were performed with ImageJ also as described by Piersma et al. (52). Subsequent 
computations and plotting was done with R. The specific cell length (Feret diameter) increase 
per hour was computed as follows: ((cumulative Feret diameter at t20 min / number of cells at t0 min 
) – (cumulative Feret diameter at t0 min / number of cells at t0 min)) / ((t20 min – t0 min) / 60 min). 
Modeling noise
Noise promoting dynamics by sRNA regulation was modeled in a stochastic simulation model 
(45-47). The considered reactions, employed parameters, and the master equation are listed in 
Fig 6. The master equation was numerically integrated by employing an in-house developed 
implementation of the Gillespie algorithm (66) for each combination of model parameters. The 
stochastic simulations were started without any molecules and were run until a quasi-stationary 
state was reached. To capture the inherent stochasticity of the model we performed, for each 
set of model parameters, 50 x 10,000 simulation replicates (i.e. 500,000 in total). This can be 
interpreted as 50 experiments involving 10,000 cells each. Mean, standard deviation, and the 




Supplementary Data are available at http://journals.plos.org/plosgenetics/article?id=10.1371/
journal.pgen.1005046
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Staphylococcus aureus is a major pathogen that persistently colonizes about 20% of the 
human population. Intriguingly, this Gram-positive bacterium can survive and thrive under 
a wide range of different conditions, both inside and outside the human body. We therefore 
investigated the condition-dependent adaptation of this versatile bacterium by analyzing the 
whole transcriptome of strain HG001 under experimental conditions ranging from optimal in 
vitro growth to internalization in host cells. Based on these data, we provide: a comprehensive 
repertoire of transcription units and non-coding RNAs; a classification of 1412 promoters 
according to their dependence on the RNA polymerase sigma factors SigA or SigB; and new 
potential targets for various transcription factors.  In particular, this study revealed a relatively 
low abundance of antisense RNAs in S. aureus, where they overlap 6% of the coding genes, and 
only 19 antisense RNAs not co-transcribed with other genes were found. Analysis of a mutant 
lacking Rho indicates that Rho-dependent termination efficiently suppresses pervasive antisense 
transcription originating from presumably spurious low-level promoter activity. Although S. 
aureus can grow without Rho, we find significantly elevated antisense transcript levels in the 
absence of Rho, which affect the mRNA levels of the overlapped genes. 
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Introduction
The Gram-positive bacterium Staphylococcus aureus is a major human pathogen causing 
infections that range from superficial skin infections to life-threatening diseases, such as 
pneumonia, endocarditis, osteomyelitis, bacteremia and sepsis (1). S. aureus is also a common 
component of skin and mucosal flora and many clinical cases arise from autoinfection (2).  In the 
healthy population the most important niche of the bacterium seems to be the anterior nares, the 
population apparently decomposing into a fraction of permanent carriers, estimated around 20%, 
and a majority of intermittent carriers (3). The S. aureus host range is not limited to humans; it 
also infects many animals (4) and frequently causes food-borne disease due to its presence on raw 
meat (5).  A growing concern is the emergence of antibiotic-resistant strains, such as methicillin-
resistant S. aureus (MRSA) (6, 7). The versatile nature of S. aureus relies on a wide range 
of virulence factors, whose expression is coordinated by a complex gene regulatory network. 
They facilitate the escape from host immune responses and adaptation to diverse environmental 
conditions (reviewed in (8, 9)). Moreover, a high genome plasticity contributes to multi-drug 
resistance and high virulence (for review, see (10)).
The potential of physiological adaptation of a bacterium lies largely at the transcriptional level 
where it is determined by a variety of regulatory mechanisms involving molecules, such as 
RNA polymerase sigma factors, transcription factors, and regulatory RNAs, to modulate mRNA 
synthesis as well as mRNA processing and degradation. Genome-wide transcriptome studies 
analyzing bacterial transcription globally and in a quantitative manner across various environmental 
conditions have provided deep insights into the bacterial transcriptome architectures (11, 12, 
13, 14). In particular, by revealing the repertoire of non-coding RNAs, they raised the interest 
in the regulatory roles of small non-coding RNAs and antisense RNAs (15, 16). A tiling array 
transcriptome study of the Gram-positive model bacterium Bacillus subtilis exposed to a wide 
range of nutritional and environmental conditions established one of the most comprehensive 
repertoires of transcription units in a prokaryote (17). It also evaluated the global contribution of 
a bacterium’s alternative sigma factors to transcriptional regulation and proposed the hypothesis 
that a large proportion of B. subtilis antisense RNAs could be attributed to transcription initiated 
by alternative sigma factors and to imperfect control of transcription termination. This raised 
the possibility that many antisense transcripts may not have a functional role but instead simply 
be generated by imperfect transcription termination and spurious transcription initiation, the 
latter being presumably less deleterious and thus less counter-selected in the course of evolution 
when linked to alternative condition-dependent sigma factors (17). In line with this hypothesis, 
other studies also proposed a possible preponderant role of transcriptional noise in antisense 
transcription based on the weak conservation of promoters associated with these RNAs between 
Escherichia coli and Salmonella enterica (18) and in another group of the Gammaproteobacteria 
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(19). However, the comprehension of the extent of spurious transcription in bacterial genomes 
and its implications remains incomplete (20, 21).
The availability of comprehensive transcriptome data for a particular organism has also proven 
a very useful resource, complementing sequence-based genome annotation, for the respective 
research community. Indeed, the information on the genetic regulatory network of an organism 
provided by the characterization of the wild-type global transcriptome across a wide range of 
conditions is complementary to more classical studies analyzing particular mutants. The most 
prominent interest of the approach is to be largely unbiased as it does not focus on preselected 
regulatory circuits and conditions. Simultaneously, it allows comprehensive and precise mapping 
of all transcriptome parts such as transcription units, non-coding RNA species, and transcription 
start sites. Taking the aforementioned B. subtilis data set as an example, the approach provides 
at least three useful pieces of information that jointly contribute to tackle the general problem of 
discriminating between direct and indirect regulatory effects. First, the observed co-expression 
patterns can complement results obtained in more targeted experiments (22). Second, the data 
facilitate detection of new regulatory RNA molecules (23) . Third, the detailed information on 
transcription units and transcription start sites facilitates the search for potential regulator binding 
sites (24). This is particularly useful for the genome-wide identification of sigma factor regulons, 
since the bipartite degenerate motifs recognized by the sigma factors lie directly upstream of 
the transcription start sites. An unsupervised algorithm to identify and map these motifs by 
combining information from the DNA sequences and the condition-dependent activities of the 
detected promoters was developed (17).
Like B. subtilis, S. aureus is a low G+C Gram-positive bacterium, but it has a smaller genome 
(~2.8 Mbp) than B. subtilis (~4.2Mbp) and a markedly different partitioning of its promoter space 
since only three alternative sigma factors are encoded by its genome. In contrast, the B. subtilis 
genome encodes 18 alternative sigma factors, 14 of which are known to be activated in response 
to environmental conditions or during developmental processes (http://www.subtiwiki.uni-
goettingen.de; (25)). In S. aureus, SigB is the major alternative sigma factor and has been by far 
the most investigated. The functions of SigH and SigS are much less understood. SigH controls 
the transcription of competence genes (26, 27, 28) and seems to be required for stabilization of 
the lysogenic state of staphylococcal phages (29). SigS is a member of the extracellular function 
(ECF) family of sigma factors, and appears to mediate resistance to various stress conditions 
including challenges imposed by components of the innate immune system (30).  
Along with transcription initiation, transcription termination is an essential determinant of 
transcriptome architecture. Two pathways of transcription termination are known of which 
several aspects remain incompletely understood (31). First, intrinsic termination, universal 
to all bacteria, depends directly on the properties of the transcribed RNA sequence and does 
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not involve factors outside the elongation complex. The second pathway involves the protein 
Rho and coexists with intrinsic termination in the vast majority of bacteria (32). Rho is an 
ATP-dependent helicase/translocase that loads onto the nascent RNA, moves 5’-3’ faster than 
the RNA polymerase, and provokes termination after hitting the elongation complex (33). 
By its mode of action Rho is particularly suited to terminate transcription of untranslated and 
unstructured RNAs on which it can load and contact the elongation complex more easily due to 
the absence of ribosomes. Other factors impact on the efficiency of Rho-dependent termination 
like the presence of an appropriate binding site for Rho (rut site) and of a pause site for the RNA 
polymerase. All these properties make the identification of Rho-dependent terminators from the 
sequence alone extremely challenging. In E. coli, Rho-dependent termination accounts for 20-
50% of the termination sites (34). The global, i.e. genome-wide, cellular function of Rho has 
been almost exclusively studied in this bacterium (34, 35, 36) in which it has also been found 
involved in distinct regulatory mechanisms (37, 38). Unlike in E. coli, Rho is dispensable in B. 
subtilis and S. aureus (39, 40) and many intrinsic transcription terminators are identified in their 
genomes (41), suggesting a more minor cellular role of Rho. However, we found that B. subtilis 
Rho is involved in termination of a particular class of transcription units, often initiated by 
alternative sigma factors, with heterogeneous 3’-ends caused by terminator read-through or lack 
of a defined termination site, which typically generate antisense transcripts (17). More than half 
of these were associated with promoters generating non-coding RNAs. At the same time, a study 
on E. coli detected a population of ~1100 antisense transcripts suppressed by Rho, of which 
~40% are generated by antisense promoters within genes (34). Therefore an important function 
of Rho could be to restrain unwanted spurious transcription in E. coli and B. subtilis alike.  
In the present study we have analyzed the condition-dependent transcriptome of S. aureus 
HG001 by strand-specific tiling array hybridizations. This strain was derived from S. aureus 
NCTC 8325, a model strain widely used in genetic and regulatory studies, but it has a repaired 
gene for the SigB activator RsbU (42). The investigated experimental conditions ranged from 
optimal in vitro growth to interaction with host cells. The data thus obtained were analyzed 
in silico, including the systematic mapping of transcription units, annotation of non-coding 
RNAs, the classification of promoters according to their dependency on SigA and SigB, and 
the prediction of potentially new transcription factor target sites. In particular, a Fur-dependent 
sRNA postulated to represent the S. aureus functional analog of FsrA/RyhB was identified. 
Antisense RNAs being of particular interest because of the small number of alternative sigma 
factors used by S. aureus were found to be relatively rare, overlapping only 6% of the annotated 
coding genes. Global analysis of the role of Rho-dependent termination in S. aureus revealed a 




Strains, growth conditions and cell culture infection models
S. aureus HG001 (42) and its isogenic ∆rho mutant were used. The ∆rho mutant was constructed 
according to the procedure described in (43). S. aureus HG001 was grown with shaking at 37°C 
in the following cultivation media: rich medium (TSB), minimal medium (CDM), cell culture 
media (RPMI, pMEM), and human plasma (plasma). Samples of the exponential growth phase 
(exp) as well as 2 hours (t2) and 4 hours (t4) after entry into stationary phase were collected 
by centrifugation with half volume of killing buffer (20 mM Tris pH 7.5, 5 mM MgCl2, 20 
mM NaN3). Pellets were frozen in liquid nitrogen and stored at -80°C until RNA preparation. 
Briefly, CDM (chemically defined medium) contains inorganic salts, glucose, citrate, FeCl3, trace 
elements, vitamins and 2 mM of all 20 proteinogenic amino acids (44). The cell culture media 
RPMI 1640 and MEM are synthetic media commonly used for the cultivation of eukaryotic 
cells. In infection studies, cell culture media are also used for the pre-cultivation of bacteria. 
The adapted cell culture medium pMEM supporting growth of S. aureus consists of HEPES-
buffered MEM and contains amino acids in concentrations of ≥ 2 mM, except for asparagine 
(0.1 mM) and methionine (1 mM) (45). In addition, S. aureus was grown in the presence of the 
cationic antimicrobial peptide colistin (colist) and sub-inhibitory concentrations of the following 
antibiotics: flucloxacillin (fluc) (0,02 µg/mL), vancomycin (vanc) (0.63 µg/mL), ciprofloxacin 
(cipro) (0.1 µg/mL) clindamycin (clind) (0.01 µg/mL), erythromycin (ery) (0.05 µg/mL), 
linezolid (line) (0.1 µg/mL), trimethoprim-sulfamethoxazole (T/Smx) (0.75 µg/mL). 
The cell culture infection experiments were performed with the human bronchial epithelial cell 
line S9 and human monocyte cell line THP-1. For the experiments with S9 cells, exponentially 
growing bacteria were diluted with MEM supplemented with 4 % fetal calf serum (FCS) thereby 
adjusting a multiplicity of infection (MOI) of 25. After adding the bacteria to the host cell layer, 
cell culture plates were incubated for 1 hour at 37°C and 5% CO2 in a humidified incubator. 
During this time bacteria were internalized by the S9 cells. After 1 hour of infection, lysostaphin 
was added to kill remaining extracellular bacteria. After 1.5 and 5.5 hours of incubation (2.5 and 
6.5 hours post infection) samples were taken and internalized staphylococci were isolated for 
RNA preparation (intS9-2h and intS9-6h). In addition, the following bacterial control samples 
were taken: i) non-adherent bacteria at different MOIs which were retrieved from the supernatant 
of S9 cells after 1 h of infection (nonad25-1h and nonad50-1h); ii) S. aureus cells after 1, 2.5, 
and 6.5 hours of incubation in the infection medium at 37°C and 5% CO2 without agitation (CO2-
1h, CO2-2h and CO2-6h); and iii) bacteria after 2.5 hours of anaerobic incubation in pMEM 
medium at 37°C (anaer-2h). For the experiments with THP-1 cells, bacteria were pre-grown in 
RPMI medium with FCS (RPMI/FCS), added to the host cells and incubated at 37°C and 5% 
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CO2 in a humidified incubator . Samples were taken 2 and 6 hours post infection (intTHP1-2h 
and intTHP1-6h).
RNA preparation and tiling array hybridization
Total RNA was prepared by acid-phenol extraction after mechanical cell disruption as described 
previously (17). The tiling array used in this study contains 383,452 probes covering both strands 
of the S. aureus NCTC 8325 genome with a tiling step of 18 nucleotides (46).  Synthesis and 
hybridization of labeled cDNA were carried out at Roche NimbleGen (Madison, WI) using the 
strand-specific method described before (47). All experiments were performed in triplicate with 
RNA isolated from independent cultures. Microarray data have been deposited in the NCBI’s 
Gene Expression Omnibus (GEO) database and are accessible through GEO Series accession 
no. GSEXXXXX.
Northern blot analysis
Northern blot analysis was carried out as described previously (48). The digoxigenin-labeled 
RNA probes were synthesized by in vitro transcription (IVT) with T7 RNA polymerase and gene 
specific PCR products as template. 5 µg of total RNA per lane were separated on 1.2% agarose 
gels. Chemiluminescence signals were detected using a ChemoCam Imager (Intas Science Image 
Instruments, Göttingen, Germany).
Tiling array data analysis
Detection of new transcribed segments, 5’-ends (signal up-shifts), 3’-ends (signal down-shifts), 
the delineation of TUs, and the computation of gene expression values, were performed exactly 
as described for B. subtilis (17). The main steps of these analyses are as follows: For each 
hybridization, the log2 of the raw signal intensity along the genome was analyzed with HMMtiling 
(49) to obtain a smoothed trajectory and the positions of probable breakpoints, accounting for 
random noise and differences in probe affinity as characterized by hybridization of genomic 
DNA (50). The repertoires of up-shifts and down-shifts corresponding to probable transcript 
5’-ends and 3’-ends were established by combining high-confidence breakpoints (credibility 
probability cut-off 0.99) from the different hybridizations. New transcripts (i.e. unannotated in 
GenBank: CP000253) were detected where the lower bound  of the 95% credibility interval for 
the smoothed trajectory reached 10-fold the chromosome median. These segments were further 
split according to breakpoints to avoid aggregation of regions with different transcription levels 
and extended on their 5’ and 3’ extremities according to a more permissive expression cut-off 
(5-fold the chromosome median) to avoid over-segmentation in regions with expression levels 
close to the 10-fold cut-off. Promoter activity was measured as the smoothed signal downstream 
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the position of the corresponding up-shift and a promoter tree was built by hierarchical clustering 
based on estimated pairwise correlation coefficients. Downstream each up-shift, a transcription 
unit (TU) was defined as the maximum continuous region where the expression level remains 
at least 5-fold higher than the chromosome median before dropping below this level or 
encountering another up-shift in at least one RNA sample. Aggregated log2-scale expression 
values for annotated genes and newly detected segments were obtained as the median of the 
smoothed signal for probes lying entirely within the considered region. For most analyses gene-
level values were quantile-normalized to make them more comparable between hybridizations.
The methods used to analyze the ∆rho-mutant data included probe-level normalization and 
differential expression analysis to detect up-regulated and down-regulated regions. Briefly, 
normalization of whole-genome transcription profiles involved fitting a quantile-normalization 
transformation on the aggregated expression values computed for the repertoire of expression 
segments and applying this transformation on the smoothed probe-level data genome-wide. 
Contiguous probes exhibiting up- or down-regulation at the specified fold-change and false 
discovery rate cut-offs were reported as differentially expressed regions.
Sequence analysis of transcript 5’-ends and 3’-ends
The classification of promoters, based on the presence of sigma factor binding site motifs 
around the up-shifts (-60bp, +40bp) was performed with the software ‘treemm’ (17) that also 
takes into account expression profiles across hybridizations. Other transcription factor binding 
sites (TFBS) were searched with MAST v4.9.0 (51) using position weight matrices built from 
known binding sites. For this purpose, we retrieved from the RegPrecise database v2.1 (52) 
the manually curated binding sites across Staphylococcaceae for the transcription factors listed 
for S. aureus N315. For WalR and GraR, not in RegPrecise, we used the binding sites listed in 
(46, 53, 54). The resulting position weight matrices were used as queries in MAST searches 
against the database of the sequences around the up-shifts (-100bp, +50bp; E-value cut-off 1). In 
keeping with the orientations of binding sites listed for S. aureus in RegPrecise, we considered 
only the occurrences with the same orientation as the up-shifts, except for WalR for which we 
took both strands into account. We compared the position of signal down-shifts to predictions 
of intrinsic terminators available at http://transterm.cbcb.umd.edu/tt/ that were made from the 
sequence alone with the software TranstermHP (41).
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Results
Comprehensive analysis of the S. aureus transcriptome
The transcriptome of S. aureus HG001 was analyzed using 156 RNA samples taken under 44 
different experimental conditions. These included exponential and stationary growth phases in 
various media with or without sub-inhibitory concentrations of clinically relevant antibiotics, 
growth in human plasma, and internalization by eukaryotic cells. Figure 1 shows the resulting 
transcription profiles for selected genomic regions.
Using a stringent signal threshold of 5-fold higher than the chromosome median (17), a 
remarkably high proportion (2524/2836; 89%) of annotated CDSs was expressed under at least 
one biological condition. Of these, 110 CDSs (3.9% of all CDSs) were found to be always highly 
expressed, i.e. rank in the 30% most highly expressed CDSs under all the conditions tested. This 
group comprises genes encoding ribosomal proteins and translation factors (18 genes), enzymes 
of central carbon metabolism (14), proteins involved in cell division and cell wall metabolism 
(10), RNA polymerase subunits (rpoA, rpoB, rpoC, sigB), and proteins involved in oxidative 
stress management (rex, perR, katA, ahpC, ahpF). Half (55/110) of the genes that were highly 
expressed under all conditions in our study, belong to the group of 351 genes of S. aureus NCTC 
8325 identified as essential for survival and growth in vitro (55).
Overall expression patterns under the different physiological conditions
To elucidate the main physiological adaptations caused by the biological conditions of our study, 
we conducted a Principal Component Analysis (PCA). This approach allowed to assess the 
general relationships between the 156 RNA samples in terms of expression profiles composed of 
aggregated values for all annotated genes and newly discovered RNA features (Figure 2A). The 
percentage of total variance captured by the successive axes revealed a major first axis (48.9%) 
followed by minor axes of smoothly decreasing importance such that 67.6% of the total variance 
could be captured with 3 axes, but 13 axes are needed to reach 90%. To gain insights into the 
biology underlying the variance associated with each axis, we investigated how the position on 
the axis correlated with the expression of each gene and which genes contributed most to the 
definition of the axis, analyzed the position of the RNA samples on the axis (Figure 2A), and 
compared how well the position on the axis describes the whole expression profile of a given 
RNA sample (root mean squared error (rmse). To account for most of the complexity of our data 
set (91.6% of the total variance, median rmse 0.31) we examined axes 1 to 15.
The first PCA axis can be interpreted as the reflection of the growth phase. While transition to 
stationary phase is certainly associated with massive changes in gene expression, the strong 
impact of the growth phase on the total data variability also arose from the study design. The 
genes whose condition-dependent expression profiles were correlated with the position of the 
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samples on the next two axes revealed for axis 2 that genes of several amino acid biosynthetic 
pathways had strong negative correlation coefficients. In the case of axis 3 some level of positive 
and negative correlation, respectively, with genes induced in response to anaerobiosis (srrA) 
and oxidative stress (sufS; trfA/ SAOUHSC_00935) was observed. Thus, the second axis most 
likely reflects amino acid availability, whereas the third axis might to some extent reflect the 
difference between aerobic and anaerobic conditions, which is supported by the position of 
the anaerobic growth condition (samples “anaer-2h”) on the third PCA axis. Many other axes 
of lesser importance in terms of fraction of total variance were also clearly linked to particular 
biological conditions and/or gene functions. In particular, as pointed out by the analysis of the 
rmse’s, the next two axes contribute to describe exponential growth in RPMI (axis 4  ) and 
the effects of colistin (axis 5), whereas axes 7 and 10 refine the description of the S. aureus 
transcriptome after internalization by eukaryotic cells and in human plasma, respectively. In 
addition to the PCA representation we displayed the expression profiles of selected reference 
Figure 1. Transcriptional landscape reconstruction leads to a new annotation of the S. aureus HG001 genome. 
Panels (A-G) show examples of the different categories of transcription segments outside annotated CDSs and RNA 
genes. Each panel shows from top-to-bottom (i) the original GenBank annotation, (ii) a selection of 30 representative 
expression profiles (horizontal black lines show for each strand the chromosome median, and the associated 5-fold 
and 10-fold cut-offs) colored according to the position of the hybridization in 3D PCA, (iii) the detected up-shifts, 
the associated transcription units, and the down-shift positions, (iv) the new annotation with unannotated expressed 
segments colored according to the classification based on the  transcriptional context. The different categories of 
terminal regions are 5’UTR and three classes of 3’ regions: 3’UTR ending with a defined termination site, 3’NT 
without defined termination site, and 3’PT downstream a site of partial termination. Two categories of intergenic 
regions are distinguished: intra for strictly intracistronic regions, and inter for regions where the downstream gene 
can be transcribed from its own promoter. Finally, depending of the presence or absence of a defined termination site, 
independent segments decompose into two categories: indep and indep-NT. Transcription segments overlapping 
(≥100bp or ≥50%) GenBank annotated genes on the opposite strand are referred to as antisense (AS).
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genes for limitations in amino acids, iron and oxygen (Figure 2B). PCA and expression profiles 
of reference genes clearly showed that the eukaryotic cell culture medium RPMI resembles 
the conditions S. aureus experiences in human plasma. As expected, the expression levels of 
iron-regulated genes  were highest during growth in human plasma and RPMI medium. Cells 
entering stationary phase in these media differed from the same time point in the other growth 
media by occupying a lower position on the first axis. In addition, the RPMI stationary phase 
samples were characterized by very low positions on the second and third principal components. 
The position of the RPMI-t4 phase samples on the second axis is most probably the consequence 
of the lower amino acid concentrations in this medium compared to the other synthetic media 
used in this study (CDM and pMEM). Indeed, time-resolved exometabolic profiles of S. aureus 
strains during growth in RPMI medium revealed that amino acids were largely taken up during 
the exponential growth phase (56). 
From the overall gene expression patterns (Figure 2A) it appears that the physiological state of 
S. aureus cells internalized for 2 and 6 hours, respectively, by human THP-1 macrophages or S9 
bronchial epithelial cells resembled exponential rather than stationary phase cells, reflecting the 
recently described intracellular growth behavior of S. aureus (57). The position of these samples 
on the second PCA axis suggested that S. aureus is particularly faced with reduced amino acid 
availability upon internalization by eukaryotic cells, which was confirmed by examination of 
reference gene expression (Figure 2B). The position on axis 7 pointed to the upregulation of 
transporter genes as already observed during internalization of S. aureus by A549 cells (58), 
in particular for glycerol, glucose-6-phosphate and phosphate (the latter specifically after 
internalization by S9 cells). Moreover, after internalization by THP-1 macrophages one of the 
four reference genes selected as reporter for oxygen limitation (ldh1) exhibited a moderate level 
of induction and, at the later time point of internalization, genes responsive to iron limitation 
were up-regulated inside both eukaryotic cell lines (Figure 2B). 
Expression patterns of virulence-associated genes 
As illustrated by the PCA and expression profiles of selected reference genes, the variance in 
the data set reflects environmental conditions encountered by S. aureus during colonization 
and infection such as changing amino acid, iron or oxygen availability. Thus, we examined the 
expression of 47 virulence factors comprising adhesins, immunomodulatory proteins, toxins, and 
secreted enzymes (59, 60)  ) throughout the different laboratory and infection related conditions 
(Figure 2B  ). 
The virulence-related genes showed a great diversity of expression profiles and all of them 
were    expressed under at least one of the growth conditions. Furthermore, as many as 37  (79%) 
genes were found to be at least two-fold upregulated (q-value≤0.05) after internalization by 
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Figure 2. The diversity of S. aureus HG001 wild-type expression profiles across 156 RNA samples from 44 
laboratory and infection-related experimental conditions. (A) The left subpanel shows a 3D representation of the 
relationships between the 156 RNA samples. This projection obtained by Principal Component Analysis accounts 
for ~67% of the total variance in the initial space of the expression levels of 4028 chromosomal regions (annotated 
genes and new segments). A different color was associated to each RNA sample according to its position in the 3D 
space, each axis being associated with a different color component (R/G/B). The right sub-panel displays the 156 
RNA samples along a single horizontal axis corresponding to the shortest tour also represented by a black polygonal 
path in the 3D representation. Below the horizontal axis, a unique identifier of the biological condition is reported 
vertically (when consecutive RNA samples arise from the same biological condition only the first biological replicate 
is labeled). Above the horizontal axis, three curves indicate the coordinates of the RNA samples on the three first 
axes of the PCA. (B) Heatmap representation of the expression profiles of selected genes: reference genes for 
amino-acid, iron and oxygen limitation; genes known to be involved in virulence ordered by hierarchical clustering. 
On the left-hand side, the scale bar provides the correspondence between colors and quantile-normalized expression 
levels. (C) Activity of the SigA and SigB regulons across RNA samples computed as the average expression level 
of SigA-dependent and SigB-dependent promoters identified by our analysis. On the left-hand side the consensus 
motifs (shown as sequence logos) defined by our analysis indicate the characteristics of the different types of sigma-
factor binding sites.
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human THP-1 macrophages and/or S9 bronchial epithelial cells. A subset of 13 (28%) genes 
(chp, eap, emp, hlb, hlgB, hlgC, lukD, lukE, scn, splA, splB, splC, vwb) even reached their 
highest expression levels in internalized staphylococci, much more than expected by chance 
(only 6% of all the genes reach their highest expression in these conditions). Most of the 37 
genes  that showed increased expression upon internalization are known as direct targets of the 
two-component system SaeRS, an important regulator of S. aureus virulence gene expression 
(61, 62).
Virulence factor genes that were particularly highly expressed during growth of S. aureus in 
human plasma (Figure 2B) comprised spa encoding the immunoglobulin-binding Protein A, isdA 
and isdB encoding iron-regulated surface determinant proteins involved in adhesion and heme-
iron acquisition as well as four SaeRS-regulated genes, namely efb (encodes fibrinogen binding 
protein), sbi (encodes immunoglobulin binding protein), chp (encodes chemotaxis inhibiting 
protein CHIPS), and scn (encodes staphylococcal complement inhibitor SCIN), which are all 
involved in evasion of immune responses (63). Five of these genes (spa, isdA, isdB, efb, and sbi) 
exhibited the highest expression levels in plasma-grown bacteria.
Transcriptional response of S. aureus to sub-inhibitory concentrations of antibiotics 
S. aureus grown in the presence of sub-inhibitory concentrations of clinically relevant 
antibiotics (vancomycin, flucloxacillin, ciprofloxacin, clindamycin, erythromycin, linezolid, 
and TMP-SMX) exhibited overall very minor gene expression changes, except for ciprofloxacin 
(exponential and stationary phase) and flucloxacillin (stationary phase) (Figure 3).
Mapping transcript ends and transcription units
For each of the 156 tiling array profiles, the transcribed regions (TRs) as well as the positions of 
abrupt signal increases and decreases (called up-shifts and down-shifts) were detected. The 1523 
RNA 5’-ends derived from the high-confidence up-shift positions are indicative of promoter 
sequences (17). Downstream of these putative promoters, we delineated 1418 transcription units 
(TUs). According to this list of TUs, approximately one-fifth (22%) of the previously annotated 
CDSs can be transcribed from more than one promoter under the condition tested.
The analysis identified 1261 high-confidence signal down-shift sites, which correspond to the 
RNA 3’-ends. RNA polymerase dissociates without the need for the termination factor Rho at 
intrinsic termination sites, which are characterized by an RNA hairpin followed by a stretch of U 
residues. When correlating with a genome-wide prediction of intrinsic transcription terminators 
based on local sequence properties using the TransTermHP software (41) with default parameters, 
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Identification and classification of RNA features
The TRs outside of annotated CDSs and RNA genes were assigned to 1192 RNA segments (S1 
to S1192) according to their structural relationship with neighboring genes. Our classification 
illustrated in Figure 1 indicates in particular the positions within TUs: 5’ of the coding region 
(5’UTR), intergenic (intra, inter), or 3’ of the coding region (3’UTR, 3’PT, 3’NT). Substantial 
complexity arises from situations of incomplete transcription termination: the suffixes PT and 
NT indicate 3’UTRs following partial termination (PT) and 3’UTRs associated with lack of 
a termination site and slow decrease in signal intensity (NT); segments referred to as “inter” 
result from continuation of transcription into a downstream region located between two TUs. 
For the RNA features transcribed from their own promoter (independently of annotated genes), 
two types of segments (indep, indep-NT) are also distinguished depending on the presence of 
a defined termination site. The complete results are summarized in Table 1. The annotation of 
transcribed segments along the chromosome is available via the Expression Data Browser at 
Figure 3. Transcriptional responses to ciprofloxacin and flucloxacillin. The presented Voronoi treemaps 
are based on the KEGG gene onthology for S. aureus, visualizing the functions of different genes. Each 
small field represents an individual gene. (A) Responses to ciprofloxacin during exponential growth, (B) 
responses to ciprofloxacin during post-exponential growth, and (C) responses to flucloxacillin during post-
exponential growth. Genes that are down-regulated are indicated in blue and genes that are upregulated in 





Our study identified the largest part (48/50) of the (predicted) non-coding RNAs of S. aureus 
NCTC 8325 from the Rfam database (64), including the generic RNAs 6S RNA, 4.5S RNA, 
tmRNA, RNase P, 33 cis-acting 5’-UTRs, and 11 trans-encoded sRNAs including RNAIII (65) 
and SprD (66). In addition, a multitude of non-coding RNAs of S. aureus has been predicted 
and/or experimentally identified by different global approaches, mostly for S. aureus N315 (67, 
68, 69, 70, 71, 72, 73). About 90 of these were confirmed by Northern Blot analysis or RT-qPCR 
(reviewed in (74). According to Felden et al. (2011)(74), the RNA-seq based study by Beaume 
et al. (2010)(73) confirmed almost all non-coding RNAs from earlier studies. Therefore, we 
referred to known non-coding RNAs of S. aureus by mapping the 186 intergenic transcripts 
(including 25 ASRNAs) of N315 reported by Beaume et al. (2010) onto the NCTC 8325 genome 
(73) . For 110 of 132 uniquely mapping transcripts our study detected a counterpart in the NCTC 
8325 transcriptome. The remaining 22 transcripts were not detected because their expression 
levels were either below the threshold value defining transcribed regions, or because these 
transcripts were absent from S. aureus NCTC 8325, at least under the conditions tested.
The 23 Indep or Indep-NT segments which are not ASRNAs or associated with predicted new 
CDSs represent potential trans-encoded regulatory RNAs (sRNAs). Of these, three are generic 
RNAs (tmRNA, 6S RNA and 4.5S RNA) and 11 correspond to intergenic transcripts of N315 
(73) classified as bona fide sRNAs. Of the remaining nine RNAs, S481 represents the cis-acting 
5’-regulatory region of pyrR. The other eight RNAs (S35, S109, S204, S414, S736, S774, S808, 
Table 1. Summary of the new transcription segments.
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and S1077) were apparently newly identified by our study and might be specific for strain 
NCTC 8325 or the applied growth conditions. In order to verify the novelty of the eight RNAs, 
we extended the comparison with earlier results by searching against the 45 experimentally 
confirmed trans-encoded sRNAs compiled by Felden et al. (2011)(74). Investigation of the 
expression patterns of these RNAs revealed that two of them (S736 and S808) were highly 
expressed under all growth conditions and S1077 specifically during growth in RPMI medium. 
The expression of the other five genes was slightly lower; S414 and S774 were additionally 
downregulated in the stationary phase. Interestingly, S414 was most highly expressed during 
growth of S. aureus in human plasma.
ASRNAs accounted for 145 (12%) of the 1192 RNA features identified by our study and occurred 
at a rate of 0.051 per Kbp. With respect to the coding genes, 6.2% (175/2836) of all CDSs were 
overlapped by ASRNAs under the set of growth conditions applied. A relatively small fraction 
(13%, 19/145) of the ASRNAs belonged to the group of RNA features generated independently 
of annotated genes (categories Indep and Indep-NT). In B. subtilis, using similar criteria to 
define ASRNAs but with a higher number of different biological conditions, the rate of ASRNAs 
was 0.10 per Kbp, the proportion of overlapped genes reached 13%, and RNAs classified as 
Indep and Indep-NT accounted for 21% (88/423) of the ASRNAs (17). ASRNAs appeared thus 
less frequent and less often initiated from their own promoter in S. aureus than in B. subtilis.
Promoters controlled by the alternative sigma factor SigB
In previous transcriptomic and proteomic studies (75, 76, 77, 78, 79, 80) the assignment of 
genes to the SigB regulon was based on the comparison of expression levels in SigB-proficient 
strains versus strains lacking (active) SigB, which entails that not all of the proposed target 
genes are directly influenced by SigB. By using an approach of promoter classification originally 
developed for the genome-wide de novo identification of sigma factor regulons in B. subtilis 
based on tiling array data (17), a binding site for SigA or SigB (the only two sigma factors 
expected to be active in strain NCTC 8325) could be assigned to most (1412, 93%) of the 1523 
S. aureus up-shifts identified by our study (Figure 4). 
Out of these 1412 promoters, 145 were classified as SigB-dependent promoters (10% versus 
6% in B. subtilis). An average activity profile for these promoters is shown in Figure 2C. It 
appears that induction ratios of SigB-controlled genes in S. aureus are rather moderate (~10-
fold) when compared to B. subtilis (~60-fold ), mainly due to higher basal activity.  The 
conditions of SigB induction seem also much less specific since the average activity of the SigB 
promoters is higher than the average activity of SigA promoters in 49% of our sample (9% in B. 
subtilis). Furthermore, unlike in B. subtilis, the predicted SigB promoters form distinct clusters 
in the promoter tree summarizing the pairwise correlations of promoter activities (Figure 4) 
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Figure 4. Promoter tree, sigma-factor and TFBS predictions. From top to bottom, the figure includes the following 
elements: A promoter tree built by hierarchical clustering of promoter activities across RNA samples based on 
pairwise correlations. The classification of up-shifts according to the type of sigma-factor binding sites identified 
(black bars for SigA, orange bars for SigB, gray bars for lack of sigma-factor binding site identification). The 
clusters of size ≥15 promoters were obtained when splitting the tree at an average Pearson correlation coefficient 
0.6. The TFBSs were identified by MAST search. Here, the different transcription factors listed on the left-hand 
side of the plot along with the counts for three different categories of up-shifts. The color codes used for counts and 
symbols are: blue for sites predicted by MAST search and included in the training (RegPrecise) set, red for sites in 
the training set but not identified by our MAST search, green for sites predicted by MAST search but not listed in 
the training set.
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underscoring a substantial diversity of activity profiles. While, in agreement with the results 
of former studies, the general pattern is an induction of SigB promoters in stationary samples 
(cluster B7), some SigB promoters are more specific for RPMI medium (cluster B10) and others 
are not induced in this medium (cluster B8).  On average, activity was highest during stationary 
phase in TSB and CDM, but also occurred in the other growth media except for human plasma 
and not always associated with stationary phase such as in CDM exponential phase samples 
(Figure 2C). A recent proteome study reported the activation of SigB following internalization 
of S. aureus by S9 cells (81). In our data we see a week induction at the early time point after 
internalization (2 and 2.5 hours, respectively, post-infection) of S. aureus by S9 epithelial cells 
and THP-1 macrophages which disappeared at the second time point (6 or 6.5 hours post-
infection). It is also interesting to note that in the promoter correlation tree we find promoters 
predicted as SigA-dependent even in the clusters the most enriched in SigB promoters (B7, 
B8 and B10), suggesting that relatively similar expression profiles are generated by different 
regulatory mechanisms.
Based on the repertoire of transcription units defined by our study, 249 genes have been found to 
be preceded by a SigB binding site. Out of these 249 genes, 163 genes (65%) were considered 
as SigB-regulated by (one of) the previous studies. Among the predicted SigB regulon members 
were the known SigB-dependent sRNA RsaA (S210/S211) (68) involved in virulence factor 
regulation through repression of the transcription factor MgrA (82), and a newly identified Indep-
MT ASRNA (S22) that covers SAOUHSC_00056 encoding a putative AraC family regulator.
Considering the ASRNAs, 12% (18/145) were identified as transcribed from SigB-dependent 
promoters, and the percentage dropped to 5% (1/19) for the ASRNAs belonging to categories 
Indep and Indep-MT. Of note, it was not always possible to classify ASRNAs as SigA or SigB-
dependent since identification of a promoter lacked for some transcribed segments, nevertheless 
75% (109/145) of the ASRNAs were identified as transcribed from SigA-dependent promoters. 
Interestingly, the proportion of ASRNAs identified as SigB-dependent in S. aureus is sharply 
less than the total contribution of alternative sigma factors to AS transcription in B. subtilis since 
in this organism 50% (213/423) of the ASRNAs were predicted to be transcribed by one of the 
alternative sigma factors and the percentage raised to 68% (60/88) for the ASRNAs classified as 
Indep or Indep-NT. The difference was not a simple consequence of the multiplicity of alternative 
sigma factors in B. subtilis, since SigB-generated ASRNAs occurred at rate 0.0067 Kbp-1 in S. 
aureus versus 0.012 Kbp-1 in B. subtilis. This lower abundance was even more pronounced for 
the ASRNAs belonging to the categories Indep and Indep-MT: 0.00035 Kbp-1 in S. aureus vs. 
0.0038 Kbp-1 in B. subtilis. In sharp contrast, the rates of SigA-dependent ASRNAs tended to be 
similar between the two organisms with 0.039 Kbp-1 in S. aureus vs. 0.057 Kbp-1 in B. subtilis 
and 0.0057 Kbp-1 vs. 0.0047 Kbp-1 for the categories Indep and Indep-MT.
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Transcription factor binding site analysis to predict new regulon members
Coordinated regulation of promoter activities is summarized in the promoter correlation tree and 
the associated clustering based on promoter activity profiles: 1242 up-shifts (82%) belonged to 
16 activity clusters with ≥15 members defined by a cutoff on average Pearson correlation set 
to 0.6 (Figure 4). The largest cluster (B1) alone gathered 46% of all the up-shifts. We used the 
known information on transcription factor (TF) regulons to better understand the contribution of 
TFs other than SigB in the regulations underlying these correlations. In particular we relied on the 
experimentally identified and manually curated inferred targets of 47 TFs from the RegPrecise 
database (52), for the identification of additional potential TF binding sites (TFBSs). The 
assignment of known and the prediction of new TFBSs requested their location in the promoter 
regions derived from the tiling array data, i.e. in the region -100 to +50 centered at one of the 
up-shift positions. The analysis was performed using MAST search based on consensus motifs 
built from known binding sites. This analysis allowed to identify 623 known or predicted TFBSs 
associated to a total of 470 up-shifts. These sites were unevenly distributed in the correlation 
tree (Figure 4). In particular, SigA-dependent promoters outside the largest activity cluster (B1) 
were markedly more frequently associated with identified TFBSs (46%) than SigA-dependent 
promoters inside this cluster (23%) or SigB-dependent promoters (19%). Furthermore, each of 
the four smaller clusters of SigA-dependent promoters standing out by their level of internal 
correlation (i.e. with the lowest diversity of induction profiles inside the cluster) was found 
associated with a distinct TF: B3 (50 promoters) with the master regulator of carbon catabolite 
repression CcpA, B5 (45 promoters) with the global nutritional regulator of stationary phase 
adaptation and virulence CodY, B14 (32 promoters) with the ferric-uptake regulator Fur, and 
B25 (21 promoters) with the redox-sensing transcriptional repressor Rex. 
For a number of regulons the MAST search allowed new predictions with strongly correlated 
expression profiles, in particular for Fur, Rex, CodY, and CcpA (Figure 4). For the Rex repressor 
involved in anaerobic gene regulation, altogether 9 promoters were newly identified, of which 
two clustered with the 14 known Rex-controlled promoters in B25. The potential new Rex 
targets associated with these promoters are two predicted membrane proteins of unknown 
function (SAOUHSC_00146 and SAOUHSC_01133). As a second example we looked at the 
Fur regulon for which 9 promoters with newly predicted binding sites were found in cluster B14 
together with the majority of known Fur-dependent promoters. Fur is a global regulator of iron 
homeostasis which generally represses genes for siderophore biosynthesis and iron transport 
under iron-sufficient conditions (83); in S. aureus, several iron uptake systems are known to 
be controlled by Fur (84, 85). Importantly, of 21 annotated genes associated with the 9 newly 
predicted Fur-regulated promoters mentioned before, 10 genes are implicated in iron/trace metal 
transport (fhu/SAOUHSC_02246, opp-1 operon, mntABC) or iron release from heme (isdI/
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SAOUHSC_00130). Except for mntABC, Fur-dependent regulation has already been reported 
for these 10 genes (86, 87) but with different localization of the Fur box. For instance, contrary 
to previous predictions, the identified Fur binding site mediating iron-dependent regulation of 
the opp-1 genes encoding a transporter for cobalt and nickel (88) is located upstream of the 
co-transcribed dapF gene (SAOUHSC_02770). Similarly, the Fur binding site implicated in 
regulation of the heme oxygenase gene isdI is located in the promoter region of the upstream gene 
of unknown function (SAOUHSC_00131). The MntABC manganese transporter is known to be 
controlled by the manganese-responsive MntR repressor. Modulation of manganese homeostasis 
by iron involving Fur indirectly has already been reported for B. subtilis and Sinorhizobium 
meliloti (89, 90). It is therefore interesting to note that our data suggests direct regulation by Fur 
in addition to MntR.
TFBS prediction also revealed a potentially Fur-dependent non-coding RNA (S596) located on 
the opposite strand of a 66 amino-acid long annotated CDS (SAOUHSC_01422) of unknown 
function. Annotation of SAOUHSC_01422 might be incorrect since short CDSs are notoriously 
difficult to identify. Indeed, an amino-acid level similarity search with blastp retrieves significant 
hits only with other hypothetical proteins of S. aureus and a few other Staphylococcus species. 
According to the SHOW CDS prediction software (91) the confidence probability associated with 
this putative CDS is also very low (value of 0.18). For this reason we consider that S596 may 
not be a cis-regulatory ASRNA, but a trans-regulatory sRNA. Indeed, the occurrence and role 
of Fur-dependent sRNAs was reported particularly for Gram-negative bacteria (e.g. RyhB of E. 
coli), but also B. subtilis (FsrA) and other Bacillus species (reviewed in (92)). Target prediction 
for S596 using CopraRNA (93) revealed enrichment of genes encoding iron-containing proteins 
and of genes with functions in cofactor metabolism, being in perfect agreement with the iron-
sparing response mediated by known Fur-regulated sRNAs. Specifically, S596 is predicted to 
repress the expression of genes encoding iron-sulfur-cluster containing enzymes (citB, fdhA, 
addB, ilvD, and miaB), heme biosynthesis enzymes (ctaA and hemE) and citrate synthase (citZ).
Transcription termination of TUs identified in the S. aureus wild-type is predominantly 
Rho-independent 
Specific sequence elements, typically encoding a hairpin structure followed by a U-rich tract, 
direct dissociation of the RNA polymerase from the DNA template at intrinsic termination 
sites. As mentioned above, these elements searched here with TransTermHP were found for 
67% of the 1261 identified high confidence down-shifts suggesting that intrinsic termination 
determines the 3’-end of a majority of the TUs with defined termination sites in S. aureus. 
Transcription termination in bacteria can also be mediated by the transcription termination 
factor Rho (for review, see (31)). In B. subtilis, where most down-shift sites were also found 
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associated with predicted intrinsic terminators, Rho was shown to be involved in termination of 
a particular class of TUs lacking a defined 3’-end and instead characterized by slowly decreasing 
expression, obviously due to the lack of an efficient intrinsic terminator (categories 3’PT and 
3’NT comprising 3’-extended mRNAs, and category Indep-NT) (17). The majority of these 
3’-regions were antisense transcripts of annotated genes . In S. aureus, only 19 (6.7 per Mbp) 
TUs lacked a defined termination site (3’NT and Indep-NT, Table 1), which is strikingly less 
than the 120 TUs (28.5 Mbp-1) found in B. subtilis; the 3’PT and AS segments were also about 
twice less frequent than in B. subtilis (26 vs. 78, 9.2 vs. 18.4 Mbp-1 for 3’PT; 145 vs. 423, 51.4 
vs. 100.3 Mbp-1 for AS). Together with the very limited impact of rho-deletion on the growth 
of S. aureus (see below) this raised the question of determining the targets of Rho-directed 
termination in this organism and prompted the analysis of the whole-transcriptome profiles of 
a rho-deletion mutant. Chromosomal regions with Rho-dependent changes in transcript levels 
were mapped by comparing the normalized tiling array transcription profiles of the ∆rho mutant 
and the parental strain HG001 harvested during exponential growth and four hours after entry 
into stationary phase in TSB rich medium and RPMI cell culture medium. In both media, growth 
of the S. aureus ∆rho mutant was almost similar to that of the parental strain, except reaching a 
slightly lower final OD (data not shown). 
When examining the TUs belonging to the 3’NT and Indep-NT classes, it was observed that 
most of them (12/19) possessed 3’-extensions in the ∆rho mutant relative to the parental strain 
(Figure 5A), supporting the assumption that termination of this class of TUs depends on Rho 
as previously shown for B. subtilis. Of the remaining seven TUs, three were not expressed in 
wild-type cells under the selected growth conditions and one exhibited higher expression levels 
in the mutant thus not allowing to conclude on the contribution of read-through to the observed 
3’-extension.
Extension of TUs lacking an intrinsic terminator (3’NT and Indep-NT) accounted for only a very 
small fraction of the increase in transcript levels detected in absence of Rho and we therefore 
decided to analyze all chromosomal regions where normalized transcript levels were 4-fold 
higher in the ∆rho mutant than in the parental strain in at least one of the four conditions (Table 
2, Figure 4A). These individual regions were up to 38 Kbp long. Globally, the fraction of the 
chromosome with higher transcript levels in the absence of Rho was largest during exponential 
growth (RPMI medium: 1.51 Mbp; TSB: 0.91 Mbp) and much smaller during stationary phase 
(RPMI-t4: 0.54 Mbp; TSB-t4: 0.16 Mbp). Despite these differences of magnitude, the regions 
subjected to up-regulation were remarkably consistent between conditions: out of the 1.65 Mb 
(distributed in 416 regions) identified in at least one of the four conditions, as much as 92% (1.51 
Mb in 358 regions) were upregulated in the absence of Rho during exponential growth in RPMI 
medium (Table 2). Importantly and expectedly, the predominant effect of Rho deficiency was 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































clearly up-regulation; using similar criteria as for up-regulation we detected only 0.16 Mbp (in 
195 regions) exhibiting down-regulation. We also noticed that the magnitude of the effect of the 
absence of Rho tended to be consistent with the expression level of rho in the S. aureus wild-
type, which is higher during exponential growth than in stationary phase, particularly in TSB 
medium. Indeed, the expression level of rho probably reflects its importance that may itself well 
be a direct function of the global level of transcriptional activity.
It was expected that most of the up-regulated regions in the ∆rho mutant would result from 
extensions beyond the transcript 3’-ends due to read-through of Rho-dependent terminators. 
We quantitatively estimated this fraction by examining whether termination sites with more 
than 2-fold higher transcript levels in the region after the down-shift positions between ∆rho 
mutant and wild-type correspond to the 5’-end of an up-regulated region in the ∆rho mutant 
identified in the same condition. The analysis revealed that the number of up-regulated regions 
that could be linked to these read-throughs is indeed rather limited. For instance, in the condition 
of exponential growth in RPMI, where the effect of Rho deletion was most pronounced, only 
59 out of the 358 up-regulated regions were linked to read-through transcription (53) or lack of 
an intrinsic terminator (6) (Table 2). Together, in the three conditions with the strongest effect 
of Rho deletion, we detected only 60 termination sites at which read-through transcription can 
be assumed to contribute significantly to higher downstream transcript levels in the mutant. 
Complete read-through occurred at three termination sites, whereas in most cases only a limited 
level of read-through in the absence of Rho was observed (Figure 5A) . Of note,   the terminators 
with altered termination efficiency in the ∆rho mutant did not predominantly correspond to 
down-shift sites lacking a predicted intrinsic terminator.
Rho prevents genome-wide appearance of new antisense transcripts
Besides read-through transcription or lack of an intrinsic terminator another source of up-regulated 
regions in the ∆rho mutant is the higher expression of coding genes sometimes followed by 
(often long) downstream extensions (Figure 5A) . These altered expression levels are likely to be 
indirect regulatory effects caused by Rho deficiency. Altogether, 180 genes were strongly (more 
than 4-fold) up-regulated in the mutant in at least one of the four growth conditions. The highest 
number of up-regulated genes (148) was observed during exponential growth in RPMI, but only 
45 of the 358 up-regulated regions were connected to higher expression of coding genes (Table 
2). Our analyses indicate that, taken together, read-through transcription (including extensions 
of TUs lacking a defined 3’-end in the wild type) or higher expression of coding genes (Table 2) 
could not account for more than one third of the up-regulated regions.
The largest group of Rho-dependent transcripts was indeed formed by those not identified in 
the S. aureus wild-type transcriptome. These transcripts, instead of possessing 3’-extensions 
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generated by read-through at TU ends, were antisense transcripts only detectable in the absence 
of Rho (Figure 5A, middle panel). Globally, of the 1.65 Mbp covered by the 416 regions up-
regulated in the ∆rho mutant, only 11% corresponded to annotated genes or RNA segments 
detected in this study , whereas 76% mapped to the antisense strand of annotated genes (Table 
2). As much as 52% of the 2.37 Mbp of annotated genes was overlapped on the antisense strand. 
Often, long genomic regions were covered by antisense transcripts in the ∆rho mutant as, for 
example, the complete prophages phi11 and phi12 that are each approx. 40 kbp long. In these 
regions, the increase in antisense transcript levels in the ∆rho mutant was most pronounced 
during exponential growth in RPMI and TSB, conditions of low prophage gene expression. 
Presumably, in the case of antisense transcripts only detectable in the ∆rho mutant, very short 
and/or unstable transcripts are generated in the wild-type because Rho terminates transcription 
shortly after initiation from promoters that are thus normally cryptic. However, Rho inactivation 
did not induce additional strong defined up-shift sites comparable to typical promoters as 
indicated by visual inspection of the transcription profiles and a systematic search for up-shifts 
in the mutant with the criteria applied for the initial mapping of the wild type promoters. Instead, 
the patterns of transcription in the ∆rho mutant seem shaped by “pervasive” low-level promoter 
Table 2. Characteristics of regions up-regulated in the ∆rho mutant across four experimental conditions.
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activity. This raised the interesting question whether the action of Rho and/or this “pervasive” 
promoter activity is really more pronounced on the antisense strand or simply masked by the 
higher levels of normal transcriptional activity on the sense strand. In RPMI where antisense 
up-regulation was the strongest, the median log2-ratio between the Δrho mutant and the wild-
type was -0.13 (no global up-regulation) for the 292 annotated genes (sense level) with log2 
expression signal ≤8 in the wild-type, as compared to 1.11 (global up-regulation) for the 2453 
antisense transcripts of annotated genes with log2 expression signal ≤8. This indicates that sense 
strands are indeed not subjected to the same amount of up-regulation than antisense strands in 
absence of Rho.
Inhibition of E. coli Rho by bicyclomycin and deletion of rho in B. subtilis also led to the 
identification of Rho-dependent transcripts initiated from promoters undetected in control 
conditions (17, 34). However, only a limited number of loci were concerned in E. coli and B. 
subtilis, whereas our results indicate that such “cryptic” promoters are a prevalent source of 
new transcripts in the S. aureus rho-deletion mutant. As the S. aureus genome is markedly more 
A+T-rich we wanted to examine whether this result might be a consequence of the different 
genome compositions of these organisms. For this purpose, we compared the rate of occurrence 
of the TATAAT hexamer corresponding to the canonical core of the -10 box for the housekeeping 
sigma factor (SigA in S. aureus and B. subtilis, Sig70 in E. coli) in the three genomes (GenBank: 
CP000253, AL009126.3, U00096.3). The TATAAT hexamer was indeed much more frequent 
(0.905 Kbp-1) in the antisense strand of protein coding genes in the S. aureus genome than in the 
B. subtilis (0.332 Kbp-1) or E. coli genome (0.091 Kbp-1). In these three genomes the TATAAT 
hexamer was also less frequent on the sense strand than on the antisense strand (e.g., 0.905 
Kbp-1 vs. 0.479 Kbp-1 in S. aureus) which probably reflects, at least partly, the fact that hexamer 
TATAAT cannot start at the second position of a codon within a gene since it contains the TAA 
stop codon.
Antisense transcription can change the expression of the overlapped genes. Therefore, we 
investigated the effect of elevated antisense transcription on sense transcript levels under Rho 
deficient conditions. Indeed, of the 167 annotated genes most down-regulated (log2-ratio≤-1, 
q-value≤0.05) in the ∆rho mutant during exponential growth in RPMI medium, 153 (92%) were 
overlapped by an up-regulated region on the opposite strand. If down-regulation is a direct 
consequence of a stoichiometric degradation of double-stranded sense-antisense complexes, 
then it may become more noticeable when the abundance of the antisense RNA is not too low 
compared to the level of sense RNA. Another potential direct down-regulation mechanism is 
transcriptional interference by which the interaction between the sense and antisense transcription 
decreases transcription rates. For this second mechanism the expected relationships between the 
level of down-regulation and the relative abundances of the sense and antisense RNA species 
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is less obvious, since a given level of antisense transcription might cause different extents of 
sense transcription inhibition. Strikingly, the antisense strands reached higher levels than sense 
strands in the ∆rho mutant for 73% of the 167 most down-regulated genes (Figure 5B), and 
in most cases (59% of 167) the antisense levels in the mutant appeared even higher than the 
sense levels in the wild-type (see medians in Figure 5B). We also analyzed more globally the 
levels of sense and antisense transcripts of all annotated genes in the wild-type and the Δrho 
mutant (Figure 5B). Indeed, antisense transcription increased predominantly in the regions 
of low sense expression leading to a strong negative correlation between sense and antisense 
expression (Pearson correlation coefficient r=-0.73) that was much weaker in the wild-type (r=-
0.30) but also statistically significant (p-value<10-15). In particular the most highly expressed 
genes showed the lowest levels of antisense transcription in the Δrho mutant. Not illogically, 
this observation suggests that down-regulation of sense expression by antisense expression is 
mirrored by down-regulation of antisense by sense expression, the impact of which increases 
with the sense expression level.
Northern Blot analysis of antisense transcripts detected in the ∆rho mutant
As documented above, our tiling array analyses showed that Rho deficiency had strong effects 
with respect to increased transcript levels outside of annotated genes, and individual regions 
with substantially higher expression levels in the ∆rho mutant were up to several kb long. To 
examine whether the observed tiling array signals originate from long RNA molecules or from 
overlapping small molecules resulting from degradation of longer transcripts (94), Northern 
blot analysis was performed for six genomic regions containing antisense transcripts that were 
longer or only present in the ∆rho mutant, mainly resulting from read-through transcription at 
TU ends. For all six antisense transcripts, the analysis confirmed the presence of larger-size 
RNA molecules that were specific for the mutant samples (Figure 6). In three cases, the size of 
the detected band suggested the presence of an intact transcript covering the complete region 
identified to be upregulated in the ∆rho mutant. In a fourth case (3’PT transcript S931), the 
obtained size matched the position of a marked drop in the tiling array signal. Strikingly, for a 9 
kb long transcribed region downstream of S234 and an 11 kb long region downstream of S596, 
Northern blot analysis detected transcripts with different sizes, all larger than 2 kb.
The example in Figure 6 shows the analysis of a read-through transcript downstream of 
SAOUHSC_00975 that faces a tricistronic TU (SAOUHSC_00972 to SAOUHSC_00974) on 
the opposite strand using probes with specificity for SAOUHSC_00975 and for the antisense 
strand of SAOUHSC_00974, i.e. the 3’-extension detected in the absence of Rho. With the first 
probe, the SAOUHSC_00975 mRNA with a size of about 0.5 kb (not expressed in stationary 
phase TSB samples as evident from the tiling data) and the read-through transcript in the ∆rho 
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mutant were detected. The Northern analysis with the antisense specific probe showed only 
the longer transcript specific to the mutant samples which has a size of 2.5 kb and hence most 
probably reaches until the downstream TSS in front of the adjacent gene on the same strand 
(SAOUHSC_00971).
Discussion
Condition-dependent whole transcriptome analysis: Using a genomic tiling array approach, 
the transcriptome of S. aureus HG001 was systematically analyzed under a broad range of 
experimental conditions to allow for a comprehensive mapping of TUs, annotation of non-coding 
RNAs and further insights into the transcriptional regulatory network of S. aureus. Indeed, in 
our study, almost 90% of the annotated genes were expressed in at least one growth condition. 
The group of 110 genes highly expressed under all the tested conditions mainly contained genes 
encoding ribosomal proteins and translation factors, enzymes of central carbon metabolism, 
proteins involved in cell division and cell wall metabolism, RNA polymerase subunits, and 
proteins involved in oxidative stress management (rex, perR, katA, ahpC, ahpF).
Gene expression under in vitro infection conditions: A recent cell culture infection study revealed 
the intracellular replication of S. aureus HG001 inside eukaryotic cells, using the human lung 
epithelial cell lines A549 and S9 and the kidney cell line HEK 293 (95). In agreement with this 
result, gene expression patterns analyzed in the present study showed that the physiological 
Figure 6. Northern blot analysis of a ∆rho mutant-specific antisense transcript facing a tri-cistronic transcription 
unit starting with SAOUHSC_00972. (A) Transcription profiles of the genomic region assayed. S. aureus wild-
type (black lines) and ∆rho mutant (colored lines) were grown in RPMI and TSB medium. (B) Northern blot 
analysis of the same RNA samples (5 µg per lane) using RNA probes (indicated by red bars) directed against 
SAOUHSC_00975 and the antisense strand of SAOUHSC_00974. The SAOUHSC_00975 probe detected the 0.5-
kb mRNA in both strains and the longer read-through transcript in the ∆rho mutant. The antisense specific probe 
detected only the 2.5-kb transcript specific to the mutant samples.
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state of S. aureus internalized by human THP-1 macrophages or S9 bronchial epithelial cells 
(analyzed up to 6.5 hours after infection) was comparable with that of exponentially growing 
in vitro cultures. More specifically, our data revealed that S. aureus is particularly faced with 
reduced amino acid availability and iron limitation upon internalization by eukaryotic cells. 
From the expression of reference genes it also appears that S. aureus cells are faced with reduced 
oxygen availability upon internalization by THP-1 macrophages. In line with this observation, the 
proteome study by Surmann et al. (2014)(95) reported elevated levels of fermentation enzymes 
and the CydAB terminal oxidase in S. aureus HG001 internalized by eukaryotic cells. These 
responses indicative of a microaerobic environment inside host cells were, however, different 
between bacteria internalized by the different cell lines; protein levels were significantly less 
increased during adaptation to S9 cells as compared to A549 and HEK cells (95). 
Virulence factor regulation: A complex regulatory network mediates the adaptation of S. aureus 
to the host environment during colonization and infection. In particular, expression of virulence 
factor genes is tightly controlled by multiple regulatory systems involving two-component 
systems (SaeRS, Agr, ArlRS, LytRS, SrrAB), transcription factors (SarA family regulators, Rot, 
MgrA, CodY), the alternative sigma factor SigB and sRNAs (RNAIII, SprD, RsaA) (96, 97, 98). 
Within this regulatory network the SaeRS system, whose impact on virulence gene expression 
during in vivo infection has recently been characterized (99) controls the expression of numerous 
genes, such as those encoding adhesins and toxins. The host signals known to activate the Sae 
system include H2O2 and sub-inhibitory concentrations of α-defensins (100). A noticeable high 
number of virulence factor genes, in particular SaeSR-dependent genes, were upregulated after 
internalization by human THP-1 macrophages and S9 bronchial epithelial cells, including eap, 
fnbA and fnbB. Extracellular adherence protein (Eap) and fibronectin-binding proteins (FnbA, 
FnbB) are major determinants facilitating invasion of host cells (101). The eap gene was amongst 
the genes most highly expressed in internalized staphylococci. 
Strikingly, several genes involved in evasion of host immune responses, in particular complement-
mediated phagocytosis (63), were most highly expressed during growth of S. aureus in human 
plasma: spa encoding the immunoglobulin binding Protein A and four SaeRS-dependent genes 
(efb, sbi, chp, and scn). The Extracellular fibrinogen-binding protein (Efb) interacts with 
complement protein C3b and attracts fibrinogen to the surface of S. aureus, thus masking C3b 
and opsonizing antibodies from recognition by phagocytic receptors (102). It was shown to 
block phagocytosis in plasma and in human whole blood. The secreted proteins Sbi, CHIPS, 
and SCIN are also required for survival of S. aureus in human blood (103, 104). The finding that 
efb, sbi, chp, and scn showed a partially different expression pattern compared to other SaeRS-
dependent genes might point to a potential involvement of additional regulators (expression of 
virulence factors in adaptation to the host environment).
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Responses to antibiotics at sub-inhibitory concentrations: When grown in the presence of 
sub-inhibitory concentrations of the clinically relevant antibiotics clindamycin, erythromycin, 
linezolid, TMP-SMX or vancomycin, S. aureus exhibited only few, if any, significant changes in 
gene expression. In contrast, sub-inhibitory concentrations of the fluoroquinolone ciprofloxacin 
and the β-lactam antibiotic flucloxacillin did induce some changes in gene expression. Of 
note, the DNA-gyrase inhibitor ciprofloxacin induced transcription of various phage-encoded 
genes, which is in line with previous observations where S. aureus was challenged with lethal 
concentrations of this antibiotic (105, 106). In particular, a large number of structural genes of the 
hlb-converting phage 13 were induced during exponential growth in the presence of a sub-lethal 
ciprofloxacin dose, which suggests the activation of this lysogenic phage. The induction of phages 
is linked to the DNA damage-induced SOS response, characterized by increased transcription 
of recA and lexA. In E. coli, activated RecA promotes the autoproteolysis of LexA, resulting in 
derepression of DNA-repair functions and inactivation of the phage lambda repressor cI (107). 
The finding that recA, lexA and several genes encoding DNA repair functions were significantly 
upregulated in the presence of ciprofloxacin, shows for the first time that also sub-inhibitory 
concentrations of this antibiotic evoke the SOS response, leading to prophage induction. Of note, 
the chp, scn and sak genes carried by phage 13 were not induced by ciprofloxacin. In response 
to sub-inhibitory concentrations of flucloxacillin, the transcription of several biosynthesis and 
metabolic operons was significantly increased during stationary phase, including the operons 
involved in the synthesis or processing of thiamine, riboflavin, choline and betaine , lactose and 
galactose, and biotin. In addition, phage-encoded genes were induced in response to sub-lethal 
levels of flucloxacillin, but to a lesser extent than observed for ciprofloxacin.  
Previous studies suggest that antibiotics at sub-lethal concentrations can drive the development 
of resistant phenotypes (108) . In this context, it is surprising that the tested antibiotics evoked 
only very few significant transcriptional responses at sub-inhibitory levels. In fact, the norA 
gene, which confers low-level resistance to fluoroquinolones (109, 110) was even found to be 
down-regulated by ciprofloxacin. The latter is in line with previous findings where S. aureus was 
challenged with a lethal dose of ciprofloxacin (105) Furthermore, none of the tested antibiotics 
caused enhanced transcription of genes for known drug efflux pumps of S. aureus, including 
norA, norB, norC, mepA, mdeA, sepA, sdrM, lmrS and msrA. These transporters were previously 
found to be upregulated in response to antibiotic challenges, and some were shown to play a role 
in drug resistance (111, 112). Altogether, these findings suggest that the most likely reason why 
antibiotics, like ciprofloxacin and flucloxacillin, could drive the development of resistance is 
the induction of prophages, because phages are effective facilitators of horizontal gene transfer 
(113, 114, 115) . 
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Identification of a potential Fur-dependent sRNA: In addition to searching for so far unknown 
SigB-controlled genes and new insights into the regulatory role of SigB, we exploited our tiling 
array data set with respect to the prediction of new target genes of well characterized transcription 
factors. An important finding revealed by this analysis is the identification of a potential 
trans-encoded regulatory RNA (sRNA) supposed to be controlled by the Fur repressor. This 
sRNA named S596 is predicted to repress the expression of genes encoding iron-sulfur-cluster 
containing enzymes (citB, fdhA, addB, ilvD, and miaB), heme biosynthesis enzymes (ctaA and 
hemE) and citrate synthase (citZ). Iron-responsive sRNAs exist in many bacteria including B. 
subtilis (116) and typically mediate an iron-sparing response, but are also known to be involved 
in regulatory processes beyond iron homeostasis, particularly in the regulation of virulence-
associated genes in Gram-negative pathogenic bacteria (reviewed in (92)). It had therefore been 
postulated that, also in S. aureus, the Fur-dependent downregulation of tricarboxylic acid cycle 
genes might be mediated by a Fur-dependent sRNA (117), as it is the case in E. coli (RyhB ) or 
B. subtilis (FsrA ). 
Antisense transcription: In B. subtilis analyzed under a wide range of biological conditions, 
we found 13% (560/4245) of the CDSs to be overlapped by ASRNAs (17). In S. aureus this 
proportion was only 6.2% (175/2836) under the conditions of the present study. Of the 1192 
previously unannotated RNAs identified by our study, 145 (12%) represented ASRNAs. This 
fraction was 27% (423/1583) in B. subtilis, where many ASRNAs were highly expressed 
only under specific conditions, such as sporulation or physical stresses. Only 19 ASRNAs 
of S. aureus, which is 13% of all ASRNAs identified, belong to the group of RNA features 
generated independently of annotated genes (categories Indep and Indep-NT) and thus represent 
ASRNAs most likely arising from spurious transcription initiation. This proportion was 21% 
and thus much higher in B. subtilis. Strikingly, the class of B. subtilis ASRNAs having their own 
promoters was characterized by a very low occurrence (23%) of SigA-dependent transcription, 
compared to 52% for all ASRNAs and even 74% for protein-coding genes (17). Consequently, 
the small number of 19 “independent” ASRNAs in S. aureus can be considered consistent with 
our initial interpretation that many B. subtilis ASRNAs may be byproducts of an extensive use of 
alternative sigma factors for condition-specific promoter recognition prone to generate spurious 
(non-functional) transcripts without major negative impact on fitness (17). This potential source 
of ASRNAs is in fact largely absent in S. aureus, where particularly in the strain used in our study 
SigB is the only relevant alternative sigma factor (27) and its activation appears less specific than 
in B. subtilis as the SigB-dependent genes were induced throughout the stationary phase in all 
growth media. In addition, in B. subtilis a subgroup of 120 TUs lacking an intrinsic terminator 
was found to have no defined 3’-end, but to possess read-through transcription generating 
ASRNAs (categories Indep-NT and 3′NT) (17), a much higher number than in S. aureus (19 
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TUs). Beyond this particular group, we identified a limited number of S. aureus termination 
sites which are Rho-dependent resulting in read-through transcription and extensions beyond 
the transcript 3’-ends.
Role of the termination factor Rho in suppressing antisense transcription: In contrast to the 
S. aureus HG001 wild-type strain, a high number of antisense transcripts was found in an 
isogenic mutant deficient for the transcription termination factor Rho. A large proportion of the 
genome (over 50%) exhibited higher transcript levels in the ∆rho mutant of which almost 80% 
mapped to the antisense strand of annotated genes. Thus, a much greater increase in genome-
wide antisense than sense transcription occurred under Rho deficient conditions in S. aureus 
substantiating the role of Rho in suppressing pervasive antisense transcription. Remarkably, the 
largest contribution to the upregulated regions came from antisense transcripts only detectable in 
the absence of Rho. Instead of representing 3’-extensions generated by read-through at TU ends, 
these ASRNAs arise from obviously spurious transcription initiation, which in S. aureus wild-
type cells is efficiently counteracted by the action of Rho. Termination of protein-coding genes 
in S. aureus is mostly independent of Rho as expected given that deletion of rho was shown to 
have no apparent effect on growth or virulence of S. aureus (40), suggesting a limited number of 
Rho-dependent terminators in S. aureus.
Previous studies in B. subtilis and E. coli had already revealed that Rho plays a major role in 
suppressing or limiting pervasive antisense transcription (17, 34). However, in these studies Rho 
was shown to mainly act on a subset of TUs possessing Rho-dependent terminators. In E. coli, 
Rho-dependent termination sites were identified by mapping the positions at which treatment with 
the Rho inhibitor bicyclomycin caused an increase in downstream transcript levels (34).  This 
study identified 1264 Rho-dependent transcripts and Rho-dependent termination of 725 of the 
2054 E. coli genes at the ends of TUs. By bicyclomycin treatment, the antisense strands of 1555 
genes (34% of all genes) were significantly upregulated. Antisense transcription suppressed by 
Rho was shown to arise from i) continuation of transcription at the end of genes into oppositely 
oriented downstream genes and ii) transcription from antisense promoters within genes, i.e. 
extension of bona fide antisense RNAs .
Unlike in E. coli and many other bacteria, Rho is dispensable in B. subtilis (39), S. aureus and 
other Gram-positive bacteria (40), presumably associated with dominance of Rho-independent 
termination in these organisms (118, 119). When comparing the tiling array expression profiles 
of a B. subtilis ∆rho mutant and its parental strain during exponential growth in rich medium, 
93 chromosomal regions comprising 367 genes exhibited a significant increase in antisense 
transcription in the absence of Rho, mainly resulting from 3’-extensions of TUs with respect 
to the parental strain (17). In addition to a particular class of TUs lacking an efficient intrinsic 
terminator and thus characterized by slowly decreasing signal intensity (generating 3’UTRs 
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referred to as 3’NT and 3’PT), additional TUs associated with a predicted terminator of low 
efficiency based on the sequence characteristics were extended in the absence of Rho (17). In 
S. aureus, the majority of the comparatively small number (19 versus 120 in B. subtilis) of TUs 
completely lacking a defined 3’-end (3’NT) was extended in the ∆rho mutant confirming the 
Rho-dependence of this particular class of TUs.
Effects of antisense transcription in the absence of Rho: In our experiments, growth of the S. 
aureus ∆rho mutant in rich medium and RPMI cell culture medium was almost similar to that 
of the wild-type with a slightly lower final OD meaning that considerably elevated antisense 
transcription was not associated with a strong inhibitory effect, at least under standard growth 
conditions. In general, antisense transcription can have deleterious effects by changing the 
expression of the overlapped genes and by diverting cellular resources. With regard to the first 
aspect, a role of individual ASRNAs in regulating the expression of their opposite genes has 
been established and can involve different mechanisms: transcription interference, transcription 
attenuation, modulation of mRNA degradation and ribosome binding (reviewed in (16, 120)). 
Peters et al. showed for E. coli that an increase in antisense transcription caused by the inhibition 
of Rho did not affect sense transcription (34). In contrast, our study revealed an effect of elevated 
antisense transcription on sense transcript levels in Rho-deficient conditions in S. aureus. The 
vast majority (92%) of downregulated genes in the ∆rho mutant during exponential growth in 
RPMI medium was overlapped by an upregulated region on the opposite strand. Moreover, the 
mutant antisense levels of downregulated genes were found to be mostly higher than the sense 
levels detected in the wild-type (Figure 5b). This observation would be in line with a mechanism 
of destabilization of sense transcripts by pairing with their antisense transcripts and degradation 
of the double-stranded products (94).
In conclusion, the present study has provided a comprehensive inventory of transcription units 
and non-coding RNAs of S. aureus HG001, along with a classification of SigA- and SigB-
dependent promoters, and targets for major transcription factors. It is anticipated that this 
compendium, which can be queried through an online genome browser, will serve as a major 
lead for future studies on S. aureus on this important pathogen’s very diverse lifestyles inside 
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The signal peptidase ComC and the thiol-disulfide 
oxidoreductase DsbA are required for optimal cell 
surface display of the pseudopilin ComGC 
in Staphylococcus aureus
Magdalena M. van der Kooi-Pol, Ewoud Reilman, Mark J.J.B. Sibbald, Yanka K. Veenstra-






Staphylococcus aureus is an important Gram-positive bacterial pathogen producing many 
secreted and cell surface-localized virulence factors. Here we report that the staphylococcal 
thiol-disulfide oxidoreductase DsbA is essential for stable biogenesis of the ComGC pseudopilin. 
The signal peptidase ComC is indispensable for ComGC maturation and optimal cell surface 
exposure. 
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Introduction
Staphylococcus aureus is a major Gram-positive bacterial pathogen causing a broad range of 
infections. To subvert its mammalian hosts, S. aureus relies on different virulence factors that 
are localized at the cell surface or secreted into the host milieu (11,20). For export of newly 
synthesized virulence factors from the cytoplasm, their translocation across the membrane, 
and post-translocational modifications an intricate secretion machinery has evolved (20). In 
recent years, the functions of many secretion machinery components of S. aureus have been 
elucidated (3,4,9,13,19,21). Intriguingly however, for several other potential secretion machinery 
components no biological functions have been described so far. For example, this applies to the 
extracytoplasmic thiol-disulfide oxidoreductase (TDOR) DsbA, which is known as one of the 
strongest bacterial TDORs (12,15). Likewise, the role of the pseudopilin export machinery of S. 
aureus has not yet been documented. This machinery is very similar to the Com machinery for 
DNA binding and uptake in the related Gram-positive bacterium Bacillus subtilis. Interestingly, 
the genes coding for most Com proteins are present in the sequenced S. aureus strains (20). The 
transcription of these genes, which are organized in the comG and comE operons, is directed by 
the staphylococcal alternative sigma factor σH (17).  
The biogenesis of the Com pseudopilin system has been well studied in B. subtilis. Among the 
B. subtilis Com proteins with orthologues in S. aureus are those encoded by the comG operon 
(1). Specifically, the B. subtilis ComGC, ComGD, ComGE, and ComGG proteins form pilin-
like structures that are localized to the cytoplasmic membrane and cell wall (6-8,22). Assembly 
of the pseudopilus in B. subtilis requires the specific signal peptidase ComC, which processes 
the N-terminal signal peptides of ComG proteins upon membrane translocation (6,22,23). 
Furthermore, stability of the B. subtilis ComGC pseudopilin requires post-translocational 
TDOR-mediated disulfide bond formation (6,10,15,16).
 
Results and Discussion
ComGC of S. aureus is processed by ComC and stabilized by DsbA 
To study the processing and stability of S. aureus ComGC, the expression of the com genes 
was induced through constitutive expression of sigH from plasmid pRIT:SigH (17). As shown 
with specific polyclonal antibodies raised against ComGC, exponentially growing cells of the S. 
aureus strains RN4220, SH1000, RN6911 and Newman produced only the precursor form of this 
pseudopilin (Figure 1). ComGC production depended strictly on ectopic expression of σH (Figure 
1). Notably, relatively small amounts of mature ComGC were detectable when the investigated 
strains were grown to stationary phase (Figure 1A). This inefficient ComGC processing was 











Figure 1. ComGC processing by ComC. S. aureus strains were grown overnight at 37°C in Luria-Bertani broth 
(LB) supplemented with 12.5 µg/ml chloramphenicol to select for pRIT:sigH or pRITH5, or 5 µg/ml erythromycin 
to select for pCN51:comC. Samples for Western blotting analyses with polyclonal rabbit antibodies against ComGC 
or chicken antibodies against SigH were collected after 4 h (t4) or 7 h of growth (A), or after 5h of growth (B). 
Cell extracts were prepared as previously described (19). Proteins were separated by SDS-PAGE (NuPage gels, 
Invitrogen) and blotted onto nitrocellulose membranes (Protran, Schleicher & Schuell). Immunodetection was 
performed with fluorescent secondary antibodies (IRDye 700 CW goat anti-rabbit, IRDye 800 goat anti-chicken, 
LiCor) in combination with the Odyssey Infrared Imaging System (LiCor Biosciences). The chromosomal comGC 
or comC genes were deleted from S. aureus strains RN4220 or Newman Δspa Δsbi (19) as previously described 
(2,14). Primers used for strain and plasmid constructions are listed in Table 1. Lanes relating to strains that carry 
pRIT:sigH for σH production are labeled with H; lanes relating to control strains with the empty vector pRIT5H that 
do not produce σH are labeled with v; lanes relating to strains that carry pCN51:comC (5) for ComC production are 
labeled with ComC+.
pCN51:comC. This resulted in close-to-complete ComGC processing (Figure 1B). Conversely, 
ComGC processing in the post-exponential growth phase was completely abolished by a comC 
deletion. Consistent with these observations, no comC expression was detectable in exponentially 
growing S. aureus cells, and low-level comC transcription was detectable in the late stationary 
growth phase (data not shown). Together, these findings show that ComC is the signal peptidase 
needed for ComGC processing, and that the investigated strains produce limiting amounts of 
ComC under the tested conditions. 
To investigate whether the stability of S. aureus ComGC depends on TDOR activity, the 
production of this protein was analyzed in strain RN4220 lacking the dsbA gene. Western 
blotting analyses showed that ComGC was barely detectable in cells lacking DsbA. This effect 
did not relate to possible changes in the σH levels, which remained unaltered in the dsbA mutant 
(Figure 2 lower panel). These observations indicate that the intramolecular disulfide bond of 
B. subtilis ComGC is conserved in S. aureus ComGC, and that the formation of this disulfide 
bond between  Cys46 and Cys87of S. aureus ComGC is catalyzed by DsbA. Furthermore, this 
disulfide bond, which is positioned within the predicted extracytoplasmic domain of S. aureus 

























































Figure 2. ComGC stabilization by DsbA. S. aureus strains were grown for 7h in LB broth as described in Figure 
1 in the presence or absence of β-mercaptoethanol (final concentrations 1 mM or 2.5 mM). The preparation of 
cell extracts, SDS-PAGE and Western blotting with specific antibodies against ComGC or σH was performed as 
described in Figure 1. The chromosomal dsbA gene was deleted from S. aureus strain RN4220 as previously 
described (2,14). Primers used for strain construction are listed in Table 1. Lanes relating to strains that carry 
pRIT:sigH for σH production are labeled with H; lanes relating to control strains with the empty vector pRIT5H that 
do not produce σH are labeled with v.
ComGC, would be necessary to stabilize ComGC upon export from the cytoplasm. To test this 
idea, the reducing agent β-mercaptoethanol was added to the growth medium at concentrations 
up to 2.5 mM, which is the highest concentration of β-mercaptoethanol that can be added to the 
cells without affecting growth and cell viability (data not shown). Clearly, in the presence of 
2.5 mM β-mercaptoethanol, ComGC was barely detectable (Figure 2, upper panels), whereas 
σH production remained unaffected (Figure 2, lower panels). The most simple explanation for 
these observations is that the TDOR activity of DsbA is required for disulfide bond formation in 
ComGC and that this disulfide bond is essential for ComGC stability. Nevertheless, it is possible 
that DsbA is indirectly involved in the stabilization of ComGC. To our knowledge, this is the 
first report describing a biological function for DsbA in S. aureus. 
ComGC localizes to the membrane, cell wall and cell surface of S. aureus 
To determine the localization of ComGC, cells of S. aureus strain RN4220 or strain RN4220 
overproducing ComC were subjected to subcellular fractionation. Cells were first protoplasted. 
Next, the protoplasts were separated from liberated cell wall proteins (i.e. the cell wall fraction) 
by centrifugation. The collected protoplasts were then disrupted by osmotic shock, and cytosolic 
proteins were separated from the membranes by ultracentrifugation as previously described (24). 
Proteins in all collected fractions were separated by SDS-PAGE and the presence of ComGC and 
thioredoxin A (TrxA) in each fraction was analyzed by Western blotting with specific antibodies 
(Figure 3A). TrxA was used as a cytoplasmic control protein. This analysis showed that both 
pre-ComGC and mature ComGC from S. aureus localize to the cytoplasmic membrane and cell 
wall. This dual localization is consistent with the localization of the homologous protein in B. 
subtilis. Furthermore, in S. aureus cells overproducing the ComC protein, we observed slightly 
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Figure 3. ComGC localizes to the membrane, cell wall and cell surface of S. aureus. (A) To determine the subcellular 
localization of ComGC in S. aureus RN4220 pRIT:sigH, or S. aureus RN4220 pRIT:sigH containing pCN51:comC, 
the cells were grown in LB broth for 5 h, collected by centrifugation and incubated for 1 h at 37°C in protoplast buffer 
(50mM Tris-HCl pH 7.6, 0.145 M NaCl, 30% sucrose, 0.01% DNase, and EDTA-free Complete protease inhibitors, 
Roche). The cell wall fraction (i.e. protoplast supernatant) was obtained by centrifugation (20 min, 3000xg, 4°C). 
Protoplasts were disrupted by osmotic shock in 0.05 M Tris-HCl pH 7.6, 30 min incubation on ice, and vortexing 
at 5 min intervals. Cytosolic and solubilized membrane proteins were collected as previously described (24). SDS-
PAGE and Western blotting with specific antibodies against ComGC or the cytoplasmic control protein TrxA was 
performed as described in Figure 1. (B) Cell surface exposure of ComGC was assessed in S. aureus Newman Δspa 
Δsbi or the parental strain (Newman) by immunofluorescence microcopy. For this purpose, cells were grown for 
5 h in LB broth and 1 OD600 unit of cells was collected by centrifugation (8000 rpm, 5’, 4°C). The cell pellet was 
resuspended in PBST+2% BSA, and incubated for 10 min on ice. Next, the cells were incubated for 60 min with 
ComGC-specific polyclonal rabbit antibodies (1:400 in PBST+1%BSA). Unbound antibodies were removed by 
three washes in PBST, and cell-bound ComGC antibodies were visualized using goat-anti-rabbit alexaFluor488 
antibodies (Life technologies) and a Leica DM5500 B microscope. The overlay of phase contrast and fluorescence 
microscopy images was done with imageJ. The strains containing pRIT:sigH for σH production are labeled with H; 
the strain containing pCN51:comC for ComC production is labeled with ComC+. The magnification is indicated 
by scale bars.
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increased amounts of ComGC in the cell wall fraction as compared to cells of the parental 
control strain that do not produce ComC under the tested conditions. Next, we investigated by 
immunofluorescence microscopy whether ComGC is detectable on the cell surface. For this 
purpose, we employed cells of strain Newman lacking the IgG-binding proteins Spa and Sbi, 
which displayed negligible background fluorescence (Figure 3B; compare panels for the spa sbi 
mutant and the parental strain Newman). Importantly, σH-producing cells showed elevated levels 
of immune fluorescence and strongly enhanced immune fluorescence was observed when the 
signal peptidase ComC was overexpressed together with σH. These observations are consistent 
with the view that the signal peptide of ComGC facilitates membrane translocation and exposure 
of ComGC to the cell wall, irrespective of signal peptide processing by ComC. Enhanced signal 
peptide processing upon ComC overproduction would then allow more of the translocated 
mature ComGC to penetrate the cell wall and to become exposed at the cell surface. These 
findings thus show that ComC-dependent processing of ComGC is of important for optimal cell 
surface exposure of ComGC. It should be noted that, for unknown reasons, cells overproducing 
ComC have a larger diameter which seems to relate mostly to a thickened cell wall (Figure 3B). 
In summary, we show that biogenesis of the pseudopilin ComGC of S. aureus requires the TDOR 
DsbA for stability and the signal peptidase ComC for precursor maturation and cell surface 
exposure. This is thus the first report where biological functions are demonstrated for S. aureus 
DsbA and ComC. In B. subtilis, the Com system is needed for DNA uptake during genetic 
competence. Whether this is also true in S. aureus remains to be demonstrated, but natural 
competence has been reported for S. aureus (18). Our present findings suggest that expression of 
comC could be a limiting factor in competence development, even if S. aureus cells overproduce 
σH for expression of other com genes.
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Table 1. Primers used in this study. Overlapping parts are shown in bold. Restriction sites used for cloning are 
underlined and shown in parentheses.
Primer Sequence (5’→3’)















Construction of pCN51:comC for S. aureus comC overexpression
ComC-F CAGCCGGATCCCATAAGGAGGTTGTCATTTGGTAG (BamHI)
ComC-R CGGAATTCCTTTAATTTTCAAAAATATACGCCTCC (EcoRI)
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The opportunistic pathogen Staphylococcus aureus has become a major threat for human health 
and well-being by developing resistance to antibiotics, and by its fast evolution into new lineages 
that rapidly spread within the healthy human population. This calls for the development of active 
or passive immunization strategies to prevent or treat acute phase infections. Since no such anti-
staphylococcal immunization approaches are available as yet, the present studies were aimed 
at identifying new leads for their development. For this purpose, we thoroughly profiled the 
cell surface-exposed staphylococcal proteome by combining two surface shaving approaches. 
In parallel, non-covalently cell wall-bound proteins were extracted with KSCN and analyzed 
by gel-free proteomics, and also the exoproteome was analyzed through gel-free proteomics. 
Lastly, we screened a selection of the identified cell wall-attached proteins for binding of 
immunoglobulin G from patients that have been challenged with different types of S. aureus 
over extended periods of time due to chronic wound colonization. The combined results of these 
analyses highlight particular cell surface-exposed S. aureus proteins with highly immunogenic 
epitopes as potentially powerful targets for the development of protective anti-staphylococcal 
immunization strategies.
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Introduction
The Gram-positive bacterium Staphylococcus aureus is an opportunistic pathogen that 
asymptomatically colonizes approximately 30% of the healthy human population (1-6). Upon 
invasive growth, S. aureus can cause a wide variety of diseases ranging from relatively mild 
skin infections to severe sepsis. A major reason for concern is the high propensity of S. aureus to 
acquire resistance to antibiotics (7, 8). This is critically underscored by the rapid development of 
resistance to the antibiotic methicillin. When methicillin was first introduced into the clinic, only 
methicillin-sensitive S. aureus (MSSA) was encountered. However, within two years, the first 
methicillin-resistant S. aureus (MRSA) isolates were observed (9). While MRSA was initially 
only a threat for hospitalized, elderly and frail individuals, the last two decades have witnessed 
the emergence of so-called community-acquired MRSA lineages that rapidly spread within the 
young and healthy population (10-12). Importantly, community-acquired MRSA lineages have 
now also entered nosocomial settings, which gives rise to increased morbidity and mortality 
rates. It is therefore a major societal challenge to develop novel, effective and long-lasting anti-
staphylococcal therapies (13-16).
In principle, vaccination is a very effective approach for protecting individuals at risk against 
pathogenic microbes. Unfortunately however, no vaccines against S. aureus in general, or MRSA 
in particular, are currently available (17, 18). While there have indeed been various attempts to 
develop vaccines for preventing staphylococcal infections, none of the candidate vaccines has 
successfully passed (pre-)clinical trials. Most likely, this relates to multiple factors, including the 
ability of S. aureus to evade or suppress the human immune system (19-23) as well as the high 
genome plasticity and adaptability of this wide-spread pathogen (24-29). Also, the published 
attempts to develop anti-staphylococcal vaccines were so far focused on a relatively narrow 
group of known S. aureus antigens, including capsular polysaccharides and a few cell wall-
associated or secreted proteins (17, 18). In this context, it is noteworthy that recent proteomics 
analyses have indicated the presence of at least 449 different proteins in the S. aureus cell 
envelope (29-34). These proteins may include powerful targets for future anti-staphylococcal 
immunization strategies, especially if they are exposed to the extracellular environment where 
they are readily recognizable by the human immune system. However, relatively little is known 
about the S. aureus cell surface-exposed proteome - the 'surfacome' - in terms of the particular 
protein domains that are directly exposed to the extracellular milieu. Even less is known about 
the presence of possible immunodominant epitopes within such exposed protein domains that 
could be used for the development of novel immunization approaches.
To pinpoint candidate targets for novel anti-staphylococcal immunization approaches, the 
present studies were focused on the identification of immunodominant cell surface-exposed 
protein domains of S. aureus. For this purpose, we first performed an in-depth proteomics 
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analysis of the surfacome based on the incubation of S. aureus cells with immobilized trypsin 
that cannot penetrate into the cell wall (i.e. ‘cell surface shaving’ (29)) or with soluble trypsin 
that can penetrate into the deeper cell wall layers. In parallel, we analyzed proteins released 
from the cells by spontaneous shedding or by treatment with the chaotropic compound KSCN, 
and we analyzed the extracellular proteome (i.e. the 'exoproteome') of the investigated cells. 
Lastly, a screen for immunodominant epitopes in the identified cell surface-exposed proteins 
was performed using peptide arrays and serum immunoglobulin G (IgG) from patients with 
the genetic blistering disease epidermolysis bullosa (EB). As shown in previous research, these 
patients are exposed to multiple and alternating types of S. aureus over long periods of time due 
to chronic wound colonization (35-37). Altogether, the present 'tryptic striptease' of the S. aureus 
cell unveils a set of cell wall-localized and surface-exposed antigens that may serve as targets for 
novel active or passive immunization approaches to prevent or treat staphylococcal infections.
Materials and methods
Bacterial strains and growth conditions
The S. aureus strains Newman, Newman ∆spa∆sbi and USA300 were grown overnight in tryptic 
soy broth (TSB, OXOID) under vigorous shaking at 37C. The cultures were then diluted into 
pre-warmed RPMI 1640 medium (PAA) to an OD600 of 0.05 and cultivation was continued under 
the same conditions. Exponentially growing cells were again diluted into fresh and pre-warmed 
RPMI medium to a final OD600 of 0.05 and their cultivation was continued to an OD600 of 0.2.
Isolation and processing of sub-proteome fractions
Exoproteome - Cells were separated from the growth medium by centrifugation (15 min, 
6750 × g, 4°C). The growth medium fraction thus obtained was filtrated (pore size 0.22 µm), 
and the exoproteome present in this fraction was precipitated overnight at 4°C with 10% 
trichloroacetic acid (TCA). Precipitated proteins were pelleted by centrifugation (20 min, 
18620 × g, 4C) and washed with acetone. Protein pellets were dried and resuspended in 50 mM 
ammonium bicarbonate and overnight digested with trypsin (Promega) at 37°C. 
Surfacome shaving with immobilized trypsin - Cells were harvested by centrifugation (10 min, 
6080 × g, 4°C) and washed twice with PBS containing 40% sucrose (Acros) and 20 mM sodium 
azide (Sigma-Aldrich). Immobilized trypsin (Pierce) was activated with 50 mM ammonium 
bicarbonate (Sigma-Aldrich), resuspended in 50 µl PBS with 40% sucrose and 20 mM sodium 
azide, and added to the washed cells. The shaving reaction was conducted for 45 min at 37°C. 
Released peptides representing the surfacome were isolated, reduced with 10 mM DTT (30 min), 
alkylated with iodoacetamide (Sigma-Aldrich), and digested with trypsin overnight at 37°C.
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Surfacome shaving with soluble trypsin - The protocol for cell shaving with soluble trypsin 
was essentially the same as the protocol for shaving with immobilized trypsin. In this case 
immobilized trypsin in 48 µl PBS with 40% sucrose and 20 mM sodium azide was added to the 
cells.
Spontaneously released proteins - The protocol for analysis of proteins spontaneously released 
from the cells was essentially the same as the protocol for shaving with immobilized trypsin. In 
this case, 50 µl PBS with 40% sucrose was added to the cells.
Non-covalently cell wall-bound proteins - Cells were harvested by centrifugation (10 min, 6750 
× g. 4°C), washed twice in PBS with 40% sucrose and 20 mM sodium azide, resuspended in 1 M 
potassium thiocyanate (KSCN), and incubated for 10 min on ice. After centrifugation (10 min, 
6750 × g. 4°C), the resulting supernatant was filtrated (pore size 0.22 µm) and proteins in the 
filtrate were precipitated with TCA. The collected proteins were digested with trypsin overnight 
at 37°C.
Mass spectrometric analyses
Reduction and alkylation, desalting of the samples, mass spectrometric (MS) analysis and 
database searches were performed as previously described (29). The strain-specific uniprot 
databases were used for the S. aureus strains Newman and USA300, respectively including 
concatenated reversed databases with 5250 and 5298 entries. Validation of MS/MS-based 
peptide and protein identifications was performed with Scaffold (version Scaffold_2_04_00, 
Proteome Software Inc., Portland, OR). Peptide identifications were accepted if they exceeded 
the specific database search engine thresholds. Sequest identifications required at least deltaCn 
scores of greater than 0.10 and XCorr scores of greater than 1.9, 2.2, 3.8 and 3.8 for singly, 
doubly, triply and quadruply charged peptides, respectively. All experiments were conducted in 
independent triplicates. Peptides were only accepted as identified if they were detected in at least 
two out of the three replicates per sample set. With these filter parameters no false positive hits 
were obtained. The identified peptides of strain Newman are listed in Supplementary Table S1 
and the identified peptides of strain USA300 are listed in Supplementary Table S2.
Western Blotting
Protein samples were separated using NuPAGE gels (Invitrogen) and separated proteins were 
subsequently transferred to a Protran nitrocellulose membrane (Whatman) by semi-dry blotting 
(75 min at 1 mA/cm²). Membranes were incubated with specific antibodies against TrxA and 




S. aureus cells were cultured in RPMI as indicated above, harvested by centrifugation (5 min, 
18620 × g, 4°C) and washed once in PBS with 20 mM sodium azide. Next, cells were resuspended 
in 100 µl PBS with 20 mM sodium azide and IsaA-specific (Sakata, Terakubo, & Mukai, 2005) 
or TrxA-specific antibodies. As a control, cells were incubated with IsaA-specific antibodies 
that had been pre-incubated with purified IsaA. After 30 min incubation on ice, the cells were 
collected by centrifugation (5 min, 18620 × g, 4°C) and resuspended in PBS with 20 mM 
sodium azide containing AlexaFluor® 594 labeled goat-anti-rabbit antibodies (Invitrogen). 
After 30 min incubation on ice, the cells were washing three times in PBS with 20 mM sodium 
azide, resuspended in MilliQ water and transferred to Polysine-slides (Thermo Scientific). After 
drying, Vectashield mounting medium (Vector Laboratories) was applied to the slides to prevent 
photobleaching. Images were recorded with a Leica DM5500 B fluorescence microscope (Leica 
Microsystems B.V), and image processing was conducted with the ImageJ 1.43m software. 
Pepscan analysis
To map regions of cell surface-exposed S. aureus proteins that are recognized by human IgGs, 
we synthesized libraries of linear 15-mer peptides with an overlap of 11 amino acids on solid 
support (Pepscan), as previously described (39). For some proteins, libraries of CLIPSTM 
constrained 15-mers were prepared as previously described (40). The peptide libraries were 
probed with heat-inactivated human sera, in a dilution of 1:1000, with goat-anti-human-HRP 
conjugate as a secondary antibody, and developed with 2,2'-azino-bis(3-ethylbenzothiazoline-
6-sulphonic acid. A charge-coupled device camera was used to register absorbance at 405 nm. 
For every single Pepscan dataset, the data was normalized to the average signal intensity of 
the analysis. Furthermore, the signals for every single protein were normalized to the median 
of the corresponding protein. In addition the standard deviations of the normalized data sets 
were calculated for each protein. Peptides with a signal exceeding the median plus twice the 
standard deviation and a normalized signal intensity higher than three were regarded as being 
immunogenic domains.
Human plasma
Whole blood samples (12 ml) from EB patients were processed immediately after donation by 
1:1 dilution in Hanks’ Balanced Salt Solution (Gibco). Plasma was obtained after separation 
from blood cells using Ficoll-Paque PLUS (GE Healthcare) according to manufacturer’s 
instructions. The collected human plasma was stored at -30oC prior to use. The authors declare 
that the experiments using human plasma were performed with institutional approval upon the 
receipt of written informed patient consent, and with adherence to the Helsinki Guidelines. 
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Results
Complementary protein and peptide identifications in different sub-proteome fractions
To identify protein domains that are exposed on the cell surface of S. aureus, a comprehensive gel-
free proteomics analysis was performed on the community-acquired MRSA strain USA300 and 
the MSSA laboratory strain Newman. Specifically, staphylococcal cells were shaved either with 
trypsin immobilized on agarose beads (Fig. 1A, 'shaving 1') or with soluble trypsin ('shaving 2'). 
Liberated peptides were collected and subsequently identified through MS. In parallel, gel-free 
proteomics was applied to define spontaneously released proteins (‘control’), non-covalently 
cell wall-bound proteins extracted with KSCN ('wall'), and proteins in the exoproteome of the 
analyzed cells. The rationale of this is approach was that the immobilized trypsin would only 
access protein domains that stick out from the cell surface, whereas the other approaches would 
help to distinguish the surface-exposed protein domains from proteins or protein domains that 
are present in the deeper cell envelope layers or in the exoproteome. Overall, this resulted in the 
identification of 255 unique proteins from the USA300 strain and 177 from the Newman strain 
(Fig. 1, B and C). Furthermore, 1191 unique peptides were identified in all samples derived 
from strain USA300, and 762 in the samples derived from strain Newman (Fig. 1, D and E). 
Importantly, only two proteins were identified in the control fractions (one protein for each 
strain), showing that the spontaneous release of proteins from the cells during collection and 
processing of the different sub-proteome fractions was negligible (Supplementary Tables S1 and 
S2). Therefore, the control fraction is not further specified in what follows. It is also noteworthy 
that shaving with immobilized trypsin identified fewer proteins/peptides than shaving with 
soluble trypsin, suggesting that the soluble trypsin does indeed reach targets in the deeper layers 
of the cell wall (Fig. 1). The complementarity of the four sub-proteome fractionation approaches 
is underscored by the relatively small numbers of proteins/peptides that were identified in 
all samples from each strain (Fig. 1). In fact, this underscores the need to combine multiple 
approaches for a comprehensive description of the cell wall-, cell surface- and extracellular 
proteomes of S. aureus. 
Comparison of KSCN-extracted wall proteins with proteins identified by tryptic shaving
The analysis of the proteins that were extracted from the bacterial wall using KSCN resulted in 
369 and 166 different peptides for strains USA300 and Newman, respectively,  representing 109 
and 49 proteins (Fig. 1, B and D). Interestingly, the number of proteins that are specific for the 
wall extracts is rather low (19% and 16%) while the number of peptides that are specific for this 
fraction is much higher (41% and 50%). This indicates that the majority of the cell wall proteins 




Figure 1. Schematic representation of the analysis of different sub-proteome fractions and proteomics results 
in numbers. (A) Cells were harvested at identical optical densities and proteins in the growth medium fraction 
(‘culture supernatant’) were precipitated and digested with trypsin. Non-covalently cell wall-attached proteins were 
extracted with 1 M KSCN and also digested with trypsin (‘wall’). Cells were incubated in PBS with 40% sucrose 
and 20 mM azide alone (‘control’), or in the same buffer with either immobilized trypsin (‘shaving 1’) or soluble 
trypsin (‘shaving 2’). The Venn diagrams summarize the results obtained for strains USA300 (B, C) and Newman 
(D, E) at the protein- (B, D) and peptide levels (D, E). ‘Shaving 1’ and ‘shaving 2’ respectively mark the results 
from cell shaving with immobilized or soluble trypsin; ‘wall proteome’ marks the results from cell wall extraction 
with KSCN, and ‘exoproteome’ marks the results from the analysis of culture supernatants.
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Comparison of the exoproteome with the wall-attached proteins
In the exoproteome of strain USA300 we identified 573 peptides from 135 different proteins, 
whereas in the exoproteome of strain Newman we identified only 277 peptides from 53 unique 
proteins (Fig. 1, B-E). The comparison of these proteins with the proteins identified in the three 
approaches addressing the wall proteome (wall, shaving 1 and 2) revealed that 30-40% of the 
proteins are shared between the fractions (50-57% on the peptide level). This comparison reveals 
that the 'shaving 2' approach has the highest complexity thereby implying either unspecificity of 
the approach or an extraordinary high complexity of the wall proteome.
Characteristics of proteins in the different sub-proteomes
The S. aureus cell wall contains besides the peptidoglycan meshwork also negatively charged 
teichoic acids. We were therefore wondering whether the possible interaction of positively 
charged protein domains with negatively charged cell wall components might cause an over-
representation of negatively charged protein domains on the cell surface. To address this question, 
we analysed the pI distribution of the identified peptides and proteins in the different subcellular 
fractions. This analysis revealed bimodal distributions of the pI-values of the identified proteins 
of S. aureus strains Newman and USA300, having peaks in the basic as well as the acidic pI 
ranges (Fig. S1, A and B). Interestingly, the pI distribution of identified proteins from strain 
USA300 tended towards the acidic range, while the pI distribution of proteins from strain 
Newman tended towards the basic range. This observation likely reflects the higher number 
of cytoplasmic protein identifications in all strain USA300-derived samples, as the majority 
of cytoplasmic proteins exhibit acidic pI values. Furthermore, the proteins identified with the 
shaving approach based on soluble trypsin revealed an under-representation of basic proteins, 
which can be explained by the higher proportion of cytoplasmic proteins. Nevertheless, the 
distribution of the pI values at the peptide level resembled a unimodal distribution with a peak in 
the acidic range (Fig. S1, C and D). Especially for the results obtained with samples from strain 
Newman, we observed a clear over-representation of peptides with a pI below 5 and an under-
representation of peptides above pI 8 for the shaving-based approaches. While ~70% of peptides 
of the shaving-derived samples have a pI below 5, this is only the case for about 40% and 50% 
for the cell wall-extracted and exoproteome samples, respectively. This indicates that the tryptic 
shaving approaches preferentially result in the identification of negatively charged peptides. 
This could either be due to a re-association of positively charged peptides with the negatively 
charged cell wall during the shaving reaction, or to an over-representation of negatively charged 
amino acids on the cell surface. 
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Strain-specific protein identifications in sub-proteome fractions
A comparison of the total protein identifications revealed that the different analyzed sub-proteome 
fractions from strain USA300 were more complex than those from strain Newman (Fig. 2, 
Supplemental Figure S2). Furthermore, a search for potential signal peptides, trans-membrane 
domains and cell wall-binding domains revealed that most proteins that were exclusively 
identified in samples from strains USA300 or Newman lack such signals, which suggests a 
predominant cytoplasmic localization (Fig. 2, upper panels). Since about four times more 
proteins were identified in samples from strain USA300 than in samples from strain Newman, it 
seems that strain USA300 is more susceptible to lysis. This view is supported by the observation 
that the bifunctional staphylococcal autolysin Atl - a typical cell wall-bound protein - was 
identified in the exoproteome of strain USA300, but not in the exproteome of strain Newman. To 
investigate the presumed lysis of strain USA300, Western blotting experiments were performed 
in which the localization of the cytoplasmic marker protein TrxA was assessed. As shown in 
Figure 3A, no TrxA was extracted from the cells with KSCN under conditions that were similar 
to those applied for cell surface shaving with trypsin. This implies that little if any lysis occurred 
during the isolation of the different cell-associated sub-proteome fractions. On the other hand, 
about two-fold more TrxA was detectable in growth medium fractions of strain USA300 than in 
the equivalent fractions of strain Newman (Fig. 3B). This suggests that strain USA300 is more 
susceptible to cell lysis than strain Newman, and that cell lysis had occurred already during 
culturing. This is an important observation, because it implies that the cytoplasmic proteins 
identified on the surface of staphylcoccal cells used for our present sub-proteome analyses had 
reached the cell surface during culturing. It should be noticed here that, while we think that 
autolysis during culturing plays an important role in the apparent export of cytoplasmic proteins 
to the cell surface and growth medium, we cannot exclude the possibility that some of these 
proteins are actively exported from the cytoplasm via as yet undefined mechanisms (41).  
Proteins common to S. aureus strains USA300 and Newman
Despite clear differences, there are also many overlaps in the proteins identified in the respective 
sub-proteome fractions from S. aureus strains Newman and USA300 (Fig. 2, Supplementary 
Table S3). This is in line with the fact that most of the proteins identified in the present 
studies are encoded by the genomes of both investigated S. aureus strains. Interestingly, seven 
proteins were identified in all four sub-proteome samples from the USA300 and Newman 
strains (Supplementary Tables 4 and 5). These are the IgG-binding protein Spa, the secretory 
antigen SsaA, the transglycosylase IsaA, the fructose-bisphosphate aldolase class 1, the DNA 
binding protein HU and the ribosomal proteins L29 and L30. To verify cell surface exposure, an 
immunofluorescence control experiment was performed for IsaA, against which a highly specific 
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antibody was available. As shown in Figure 3C, the IsaA antibody bound effectively to the 
cells of a ∆spa∆sbi mutant of strain Newman, which lacks the immunoglobulin-binding proteins 
Spa and Sbi. Titration of the antibodies with increasing amounts of purified recombinant IsaA 
confirmed the specificity of the IsaA antibody binding to the cells (Fig. 3, D-J). Furthermore, 
antibodies against the secreted thermonuclease, which was not detected on the cell surface of 
strains Newman or USA300 did not bind to the cells (Fig. 3K), and the same was true for 
antibodies against the cytoplasmic marker protein TrxA (Fig. 3l), which was also not identified 
as being bound to the cell surface (Fig. 3A). Based on these findings, we conclude that the 
surface shaving approach does indeed yield specific information on the surface exposure of 
particular S. aureus proteins.
Epitope mapping in surface proteins of S. aureus
Altogether, our proteomics analyses led to the identification of 281 unique proteins (Supplementary 
Table 6S, sheet A). Thereof, we selected 54 proteins for further analysis by Pepscan epitope-
mapping. The selected proteins include predicted cytosolic, membrane, lipid-modified, cell wall-
associated as well as extracellular proteins (Supplementary Table 6S, sheet B). For all of these 
Figure 2. Predicted subcellular localization of the proteins identified for strains USA300 and Newman. The 
overlapping as well as unique proteins identified in the four sub-proteome fractions from strains USA300 and 
Newman were analyzed with respect to their predicted subcellular localization as previously described (9). CW, 
covalently wall-bound proteins; M, transmembrane- and lipoproteins; Sec, secreted proteins; No, proteins with no 
predicted motif for subcellular localization.
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proteins linear 15-mer peptide arrays with 11-mer overlaps were prepared. Additionally, arrays 
with CLIPSTM constrained 15-mers were prepared for the IsaA, LytM and Nuc proteins. Plasma 
donated by seven different EB patients, who have high IgG responses against staphylococcal 
proteins (36), was then used for the detection of immunogenic domains. In total, we analyzed the 
interaction of 6821 peptides with IgG’s in the plasma of EB patients. This revealed 358 human 
IgG-binding peptides from 48 different S. aureus proteins. Merging of overlapping sequences 
finally resulted in the delineation of 201 immunodominant domains (Supplementary Table 6S, 
sheet C). The most conserved peptides recognized by IgGs from human serum belong to a Zinc-
binding lipoprotein (A6QJP6), the extracellular matrix-binding protein (Emp), and the iron-
regulated surface determinant (IsdB) (Supplementary Table S6, sheet D; Supplementary Fig. 
S3). The relative localization of immunodominant protein regions and peptides identified in 
the different investigated sub-proteomes is schematically presented in Supplementary Figure 
S4 and Table S7. Notably, the peptides from certain other cell surface-exposed proteins did not 
bind IgGs from EB patient plasma (i.e. FtsL, RS7, the DNA binding protein HU, a putative 
thioredoxin, two CsbD-like proteins and an uncharacterized), and these proteins can thus be 
regarded as negative controls for our epitope mapping analysis.
Figure 3. Lysis controls and verification of cell surface localization of IsaA. (A) Cells were harvested from cultures 
with an OD600 of 0.2, washed, and non-covalently cell wall-bound proteins were extracted with KSCN. The extracted 
wall proteins (cw) as well as crude cell extracts (ce) were analyzed by Western blotting with specific antibodies 
against the cytosolic marker protein TrxA. (B) Cultures were harvested at an OD600 of 0.2. Cells were separated 
from the growth medium by centrifugation, and the presence of TrxA in crude cell extracts (ce) or growth medium 
fractions (sec) was assessed by Western blotting with specific antibodies. (C) Cells of S. aureus Newman ∆spa∆sbi 
were harvested at OD600 0.2, incubated with an IsaA-specific antibody plus a secondary antibody labeled with 
AlexaFluor® 594, and inspected by fluorescence microscopy. As a control for specific antibody binding, the IsaA-
specific antibody was pre-incubated with increasing amounts of purified IsaA prior to fluorescence microscopy: 
(D) 10 pg IsaA, (E) 100 pg IsaA, (F) 1 ng IsaA, (G) 10 ng IsaA, (H) 100 ng IsaA, (I) 1 µg IsaA, (J) 10µg IsaA. 
Antibodies directed against (K) the secreted thermonuclease Nuc, or (L) the cytosolic marker protein TrxA were 
applied as negative controls for immuno-fluorescence.
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The highest number of IgG-binding peptides was identified for IsdB, and a close analysis of 
their location within this protein revealed a highly immunodominant domain between amino 
acids 47 and 129. This domain was also identified by shaving with immobilized trypsin as being 
cell surface-exposed (Fig. 4A, 'shaving 1'). A second immunogenic region was detected in the 
C-terminal part of IsdB between amino acids 395 and 565, which is also identified by surface 
shaving. Notably, surface shaving with immobilized trypsin ('shaving 1') identified only peptides 
from the N- and C-terminal regions in IsdB, whereas shaving with soluble trypsin ('shaving 
2') also identified peptides from the central region of IsdB. Peptides from the central region 
were also identified in extracellular IsdB. Thus, the central region of IsdB is not a substrate for 
immobilized trypsin, suggesting that it is protected by the cell wall.
A remarkable finding was that especially the surface-exposed N-terminal pro-region of the 
autolysin Atl was very well recognized by the IgGs from EB patients (Fig. 4B). It should be noted 
that this region is removed from Atl during the processing of the exported pro-Atl into the active 
amidase and glucosaminidase domains (42). Furthermore, we detected strong immunogenic 
signals in apparently surface-exposed domains of other proteins, such as the extracellular matrix-
binding protein (Emp), coagulase (Coa), fibronectin-binding protein A (FnbpA) and clumping 
factor B (ClfB) (Supplementary Fig. S4). However, we also observed that for some proteins, 
such as the chemotaxis inhibitory protein (CHIPS), different protein regions were identified by 
cell surface shaving and epitope mapping. In the case of CHIPS, we observed an IgG-binding 
domain in the N-terminus, next to the signal peptide, whereas proteomics identified most 
peptides in the C-terminal half of this protein (Fig. S4). Interestingly, immunogenic domains 
positioned next to the signal peptides were observed also for other proteins, such as Atl, Emp, 
the FPRL1 inhibitory protein (FLIPr), the lipoprotein YkyA, a peptide binding protein (Q2FKI7) 
and the MHC class II analog protein (Omp7; Fig. S4). Lastly, the epitope mapping revealed 
also numerous IgG-binding domains in typical cytoplasmic proteins that were found to be 
exposed on the S. aureus cell surface. These include the fructose-bisphosphate aldolase Alf1, the 
enolase Eno, the triosephosphate isomerase Tim, the elongation factors G and Ts, the ribosomal 
proteins S5, S13 and L25, the phosphoglycerate kinase Pgk and the glyceraldehyde-3-phosphate 
dehydrogenase GAPDH (Supplementary Fig. S4). 
Discussion
The world-wide spread of highly antibiotic-resistant lineages of S. aureus calls for the development 
of novel anti-staphylococcal therapies. Such therapies could very well include active or passive 
immunization. Unfortunately, attempts to develop anti-staphylococcal immunotherapy have so 
far remained unsuccessful, which may relate to the selected antigens. We therefore set out to 
define cell surface-exposed immunodominant epitopes in two important model strains for S. 
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Figure 4. Comparison of proteome and epitope mapping results. Peptides of the IsdB and Atl proteins as identified 
by proteomics analyses of four different sub-proteomes of S. aureus strains USA300 and Newman are highlighted 
in the linearly depicted protein sequence. In addition known protein domains are indicated. The graphs display the 
signals from the epitope mapping normalized to the median signal of the respective protein and serum for the seven 
different EB patients.
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aureus, namely the laboratory MSSA strain Newman and the community-acquired MRSA strain 
USA300. 
Various elegant studies on the staphylococcal exoproteome, wall proteome and surfacome 
were published in recent years (24, 29, 32-34). However, the usefulness of these studies for the 
rational design of novel antistaphylococcal immunotherapy was limited by the fact that they 
were based on different S. aureus isolates grown in different media under different conditions, 
and that very different technical approaches were applied (30). Therefore, we designed an 
integrated workflow in which the cell wall proteomes, surfacomes and exoproteomes of two 
different strains (Newman and USA300) grown under identical conditions were analyzed in 
parallel following exactly the same protocol. An important outcome was that, despite substantial 
differences, there was indeed a significant overlap in the identified proteins of both investigated 
strains. A major pool of differentially identified proteins was formed by typical cytoplasmic 
proteins that were detected in and on the wall of both strains. While it is currently debated how 
such proteins leave the cytoplasm to become localized to the cell wall or the extracellular milieu, 
it is becoming increasingly clear that some of them have so-called 'moonlighting functions' 
in virulence (43). In line with this notion, our present studies show that the plasma of EB 
patients suffering from chronic staphylococcal wound colonization does indeed contain IgGs 
that specifically bind to a range of cytoplasmic proteins and that there is significant overlap 
between the IgG-binding domains and domains identified in our proteomic analysis (e.g. Tim, 
RS5, Eno, GAPDH). Notably, antibodies directed against Eno have been demonstrated to cause 
opsonophagocytic killing of S. aureus and this protein is a known protective antigen on the cell 
surface of Streptococcus suis (31, 44). Furthermore vaccination of rats with recombinant Eno 
caused protection against dental caries (45). First results also indicate GAPDH as a candidate for 
a broad spectrum vaccine to reduce infection in aquacultures (46). 
The direct comparison of the two different shaving approaches using immobilized and soluble 
trypsin, respectively demonstrates how different the outcome of the two closely related 
experiments is. The shaving reaction with the soluble trypsin resulted in the liberation of 2.6 times 
more peptides representing 2.2/2.35 times more proteins than the assay with the immobilized 
trypsin. However, the majority of the peptide and protein identifications from the assays with 
the immobilized trypsin overlap with the results from the experiments using the soluble trypsin. 
The majority of the protein identifications that were unique for the soluble trypsin shaving 
approach are cytosolic proteins, like ribosomal and metabolic enzymes and also the pre-protein 
translocase unit SecA1. This suggests that the soluble trypsin penetrates the whole cell wall 
and digests also membrane proteins thereby enabling leakage of cytosolic proteins into the 
environment. However, with the soluble trypsin approach we were also able to identify known 
cell envelope-associated proteins like penicillin-binding protein 3 (PbpC), the iron-regulated 
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surface determinant protein IsdB, subunits of the ATP synthetase complex (α, β, b) as well as 
the iron compound binding protein (Q2FEK8, A6QJC5). In the corresponding negative controls 
only two peptides were reproducibly identified per strain (Supplementary Tables S1 and S2). 
From these control experiments we conclude that the shaving assays are essentially free of false-
positive identifications due to cell lysis or spontaneous liberation of proteins from the bacterial 
cell envelope. 
Notably, several surface-exposed proteins that were subjected to epitope mapping revealed 
clusters of epitopes that were specifically localized to certain domains within these proteins. 
This is best exemplified by the wall-anchored IsdB protein, the autolysin Atl, the adhesin Emp 
and the transglycosylase IsaA. The significance of these results is underlined by recent efforts to 
develop an IsdB-based vaccine, which showed that this protein is highly immunogenic (47, 48), 
and a study in which the binding site of a human monoclonal antibody was located to the IsdB 
domain between residues 50 to 285 (49). In the present studies, we identified the IsdB domain 
between residues 47 and 129 as a hot spot for recognition by IgGs from EB patients. This overlap 
is striking, especially because of the very different approaches that have been applied. Less 
effort has as yet been put into the development of vaccines containing Emp or Atl, but passive 
immunization with antibodies against Emp did show a reduction of staphylococcal loads in an 
animal model (50), and passive immunization with a monoclonal antibody against IsaA gave 
protection against S. aureus in a central venous catheter-related infection model and a sepsis 
survival model (51). Furthermore, Atl was previously identified as a strong antigen through gel-
based immunoproteomic approaches on growth medium fractions of S. aureus (52, 53). On this 
basis, it would be interesting to test the application potential of the N-terminal segment of Atl as 
a target for active or passive immunization. 
Interestingly, the IgGs from different EB patients did not always bind to the same S. aureus 
proteins or protein domains. This may have different reasons. Firstly, the Pepscan approach was 
based mainly on linear peptides and, therefore, certain conformational epitopes of particular 
proteins recognized by IgGs of the EB patients might be overlooked. A second reason for the 
observed variability in IgG responses could be that the different patients did not carry the same 
S. aureus types (36). Thus, it is conceivable that different surface-exposed antigens were either 
produced at low levels or not at all. This is a realistic possibility since an analysis of 58 different 
S. aureus genome sequences showed large variations in the composition and presence of genes 
for 25 surface-bound and/or immune-evasive proteins (28). Eighteen of these proteins were 
identified by our proteomic analyses of strains USA300 and Newman (i.e. ClfA, ClfB, Coa, Eap, 
Efb, EbpS, Emp, EsxA, FLIPr, FnbpA, IsdA, IsdB, SasG, Sbi, SCIN, SdrD, Spa, VWbp), and 12 
were analyzed by our Pepscan approach showing that they were recognized by antibodies from 
at least one EB patient (i.e. ClfB, Coa, EbpS, Efb, Emp, EsxA, FLIPr, FnbpA, IsdB, SasG, Sbi, 
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SdrD). It is relevant to note that some of the latter proteins, such as Coa, IsdA, IsdB and Spa, 
have been implicated as potentially effective targets for immunotherapy (54-56).  
Altogether, our present analyses highlight several immunodominant cell surface-exposed proteins 
of S. aureus and specific sub-domains of these proteins as potential targets for novel active or 
passive immunization approaches. These include the covalently cell wall-bound proteins ClfB 
and IsdB, a YkyA-like cell wall-binding lipoprotein, the membrane proteins EbpS and LtaS, the 
non-covalently cell wall-bound and secreted proteins Atl, Sbi, IsaA, Emp, and the cytoplasmic 
proteins Afl1, Eno, and GAPDH. Future studies will show whether any of these proteins can 
indeed serve as effective targets for antistaphylococcal immunotherapy.
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A large proportion of hospital-related infections are acquired and spread due to the direct contacts 
between patients and healthcare workers. Accordingly, proper infection prevention measures, and 
especially hand hygiene, are key to limit the spread of infections in nosocomial settings. However, 
healthcare workers frequently experience difficulties in complying strictly to hand disinfection 
protocols. This study was therefore aimed at the development of a hand rub with antimicrobial 
activity that forms a protective film on the hand, a so-called microglove, in order to enhance 
hand hygiene. For this purpose, various co-polymer formulations consisting of different ratios of 
Polyvinylpyrrolidone (PVP) and a branched C20 derivatized maleate (M20) in combination with 
the known biocide benzalkonium chloride (BKC) were tested for their combined film-forming 
and antimicrobial activities. The results of a series of novel contamination and transmission 
assays show that a formulation of 80% PVP and 20% M20 co-polymer with 0.9% BKC fulfils 
the elementary requirements for an antimicrobial microglove. 
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Introduction
One of the major concerns for hospitals and other healthcare institutions is the continuous threat 
of infections caused by a wide range of opportunistic microorganisms. Hospitalized patients 
are especially susceptible for infections due to their underlying illnesses that may render them 
frail and/or immunocompromised. Additionally, wounds resulting from trauma or surgical 
interventions represent a breach of the primary skin barrier through which pathogens can readily 
gain access to normally well-protected body sites. Today, the majority of the infections caused 
by bacteria can still be treated reasonably well with antibiotics. However, the growing incidence 
of infections with antibiotic resistant bacteria makes treatment increasingly difficult and very 
costly (1, 2). This is underpinned by recent studies showing that infections with multi-drug 
resistant bacteria, such as methicillin resistant Staphylococcus aureus (MRSA), lead to increased 
morbidity, mortality and length of stay in hospitals (3, 4). Especially hospital-acquired (HA) 
bacterial infections are notorious for their drug resistant phenotypes, which originate from the 
continuously applied antibiotic pressure in nosocomial settings. Importantly, HA infections are 
to a large extent acquired and spread through direct contacts between patients and healthcare 
workers (5, 6, 7). Therefore, a major prerequisite for success in the fight against HA infections 
is the strict implementation of effective infection prevention measures (8). 
One of the most effective precautions to minimize the spread of pathogens in healthcare settings 
is the routine decontamination of the hands of healthcare workers in-between patient contacts 
(7, 9). On a worldwide scale, it has been estimated that the strict implementation of standard 
control measures, in particular hand hygiene, could save one million lives annually (10, 11). 
Importantly, the success of the implementation of such control measures relies strongly on the 
strict adherence of healthcare workers to the protocol for hand disinfection between patient 
contacts. Yet, it has been noted that many healthcare workers experience difficulties in complying 
strictly to hand disinfection protocols for a range of different reasons (12, 13, 14). A key problem 
resides in the fact that effective hand hygiene requires the frequent re-application of soaps and 
alcohol- or chlorhexidine-based disinfectants. This can, on the long term, negatively affect the 
quality of the skin, resulting in skin irritation (15). In addition, skin damage due to the use of 
aggressive hand-washing products makes the skin more prone to colonization by pathogenic 
micro-organisms (16). 
To circumvent the drawbacks of the repeated use of soaps or other disinfectants, the present study 
was aimed at the development of a new antimicrobial hand coating – a so-called ‘microglove’ - 
with a protective effect that would last in the minute to hour time range. Ideally, the antimicrobial 
microglove should consist of a thin comfortable polymer film that can be applied in the form 
of a hand rub, and that then covers the surface of the hands. Furthermore, to avoid interference 
with established hygiene regimens, the microglove coating should be readily removable by hand 
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washing with regular soap and water. We therefore focused the present study on developing a 
Polyvinylpyrrolidone (PVP)-based hand rub, since PVP is a water-soluble excipient that is widely 
used both in the pharmaceutical industry, the food industry (E1201), and in numerous personal 
care products. For example, PVP is applied in syrups, soft gelatin capsules, shampoos, toothpastes, 
hair sprays and gels, and in contact lens solutions. Accordingly, PVP is generally considered 
safe. In addition, its unique physical and mechanical properties make PVP an ideal candidate for 
a polymer-based hand rub. By using PVP in combination with a derivatized maleate it is possible 
to create PVP-based co-polymers, so called Aegimers, with different solubility properties 
(17). In the present study, we therefore tested various co-polymer formulations consisting of 
different ratios of PVP and a branched C20 derivatized maleate named M20 for their film and 
texture properties. For proof-of-principle, the polymer formulations were combined with the 
known biocide benzalkonium chloride (BKC). BKC is a quaternary ammonium compound with 
chemical properties that make it interesting for use as a biocidal, cationic surfactant and phase 
transfer agent (18). As a biocidal, BKC has been applied in a large range of cosmetic products, 
non-alcoholic hand sanitizers, skin antiseptics, wet towels, mouth washes, and ophthalmic 
preparations, even though it can cause irritations of the skin (19). The resulting polymer-biocide 
formulations were analyzed for their antibacterial activity. Using simulated contamination and 
transmission assays, a promising candidate ‘microglove’ formulation was identified, which 
consists of a co-polymer of 80% PVP and 20% M20 supplemented with 0.9% BKC (in short 
PVPM20-80:20-0.9% BKC). 
Results
PVPM20 can function as coating-carrier for benzalkonium chloride  
An antimicrobial microglove should be composed of a thin polymer film that is retained on 
the surface of the hand for a period of time in the minutes to hours range. In this study, such a 
polymer film was created through a co-polymer formulation consisting of PVP and M20 (i.e. 
PVPM20). In a first approach, PVP and M20 were used in a 90% to 10% ratio, respectively. 
Different PVPM20-90:10 formulations that either contained 0.1%, 0.5% or 1.0% BKC, or that 
lacked BKC, were tested for their antimicrobial activity. To this end, aliquots of an exponentially 
growing S. aureus HG001 culture in Tryptic Soy Broth (TSB) were exposed to the different 
polymer coatings applied to the bottom of 96-well microtiter plate wells. Coatings with the 
PVPM20 polymer, but without BKC had no effect on growth of S. aureus HG001 at 37°C as the 
cells that were introduced into the wells with only PVPM20-90:10 showed comparable growth 
rates as cells introduced into the untreated wells (Figure 1A). This showed that PVPM20 itself 
has no antimicrobial activity. When we supplemented the PVPM20-90:10 with 0.1% BKC, the 
application of 5 µl of undiluted coating resulted in a complete inhibition of growth. However, 
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when this formulation was diluted 10-fold, neither the 2 µl nor the 5 µl coatings were able 
to inhibit growth (Figure 1B). By increasing the concentration of BKC to 0.5% the growth-
inhibiting power of the polymer formulation increased considerably. In this case, coatings of 2 
µl and 5 µl of the 10-fold diluted PVPM20-90:10 with 0.5% BKC were efficiently preventing 
growth of S. aureus (Figure 1C). Growth inhibition was even further enhanced by using a 
PVPM20-90:10 formulation with 1.0% BKC, where even the 5 µl coating of a 100-fold diluted 
formulation was sufficient to stop the growth of S. aureus (Figure 1D). Interestingly, coatings of 
BKC without the PVPM20 polymer, were slightly more effective in stopping the growth of S. 
aureus HG001 (Figure 1, E-G). 
The observation that the PVPM20-90:10 polymer formulation slightly decreased the antibacterial 
effects of BKC suggested that the polymer coating of the microtiter plate inhibited the release of 
BKC into the culture medium. This idea was tested in a disk diffusion assay using Tryptic Soy 
Agar (TSA) plates confluently inoculated with S. aureus HG001. After overnight incubation at 
37°C, the growth inhibition zones around the paper disks were examined. Upon comparison of 
the growth inhibition zones around paper disks with PVPM20-90:10 plus BKC or with BKC 
Figure 1. Growth of S. aureus HG001 in polymer-coated microtiter plates. Different amounts of serially diluted 
PVPM20-90:10 formulations and unaided BKC solutions were used to coat wells in a 96-well microtiter plate. These 
PVPM20-90:10 formulations and unaided BKC solutions contained increasing BKC concentrations as indicated. 
S. aureus HG001 was pre-cultured in TSB using uncoated 96-well microtiter plates until early exponential growth 
after which aliquots of 100 µl were transferred to the polymer-coated wells (indicated by the arrows). Subsequently, 
growth at 37°C for 1000 min was monitored by optical density readings at 600 nm.
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Figure 2. BKC disk diffusion assay in the presence or absence of PVPM20-90:10. TSA plates were inoculated 
confluently with S. aureus HG001. Next, Whatman paper disks loaded with BKC at different concentrations (0.1%, 
0.5% or 1%) either with or without PVPM20-90:10 were placed on top of the plates. After overnight incubation 
at 37°C growth inhibition zones were detectable around the paper disks. The circles underneath the images of the 
plates represent the respective sizes of the inhibition zones when disks were loaded with BKC alone (red) or with 
BKC plus PVPM20-90:10 (green); the red circle underneath the first plate (no BKC) indicates the size of the paper 
disk. 
alone, but both containing BKC at the same concentration, it was clearly evident that PVPM20-
90:10 indeed inhibited the diffusion of BKC into the surrounding agar medium. Already at a 
BKC concentration of 0.1% the PVPM20-90:10 polymer resulted in a substantial reduction 
of the inhibition zone (Figure 2). This inhibitory effect of PVPM20-90:10 on BKC diffusion 
became less prominent when higher concentrations of BKC were used. The latter observation 
can be explained by the higher concentration gradient of BKC in the PVPM20 relative to the 
surrounding agar medium, resulting in a faster release of the BKC and effectively more BKC 
that is available to diffuse from the paper disk into the surrounding agar medium. Alternatively, 
the PVPM20 coating may become saturated with BKC, allowing the BKC that is available in 
excess to diffuse rapidly from the paper disk into the surrounding agar medium. The fact that 
PVPM20-90:10 can set a limit to the diffusion of BKC into the surrounding medium implied that 
PVPM20 could represent an attractive slow-release carrier for antimicrobial compounds, such as 
BKC. In turn, this made the PVPM20-90:10 formulation with BKC an attractive candidate for 
further proof-of-principle studies on the antibacterial microglove concept.
PVPM20-80:20-0.5% BKC effectively prevents S. aureus transmission
In the initial experiments described above, PVP and M20 were used in a 90% to 10% ratio. 
Since the PVP:M20 ratio is an important parameter for the properties of the co-polymer film 
that is to represent a microglove, we synthesized three formulations with different PVP:M20 
ratios, namely 90:10 (PVPM20-90:10), 85:15 (PVPM20-85:15), and 80:20 (PVPM20-80:20). 
These polymer formulations were tested in combination with different BKC concentrations in 
an in-house developed contamination and transmission assay of which the different steps are 
schematically represented in Figure 3. Briefly, stamps covered with a nitrile examination glove 
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were either coated with a co-polymer formulation or they were left untreated. These stamps were 
contaminated by pressing them on a TSA plate inoculated with S. aureus HG001 (Figure 3C). 
Next the stamp was pressed against a second stamp (Figure 3D) and the second stamp was then 
pressed against a third stamp (Figure 3E). All three stamps were subsequently pressed on fresh 
TSA plates (Figure 3F), which were incubated overnight at 37°C. This assay demonstrated that 
using the non-coated control stamps, transmission of S. aureus HG001 was detectable from the 
initially contaminated stamp to both the second and third stamps (Figure 4). The numbers of 
transmitted bacteria decreased visibly after each transfer. Furthermore, the imprints left by the 
control stamps on the inoculated bioassay plate that was used for stamp contamination showed 
Figure 3. Design of a contamination and transmission assay. (A) Stamp design; stamps were made of screw caps for 
laboratory flasks on top of which absorption paper was fixed with parafilm. (B) Example of one of the three stamps 
wrapped with a nitrile examination glove. (C) Contamination procedure; a first stamp (no. 1) was pressed for 10 sec 
onto a TSA plate inoculated with S. aureus HG001. (D) First transmission step; stamp no. 1 was pressed to stamp 
no. 2 for 5 sec. (E) Second transmission step; stamp no. 2 was pressed to stamp no. 3 for 5 sec. (F) Contamination 
of stamps with S. aureus HG001 was assessed by pressing the stamps onto TSA plates. 
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Figure 4. Controls for the contamination and transmission assay. The first three columns depict the contamination of the three 
stamps with S. aureus HG001 as reflected by colony formation on the fresh TSA plates onto which the non-polymer-coated 
stamps were pressed. The last column shows the imprint that was left on the ‘contamination plate’ (inoculated with S. aureus 
HG001) after overnight incubation. 
only the outline of the stamps and, as expected, there was no inhibition of bacterial growth. 
When stamps were coated with the original PVPM20-90:10 formulation containing 0.1% BKC 
(Figure 5A), there was still a considerable amount of bacterial transmission by the three stamps. 
Contamination of the first stamp was slightly reduced compared to the uncoated control stamps. 
The imprint on the bioassay plate showed a small clearing zone, which suggests that part of the 
polymer coating was released upon contact with the agar. This can be explained by the fact that 
BKC residing in the polymer coating will diffuse into the agar, resulting in the clearing zones in 
which bacterial growth is inhibited. Increasing the concentration of BKC to 0.3% (Figure 5A) 
prevented transmission to stamps no. 2 and no. 3, and even stamp no. 1 did not transmit viable 
bacteria, suggesting that the antibacterial coating was successfully applied. However, the imprint 
on the bioassay plate was characterized by a large clearing zone (Figure 5A). This is likely due to 
the diffusion of BKC, which implies the release of some of the polymer film applied to the stamp. 
Increasing the BKC concentration to 0.5%, 1%, 2% and 5% resulted in even larger clearing zones 
(Figure 5A). This can be explained as a direct consequence of increasing the BKC concentration. 
However, this can, at least in part, also be attributed to a secondary effect of the increasing 
BKC concentrations, since BKC is a well-known surfactant and phase-transfer catalyst that may 
change the water-resistant properties of the polymer film. Upon changing the PVP and M20 ratio 
to 85% and 15%, respectively (i.e. PVPM20-85:15), the addition of 0.1% BKC did not prevent 
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the contamination of stamps no. 2 and no. 3 (Figure 5B). Increasing the BKC concentration to 
0.3%, which proved to be effective when using the PVPM20-90:10 formulation, was also not 
sufficient to fully prevent transmission to stamp no. 3. Nevertheless, the number of transmitted 
bacteria was clearly reduced. This was most likely due to some release of the polymer film, 
as was also reflected by the large clearing zone on the inoculated bioassay plate (Figure 5B). 
Applying PVPM20-85:15 with a BKC concentration of 0.5% prevented bacterial transmission 
to stamp no. 2 and no. 3, but could not prevent contamination of the stamp no. 1. When the 
BKC concentration was increased to 1% and higher, none of the stamps showed contamination. 
However, the large clearing zones on the inoculated bioassay plate were indicative for the release 
of the polymer film obtained when PVP and M20 were present at a ratio of 80% and 20%, 
respectively (i.e. PVPM20-80:20). In combination with 0.1% BKC, the PVPM20-80:20 was still 
not sufficient in preventing transmission to stamp no. 3, However, the coating of the stamps with 
PVPM20-80:20 containing 0.3% BKC resulted in a substantial reduction of S. aureus HG001 
transmission, although it was not completely prevented. Importantly, in this case, no clearing 
zones were detectable on the inoculated bioassay plate used to start the transmission experiment 
(Figure 5C). Increasing the BKC concentration to 0.5% completely abolished the contamination 
of all three stamps, again without generating a clearing zone on the inoculated bioassay plate 
(Figure 5C). This indicates that while the polymer film remained intact on the stamp it was able 
to prevent stamp contamination with bacteria and their subsequent transmission. PVPM20-80:20 
polymer films containing BKC concentrations of 1% or more released substantial amounts of 
BKC onto the inoculated bioassay plate, as reflected by large clearing zones (Figure 5C). Based 
on the significant antibacterial activity of the PVPM20-80:20 supplemented with 0.5% BKC, 
and on the stable film that it forms, the PVPM20-80:20 formulation was selected for further 
testing.
PVPM20-80:20 coating facilitates slow BKC release 
The slow BKC release properties of the PVPM20-80:20 co-polymer formulation were verified 
in a BKC release test that was performed in a 96-well plate. In this experiment the PVPM20-
90:10, PVPM20-80:20 and PVPM20-75:25 formulations were supplemented with 0.9% BKC 
and coated to the first well of each row of a 96-well plate. After evaporation of the 2-propanol 
solvent, an aqueous bromophenol blue (BPB) solution was added to the coated wells and the plate 
was incubated for 1 min at room temperature. BPB forms a blue complex with free BKC when it 
is released from the polymer film into aqueous solution. Of note, the BPB-BKC complex is blue, 
whereas the BPB solution itself is purple (20). After incubation, the solution was transferred 
to the second well, and the color shift was assessed visually. Subsequently, new BPB solution 
was added to the polymer-BKC-coated wells, and incubated for 1 min and transferred to the 
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Figure 5. Effects of polym
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third well. This course of actions was repeated until blue BPB-BKC complexes were no longer 
observed. The number of cycles needed to release readily detectable amounts of BKC was used 
as a measure to assess the BKC-retaining properties of the different polymer formulations. The 
results of this test showed that the PVPM20-80:20 formulation was most efficient in releasing 
BKC from the film (Figure 6), as it took up to 8 consecutive incubations with the aqueous BPB 
solution until BKC was no longer detectably released (Figure 6). In contrast, the film made with 
the PVPM20-75:25 formulation showed BKC release for only 2 incubations, after which the film 
completely disintegrated. The PVPM20-90:10 formulation performed slightly better, but after 5 
consecutive incubations with the BPB solution no detectable amounts of BKC were released from 
the film. These findings were consistent with the results shown in Figure 5, which indicated that 
the PVPM20-80:20 formulation was the most suitable candidate formulation for further testing. 
Additionally, we tested the BKC release from a 0.9% BKC coating without PVPM20-80:20. 
In this case, all coated material dissolved instantaneously upon addition of the BPB solution 
and all BKC was thereby released. Of note, the BKC concentration in commercially available 
formulations is lower (~0.2%) than the concentration used in our present polymer formulations. 
However, the BKC-release assay shows that by using BKC in combination with the PVPM20-
80:20 polymer, the actual release of free BKC from the polymer film is considerably lower than 
that of unaided BKC as implemented in commercial BKC-based disinfectants. Combined with 
the other data presented above, it can thus be concluded that the high concentration of BKC is 
retained within the PVPM20-80:20 polymer film and is only slowly released upon contact with 
water. This slow BKC release combined with the good film properties implied that the PVPM20-
80:20 0.9%BKC formulation matched the basic requirements for a hand rub that facilitates the 
establishment of an antibacterial microglove.
Figure 6. Release of BKC from different polymer formulations. Picture of the 96-well microtiter plate assay where 
the first well (marked ‘coated’) was used for the polymer coating and subsequent incubation steps with bromophenol 
blue (BPB) solution. Wells 1-10 contain the BPB solutions after incubation with the coating in the first well. The 
applied polymer formulations and the respective BKC concentrations are indicated. 
Chapter 7
180
Validation of the antibacterial microglove concept
To test whether the PVPM20-80:20 0.9%BKC formulation could function as a microglove 
that offers protection against microbial contamination, its functionality was evaluated using a 
glove contamination assay. In this assay 13 volunteers were asked to wear a PVPM20-80:20 
0.9%BKC-treated and an untreated examination glove (control), while performing their normal 
daily activities. After approximately 3 hours, both gloved hands were pressed gently on a 
Lysogeny Broth (LB) agar plate to assess the levels of microbial glove contamination. The plates 
were incubated overnight at 37°C, and the next day the colony-forming units (CFUs) on the 
plates (Figure 7A) were counted. Indeed, the gloves coated with the PVPM20-80:20 0.9%BKC 
formulation yielded significantly lower numbers of CFUs on the inner hand surface than the non-
coated gloves, demonstrating a protective antimicrobial effect of the polymer coating (Figure 
7B). Overall, the numbers of CFUs were approximately halved when a glove was treated with 
PVPM20-80:20 0.9%BKC, but in some individual experiments the effect was substantially 
more prominent with up to 40-fold reductions in CFUs. For unknown reasons, other experiments 
showed less pronounced antimicrobial effects of the polymer coating. Even so, in each single 
Figure 7. Effects of polymer coating on microbial glove contamination. (A) Example plate depicting the 
contamination of polymer-coated and non-coated examination gloves. The gloves were worn by a volunteer for 3 
hours during which time the volunteer performed regular activities. Subsequently, the volunteer gently pressed the 
gloves onto a bioassay plate with LB agar. The picture was taken with the Syngene G:box after overnight incubation 
at 37°C. In this example, the left glove was used as an uncoated control, while the right glove was coated with 
PVPM20-80:20 0.9%BKC. (B) Results of the glove contamination assays. Coated and non-coated gloves were 
worn by 13 volunteers for about 3 hours. Colony forming units on the LB plates onto which the used gloves were 
pressed, were counted with the Syngene software. The outcome of each individual experiment is indicated with a 
different color code, allowing the comparison of the contamination of each pair of coated and non-coated gloves. 
Statistical analyses were done using the Mann–Whitney U test. Horizontal black bars indicate average numbers of 
colony forming units. 
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experiment the coating of a glove with PVPM20-80:20 0.9%BKC led to a reduced number of 
microbial contaminants compared to the respective control (Figure 7B). 
Since the surface of a nitrile examination glove only mimics the situation on the human skin, we 
decided to test the microglove concept on the hands of three volunteers, which was acceptable 
since the components of the PVPM20-80:20 0.9%BKC formulation can be considered as safe 
based on the extensive history of usage. Thus, for each volunteer one hand was treated with 
the polymer formulation, while the other hand remained untreated. After approximately 3 
hours, both hands were pressed gently on a LB agar plate to assess the levels of microbial glove 
contamination. This analysis revealed that hands coated with the PVPM20-80:20 0.9%BKC 
formulation showed a significant reduction in CFU counts (Figure 8). For the non-treated hands 
an average of 301 CFUs was counted, while the coated hands carried on average 52 CFUs. This 
six-fold reduction in microbial contamination shows that the microglove concept has indeed a 
considerable protective effect against newly acquired contaminants for a period of approximately 
3 hours. Importantly, we observed that the effect of the PVPM20-80:20 0.9%BKC coating was 
even more effective on the hands of volunteers than on examination gloves. Conceivably, this 
difference could relate to the moisture of human hands, which is absent from the examination 
gloves. 
Discussion
In this study, we provide the proof-of-principle for a new type of antimicrobial hand rub 
that forms a protective microglove and has the potential to be used as an alternative for the 
current disinfectants applied by healthcare workers. The great advantage of the antimicrobial 
microglove concept is that it reduces the risks of microbial hand contamination for healthcare 
workers and, consequently, the risks of transmission of pathogens from healthcare workers to 
patients for a period of time that is sufficiently long for patient examination and the provision of 
care. Due to its antimicrobial activity, the microglove may reduce the critical need for repetitive 
hand disinfection procedures. Importantly, since in principle fewer hand disinfection events are 
needed for protection, the microglove could potentially enhance the compliance of healthcare 
workers with established hygiene protocols.
The present microglove formulation is based on a co-polymer of PVP and the branched C20 
derivatized maleate M20. This co-polymer is dissolved at a concentration of 5% in 2-propanol 
and is supplemented with 0.9% BKC. Like in commercially available alcohol-based disinfectants, 
such as Sterillium®, the initial disinfection is most likely caused by the solvent 2-propanol. 
However, after the 2-propanol evaporates, a thin polymer film containing the active biocide 
BKC remains on the skin forming the protective microglove. Of note, there are other BKC-based 
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Figure 8. Effects of polymer coating on microbial hand contamination. One hand of three volunteers was coated 
with PVPM20-80:20 0.9%BKC, while the other hand of these volunteers was left untreated. After 3 hours of 
regular activity, the volunteers pressed their hands gently onto LB bioassay plates. The plates were then incubated 
overnight at 37°C. Next day, images of the plates were recorded with the Syngene G:box, and colony forming 
units where assigned with the Syngene software. All individual experiments, including repeats, are indicated with 
different colors, allowing the comparison of the contamination of each pair of polymer-coated and non-coated 
hands. Statistical analyses were done using the Mann–Whitney U test. Horizontal black bars indicate average 
numbers of colony forming units.
disinfectants currently on the market, but these do not protect users against renewed microbial 
contamination after they have disinfected their hands. 
Most of the currently commercially available BKC-based products contain about 0.2% BKC, 
while the present microglove formulation contains 0.9% BKC. Importantly, our present findings 
indicate that not all of this BKC is instantaneously released from the co-polymer film. Instead, 
the BKC is retained by the polymers and slowly released into the environment. We consider 
this as an advantageous property to protect hands against microbial contamination, and also to 
limit the subsequent transmission of microbial contaminants. Furthermore, the fact that most 
of the BKC in the microglove formulation remains confined in the polymer film, and is not 
immediately released, is likely to limit the actual hand exposure to BKC, thereby minimizing a 
possible irritation of the skin by BKC.
In conclusion, the present study demonstrates the feasibility of a disinfecting hand sanitizer that 
can be regarded as an antimicrobial microglove. The microglove formulation that was tested 
provided protection against newly acquired microbial contaminants for a period of at least three 
hours. Although our microglove concept is technically feasible, it is key to realize that this type 
of product cannot replace strict hygiene protocols. Instead, it should be regarded as a tool that 
is complementary to existing hygiene protocols, and that can potentially enhance the efficacy of 
such protocols. Lastly, it should be noted that further optimization studies will be needed before 
an antimicrobial microglove can be implemented in the daily routine. This relates especially to the 
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fact that in our studies the current formulation and/or amounts applied convey a certain stickiness 
to the hands that could be perceived as unpleasant. However, a great advantage of the PVPM20 
co-polymer system is that its chemical and physical properties can be easily modified and this, 
in combination with optimization of the hand rub formulation, provides ample possibilities for 
further development towards a novel solution in reducing hospital-acquired infections.
Materials and Methods
Strains and growth media
S. aureus HG001 (21) was grown in TSB or on TSA. Liquid S. aureus HG001 cultures were 
grown in 96-well plates at 37°C and under constant agitation using a Biotek powerwave 
microplate reader.  
Co-polymers
Co-polymers with different ratios of PVP and M20 were prepared by PolyVation BV.  These 
different co-polymers (in short PVPM20) were dissolved to a final concentration of 5% 
in 2-propanol. The resulting PVPM20 solutions were then supplemented with different 
concentrations of BKC (Sigma Aldrich). 
Co-polymer screening for antimicrobial activity
The co-polymer antimicrobial activity screen was performed with PVP and M20, mixed at a 
90% to 10% ratio, respectively, and supplemented with 0.1%, 0.5% or 1.0% BKC from a 50% 
(w/v) stock solution. PVPM20-90:10 without BKC, and BKC solutions of 0.1%, 0.5% or 1.0% 
without PVPM20 were used as controls. The different formulations were used to coat 96-well 
microtiter plates by applying different aliquots to the bottoms of the wells; 5 µl of the original 
5% PVPM20 solutions, 2 µl and 5 µl of 0.5% PVPM20 solutions (10x diluted), and 2 µl and 5 µl 
of 0.05% PVPM20 solutions (100x diluted). The wells were air-dried, resulting in the deposition 
of a polymer film on the bottom of the wells. The BKC controls were applied using the same 
approach. Next, 100 µl aliquots of a culture of exponentially growing S. aureus HG001 in TSB 
were added to the wells and growth was monitored for 14 hours by optical density readings at 
600 nm (OD600) using a Biotek powerwave plate reader at maximal shaking.  
Disk diffusion assay
PVPM20-90:10 (5%) formulations with either 0.1%, 0.5% or 1% BKC were spotted in 5 µl 
aliquots on 5 mm Whatman® paper disks. Alternatively, 5 µl aliquots of 0.1%, 0.5% or 1% BKC 
solutions were spotted on the disks. After disk drying at room temperature, the disks were placed 
on TSA plates onto which S. aureus HG001 had been spread to obtain a confluent lawn of cells. 
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These plates were then incubated overnight at 37°C and, the next day, the sizes of the observed 
inhibition zones were measured to estimate the diffusion of BKC from the paper disks 
S. aureus contamination and transmission assay
To assay the impact of different polymer formulations on the contamination of surfaces with 
S. aureus and the subsequent S. aureus transmission to other surfaces, a dedicated assay was 
developed. Briefly, an overnight culture of S. aureus HG001 was diluted 1:10.000 and 1 ml 
was plated confluently onto two large bioassay plates with TSA. After inoculation, the plates 
were dried at 37°C for approximately 30 min to allow bacteria to settle and to remove access 
moisture. Nitrile examination gloves were wrapped around self-fabricated stamps (Figure 3, A 
and B), which were made from absorption towel placed on a bottle cap and secured by a parafilm 
wrapping (Figure 3A). The gloved stamps were coated with 50 µl polymer formulations, or 
they were left untreated (control). Contamination and transmission was achieved by pressing 
the gloved stamp (no. 1) onto the plate inoculated with S. aureus for approximately 10 sec 
(Figure 3C). The stamp was then used to contaminate a second stamp (no. 2) by pressing the two 
together for 5 sec (Figure 3D), after which it was pressed for 5 sec onto a clean TSA plate (Figure 
3F). Subsequently, the second stamp was first pressed against a third stamp (no. 3; Figure 3E), 
and both stamps were then pressed onto clean TSA plates for 5 sec (Figure 3F). All plates were 
incubated overnight at 37°C. Bacterial growth on the agar plates, including that on the two bio-
assay plates used for the initial contamination of stamp no. 1, was used to assess the quality and 
anti-bacterial capacity of the polymer films applied to the stamps. Importantly, we included five 
non-coated control stamps, which were pressed onto different locations on the bioassay plates, 
to preclude a possible position-related assay bias. 
BKC release assay
The different polymer formulations (i.e. PVPM20-90:10, PVPM20-80:20, and PVPM20-75:25 
in 2-propanol) were supplemented with 0.9% BKC and 20 µl coated to the first well of each 
row of a 96-well plate. After evaporation of the 2-propanol solvent, 100 µl of an aqueous BPB 
solution (6×10-4 mmol/L) was added to the coated wells and the plate was incubated for 1 min 
at room temperature. Next, the aqueous phase was removed from the well and the formation 
of blue BPB-BKC complexes was assessed by visual inspection. This process was repeated 
until blue BPB-BKC complexes were no longer observed, and the number of repeated BPB 
incubation steps was recorded. 
Glove contamination assay
Nitrile examination gloves (Sterling Nitrile Powder-Free Exam Gloves, Kimberly-Clark) were 
coated with 1 ml of PVPM20-80:20 (5%) dissolved in 2-propanol and supplemented with 0.9% 
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BKC. As a control, untreated nitrile examination gloves were used. Next, 13 volunteers were 
asked to wear a PVPM20-80:20 0.9%BKC-treated and an untreated examination glove (control), 
while performing their normal daily activities. To prevent a dominant hand bias, the coated 
glove was randomly assigned to the left or right hands of the volunteers. After ~3 hours, both 
gloved hands were pressed gently on a LB agar plate which was then incubated overnight at 
37°C. Images were recorded with a G:BOX gel documentation and analysis system (Syngene). 
The numbers of CFUs on the plate were automatically assigned using the Syngene software 
package. CFU numbers thus determined were used as a measure for the numbers of microbial 
contaminants that had adhered to the glove. 
Hand contamination assay 
Both hands of a volunteer were first decontaminated with Sterillium. Next, the volunteer was 
asked to apply 1 ml of a PVPM20-80:20 0.9%BKC solution onto one hand by hand rubbing, 
and, therefore, the other hand was protected from coating with a nitrile examination glove. After 
approximately 3 hours of normal daily activities, both hands were pressed gently on a LB agar 
plate. Upon overnight incubation of the plate at 37°C, the microbial contamination of the hands 
of the volunteers was assessed by CFU counting as described for the glove contamination assay.
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General summary and discussion 
Antibiotic resistance is currently one of the major threats for public health. Bacterial infections 
that were relatively easy to treat since the discovery and large-scale clinical introduction of 
antibiotics are becoming, again, difficult to treat effectively. In particular, the large-scale use, 
or abuse, of antibiotics has provoked the emergence of a range of drug resistant bacterial 
lineages. In some cases these bacteria only acquired resistance to the first-line of antibiotics (e.g. 
amoxicillin, co-trimoxazole, and doxycycline), and are still responsive to second-line antibiotics 
(e.g. amoxicillin/clavulanic acid, and macrolides such as clarithromycin). However, in recent 
years several bacterial lineages have emerged that have acquired resistance to a large number 
of different antibiotics, sometimes even leading to total drug resistance (TDR). The latter is 
exemplified by the TDR variants of Mycobacterium tuberculosis that have recently emerged in 
different areas around the globe (1, 2, 3, 4, 5). The increasing incidence of antibiotic resistant 
phenotypes in dangerous bacteria is highly disturbing, because the development of alternative 
strategies to combat infections caused by these resistant bacteria is outcompeted by their spread. 
This is clearly illustrated by the rapid spread of carbapenemase-producing enterobacteriaceae in 
Europe (6).  
This thesis “on antibiotic resistance” provides the reader with an overview of different aspects 
of the current antibiotic resistance problem. Chapter 1 introduces this topic by addressing the 
origins of antibiotic resistance, the molecular mechanisms leading to resistance, the acquisition 
of resistance by bacterial pathogens, as well as alternative strategies to combat resistance. 
Herein it is discussed that antibiotic resistance should not be considered as a new bacterial trait, 
but rather as an ancient natural phenomenon where bacteria protect themselves against toxic 
compounds produced by other organisms in their ecological niche. Nevertheless, the start of the 
use of antibiotics in human medicine and animal husbandry has led to an increased selection for 
the expression of resistance genotypes that were already widely distributed in nature. 
The studies described in chapter 2 relate to the fact that resistance genes are present in most 
microorganisms, including numerous non-pathogenic bacteria, such as the Gram-positive 
bacterium Bacillus subtilis, which is a resident of the soil and plant rhizosphere. In fact, this 
bacterium is generally regarded as safe, and it is therefore used in a wide range of biotechnological 
applications (7, 8). Despite its ‘friendly nature’, B. subtilis is loaded with an extensive arsenal of 
antibiotic efflux pumps, including the ATP-binding Cassette (ABC) transporter BmrCD, which 
was the focus of the studies described in chapter 2. It seems likely that B. subtilis acquired 
a wide range of resistance traits due to its constant battle for natural resources with other 
soil-dwelling bacteria. Many of these deploy a range of strategies, including the production 
of antibiotic compounds to secure their biological niche. Importantly, many of such naturally 
occurring compounds produced by fungi, streptomycetes and bacilli have found their way into 
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the clinic in the form of antibiotics. 
Specifically, chapter 2 reports on the mechanism of induction of the multi-drug resistance 
(MDR) ABC transporter BmrCD of B. subtilis. The BmrC and BmrD proteins form a 
heterodimeric ABC transporter that is able to excrete a number of typical MDR ligands (9, 10). 
Of note, the BmrCD transporter is induced by several clinically relevant antibiotics (9, 11). The 
specialized regulatory mechanism of BmrCD, described in chapter 2, suggests that this system 
has especially evolved to sense and act to antibiotic compounds that target the cellular protein 
synthesis machinery, namely the ribosome. The results show that antibiotic-induced expression 
of the brmC and bmrD genes is regulated via a transcriptional attenuation mechanism. This 
mechanism involves terminator and anti-terminator structures that are located in bmrB, a 162-bp 
open reading frame (ORF) upstream of brmC. The bmrB gene is co-transcribed with the bmrC 
and bmrD genes, and the encoded BmrB protein functions as a regulatory leader peptide. It 
was demonstrated that translation of bmrB is essential for the antibiotic-induced expression of 
BmrCD. Based on these findings, it is hypothesized that in the absence of antibiotics that target 
protein synthesis, translation of brmB proceeds unhindered, resulting in the formation of the 
transcriptional terminator, which prevents the transcription of bmrC and bmrD. In contrast, in 
the presence of ribosome-targeted antibiotics, such as lincomycin, translation of brmB is slowed 
down, providing more time for the less stable anti-terminator structure to be formed. This in turn, 
prevents the formation of the transcriptional terminator, and thereby facilitates transcription of 
the downstream ABC transporter genes bmrC and bmrD. In addition, the live cell array approach 
that was applied in this study, revealed that the antibiotic-induced expression of BmrCD was 
restricted to the late-exponential and stationary growth stages. This growth phase-dependent 
expression profile turned out to depend on the transition phase regulator AbrB. The fact that 
BrmCD was only expressed during the later stages of growth, irrespective of the time point of 
the antibiotic challenge, raised some questions about its proposed role in antibiotic resistance. 
Especially, what could be the use of an antibiotic efflux transporter that does not respond 
immediately to an antibiotic challenge? However, in this context, one has to bear in mind that 
B. subtilis is packed with transporter systems that can facilitate the export of toxic compounds 
(12, 13). The delayed response in the expression of BrmCD might thus relate to this redundancy 
and suggests that this system is simply not needed during exponential growth. Additionally, the 
expression and secretion of antibiotics is often a response to a limiting availability of nutrients, 
such as encountered during late-exponential and stationary growth stages. Therefore, it seems 
as if B. subtilis anticipates on a possible nutrient shortage combined with an antibiotic challenge 
through the typical regulation of BmrCD expression. The combined results indicate that a better 
understanding of the molecular mechanisms and regulatory systems that are involved in antibiotic 
resistance is needed to fully comprehend how bacteria develop resistance to antibiotics.
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Also, the development of persister cells is currently not well understood. As discussed in chapter 
1, a bacterial population often consists of a small sub-population of persister cells that, due to 
their low metabolic state, are less susceptible to the toxic effects of antibiotics (14). The data 
presented in chapter 3 show that heterogenic expression of AbrB, the transition state regulator 
that also controls the timing of BmrCD expression, results in variable growth rates. The cell-
to-cell variation in AbrB protein levels is at least partly controlled by an interaction of the abrB 
mRNA with the small regulatory (s)RNA RnaC/S1022. A strain lacking RnaC/S1022 reached 
higher optical densities on a minimal growth medium, suggesting that deletion of this sRNA 
segment improved the growth of B. subtilis. Using an in silico sRNA target prediction pipeline, 
abrB was recognized as a potential target for RnaC/S1022-mediated regulation. Subsequent 
Western and Northern blotting analyses demonstrated that the ArbB protein and abrB mRNA 
levels were indeed negatively correlated with the expression of RnaC/S1022, which would 
explain the apparent growth phenotype of the RnaC/S1022 mutant strain. In addition, strains 
carrying AbrB-GFP fusion proteins were analysed by flow cytometry. This single cell approach 
showed that in the wild-type strain, the intrinsic AbrB-GFP expression noise was relatively large. 
Deletion of the RnaC/S1022 segments resulted in significantly lower AbrB-GFP expression 
noise. This shows that the sRNA modulates, at least partly, the observed cell-to-cell variation 
in AbrB expression. RnaC/S1022 regulates abrB mRNA levels via a direct sequence-dependent 
sRNA-mRNA interaction. The AbrB expression noise thus triggered by RnaC/S1022 generates 
diversity in growth rates during the exponential growth phase, which was demonstrated by live 
cell imaging. This formation of sub-populations of slow- and fast-growing cells could be of 
significant relevance for drug resistance because, as discussed, slowly growing cells are generally 
less susceptible to the actions of antibiotics than rapidly growing cells.
The studies described in chapters 2 and 3 were performed with B. subtilis, which has been 
extensively used as a Gram-positive model bacterium. This is one of the reasons why B. 
subtilis was used for a multi-condition transcriptome analysis with high-density tiling arrays, 
which provided novel insights into this bacterium’s regulatory architecture (15). The resulting 
information was in fact critical for the work described in the first two experimental chapters 
of this thesis and it served as an example for the studies described in chapter 4, where the 
transcriptome of the major human pathogen Staphylococcus aureus was investigated. Like B. 
subtilis, S. aureus is a Gram-positive bacterium. However, in contrast to B. subtilis, S. aureus 
is an important colonizer of human beings that is carried by about 30% of the population (16, 
17). Although S. aureus carriage is usually asymptomatic, this bacterium can cause severe 
invasive infections. Such infections are increasingly difficult to treat due to fact that S. aureus 
has acquired resistance to many antibiotics. In this respect, the methicillin resistant S. aureus 
(MRSA) has become a notorious example of the current antibiotic resistance crisis. In the study 
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described in chapter 4, S. aureus was subjected to a variety of different infection-mimicking 
conditions, including challenges with several clinically relevant antibiotics. However, in this 
case subinhibitory concentrations were used to detect possible responses. This showed that 
the transcriptional responses to most of the tested antibiotics were fairly limited. Using higher 
inhibitory concentrations of antibiotics would probably have yielded stronger responses, but 
this would have made it hard to distinguish between the direct effects of the antibiotics and 
the indirect effects due to the significant reduction in growth. Importantly, previous studies 
suggested that antibiotics at sub-lethal concentrations can drive the development of resistant 
phenotypes (18). It was therefore surprising to see that the tested antibiotics evoked only very 
few significant transcriptional responses at sub-inhibitory levels. Of note, none of the genes for 
known drug efflux pumps of S. aureus, was induced, while these transporters were previously 
found to be upregulated in response to lethal antibiotic challenges and some of them were in fact 
shown to play a role in drug resistance (19, 20). The main significant observation concerned the 
induction of prophage genes by sub-lethal concentrations of ciprofloxacin and flucloxacillin. 
Together, these findings suggest that the most likely reason why antibiotics, like ciprofloxacin 
and flucloxacillin, could drive the development of resistance is the induction of prophages, 
because phages are effective facilitators of horizontal gene transfer (21, 22, 23).
Many of the clinically relevant antibiotic resistance genes in S. aureus have been acquired via 
horizontal gene transfer. As outlined in chapter 1, bacteria can acquire resistance genes via 
conjugation, transduction or transformation, of which the latter has been addressed in chapter 5. 
The study described in this chapter, was focused on the post-translational processing of ComGC, 
a protein of the potential competence system of S. aureus. This system is homologous to the 
competence system of B. subtilis and is therefore thought to play a role in DNA uptake by S. 
aureus. However, despite clear evidence demonstrating natural competence in S. aureus (24, 
25), the system for DNA binding and uptake is far from being completely elucidated. The results 
presented in chapter 5 demonstrate that, as for its counterpart in B. subtilis, the ComGC protein 
is assembled in the cytoplasmic membrane and cell wall, presumably forming a pilin-like 
structure. The stability of the ComGC protein was shown to depend on disulfide bond formation, 
facilitated by the thiol-disulphide oxidoreductase DsbA. In addition, it was demonstrated that 
the pseudopilin-specific signal peptidase ComC is essential for the correct processing and 
cell surface exposure of ComGC. This is the first study that assigns a biological function to 
DsbA and ComC in S. aureus. The signal peptidase function of ComC in the processing of 
ComGC is highly similar to that of its homologue in B. subtilis (26) and could be regarded 
as additional evidence that the Com system in S. aureus is indeed involved in competence. A 
better understanding of competence development and horizontal gene transfer in S. aureus is 
of significant importance, since this organism is notorious for its ability to adapt quickly to its 
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environment via the acquisition of mobile genetic elements. Accordingly, it has been shown 
that at least one staphylococcal cassette chromosome with a mecA gene (SCCmec), which 
determines the methicillin resistance of MRSA strains, can be acquired by transformation (25). 
Yet, it should be noted that transduction via phages plays probably an even more important role 
in the horizontal transfer of genes encoding toxins and immune evasion factors, plasmids, S. 
aureus pathogenicity islands (SaPI’s) and, last but not least, genes or gene clusters that confer 
antibiotic resistance (e.g. SCCmec) to the recipient cell (21, 22, 23, 27). 
The high ability of S. aureus, and also other pathogens, to quickly adapt to environmental 
changes and to acquire resistance to antibiotics explains why it is so hard to develop new 
strategies to combat the antibiotic resistance problem. Accordingly, there is a great need for 
complementary strategies to further support or replace the current antibiotic therapies. One 
such approach is vaccination, be it passive or active, to prevent or combat dangerous invasive 
infections. Active vaccination has, for instance, been a successful approach in the prevention of 
severe pneumococcal disease. Thus, the use of a pneumococcal conjugate vaccine, containing 
the capsular polysaccharides of seven of the most prominent S. pneumoniae serotypes, resulted 
in a reduction of invasive pneumococcal disease, reduced carriage rates and - of note – a reduced 
incidence of antibiotic resistant strains (28). In the last decades, several attempts have been made 
to develop effective vaccines for combating S. aureus infections (29, 30, 31). However, up until 
this day, none of the vaccines that were tested in clinical trials could provide their recipients 
with a protective immunity against S. aureus. The failures in the development of a protective 
vaccine have been attributed to various different factors. Firstly, the protective immunity is 
not completely understood, which is related to the fact that animal models do not fully reflect 
disease onset and progression in humans. Secondly, S. aureus is equipped with a large number 
of virulence factors, and effective vaccines should counter most of them. Thirdly, S. aureus can 
cause a variety of different diseases, which need different therapeutic approaches, and fourthly, 
S. aureus employs a range of immune evasion factors that can effectively neutralize the host 
immune response (32). Chapter 6 describes the identification of potential new targets for the 
development of S. aureus-directed vaccines. In this study, surface-associated and secreted 
proteins of S. aureus were identified using a thorough proteomic analysis. Two different surface 
shaving approaches, combined with the analysis of non-covalently cell wall-bound proteins and 
the exoproteome provided an extensive inventory of potential vaccine candidates, all of which 
were identified by gel-free mass spectrometry (MS). Specifically, this approach was applied to 
two different S. aureus strains, namely the methicillin sensitive S. aureus (MSSA) strain Newman 
and the community-associated MRSA strain USA300. Importantly, plasma of patients with 
epidermolysis bullosa (EB), whose wounds are heavily colonized by S. aureus (33), was used to 
screen for immunodominant epitopes recognized by immunoglobulin G (IgG) against S. aureus. 
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The proteomic analyses identified a large number of cytoplasmic proteins in and on the surface 
and the cell wall of both investigated S. aureus strains, but particularly the USA300 strain. This 
typical localization of these so-called moon-lighting proteins has also been reported in previous 
studies, and it has been hypothesized that these proteins have a function in virulence (34). In 
accordance with this theory, it was demonstrated that the plasma of EB patients contained IgGs 
directed against several of these moonlighting proteins, including glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), several ribosomal proteins and enolase (Eno). Importantly, it has 
already been demonstrated that antibodies directed to Eno can induce the opsonophagocytic 
killing of S. aureus (35), and in Streptococcus suis this protein was identified as a protective 
surface antigen (36). In addition to these “atypical” surface proteins, the shaving approach 
identified epitopes of several surface and cell wall proteins that seem to protrude the cell surface 
and are exposed to the extracellular milieu. These included the cell wall-anchored IsdB protein, 
the bifunctional autolysin Atl, the adhesin Emp and the transglycosylase IsaA. Recent progress on 
the development of an IsdB-based vaccine demonstrated that this protein is highly immunogenic 
(37, 38), which underpins the potential significance of this selection of surface-exposed proteins. 
Altogether, the experiments described in chapter 6 identified several new immunodominant 
cell surface-exposed proteins of S. aureus that could serve as potential targets for novel active 
or passive immunization approaches. Among these are the covalently cell wall-bound proteins 
ClfB and IsdB, an ‘YkyA-like’ cell wall-binding lipoprotein, the membrane proteins EbpS 
and LtaS, the non-covalently cell wall-bound and secreted proteins Atl, Sbi, IsaA, Emp, and 
the cytoplasmic proteins Afl1, Eno, and GAPDH. Whether any of these proteins can serve as 
potential targets for an effective antistaphylococcal immunotherapy will have to be resolved 
in future studies. However, this goal seems achievable as persistent S. aureus carriage seems 
to lower the risk of dying from severe bacteremia caused by this pathogen (16, 39, 40). This 
suggests that some level of immunity against S. aureus infections can be achieved, supporting 
the concept of protective antistaphylococcal immunization. 
A highly effective approach for combating the spread and development of MDR strains is to 
create a higher awareness for a more responsible use of antibiotics. Worldwide several initiatives 
have been deployed to stimulate the proper use of antibiotics, not only in the clinic, but also, 
or especially, in livestock farming and veterinary medicine. These initiatives are referred to 
as antimicrobial stewardships and they involve a multifaceted approach to optimize the use 
of antibiotics while minimizing the development of resistance and other adverse effects (41). 
Included are familiar guidelines, such as the selection of the appropriate antimicrobial to treat an 
infection, identification of the infectious organism, preferred use of small spectrum antibiotics, 
and the correct dose and duration of the antibiotic treatment. However, one of the most essential 
and effective elements in antibiotic stewardship is considered to be infection prevention. 
Chapter 8
196
Especially in hospital settings, successful implementation of infection prevention measures can 
be highly effective for reducing the incidence and consequences of infections by drug resistant 
bacteria. In here, patients are an especially vulnerable group for bacterial infections due to 
their underlying illnesses that often render them frail and/or immunocompromised. Notably, 
a significant fraction of the bacterial infections encountered in hospital environments has been 
acquired in the same clinical setting. The treatment of these hospital-acquired (HA) infections is 
becoming increasingly difficult due to the increasing incidence of MDR-type bacterial pathogens. 
Preventing the spread of such pathogens by the implementation of strict hand hygiene protocols 
for healthcare workers is considered to be one of the most effective measures (42, 43). However, 
the main hurdle for the strict implementation of hygiene protocols relates to the full compliance 
of healthcare personnel with hand washing protocols. Therefore, the development of alternative 
approaches that complement and enhance the compliance with hygiene protocols could be a 
next important step in the fight against antibiotic resistant pathogens. Chapter 7 of this thesis 
describes a study that investigated the possibilities to develop an antimicrobial hand sanitizer 
that could serve as a protective ‘microglove’. The basic concept of such a hand sanitizer involves 
the formation of a thin film that covers the surface of the hand and contains an antimicrobial 
compound. Several different polymer formulations were tested for their film-forming properties 
and their ability to include and slowly release antimicrobial compounds for periods of time in 
the minute to hour range. This would protect the hands of healthcare workers against microbial 
contamination and would limit the transmission of microbes from the healthcare workers to 
patients. The compounds that were tested comprised co-polymers of polyvinylpyrrolidone (PVP) 
and derivatized maleate, which were mixed at different ratios. This ratio largely determined the 
chemical and physical properties of the film. The applied antimicrobial compound in this study 
was benzalkonium chloride (BKC). BKC is a quaternary ammonium compound with chemical 
properties that make it interesting as a biocide, cationic surfactant and phase transfer agent. 
As a biocide, BKC has been successfully applied in a wide range of cosmetic products and 
non-alcoholic hand sanitizers. For the studies presented in chapter 7, BKC was applied to the 
selected polymer formulations at different concentration, which were then together assessed for 
their ability to prevent contamination and transmission of S. aureus. From these experiments, 
it was concluded that PVP and the derivatized maleate M20 (i.e. PVPM20), mixed at a ratio of 
80:20 and supplemented with 0.9% BKC, was the most suitable formulation that fulfilled all 
the requirements for an antimicrobial microglove. In a series of proof-of-principle experiments, 
involving three hours of normal daily activities, it was demonstrated that hands of volunteers that 
were treated with this polymer formulation showed significantly less contamination compared 
to the control hands. Importantly, an antimicrobial microglove as described in chapter 7 
will provide significantly better protection against microbial contamination and subsequent 
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transmission than currently applied hand sanitizers that disinfect the hands only at the moment 
of application. Although the microglove concept is technically feasible, it is important to bear 
in mind that this type of product cannot replace strict hygiene protocols. Instead, it needs to be 
regarded as a tool that is complementary to existing hygiene protocols, and that can potentially 
enhance their efficacy. 
Altogether, the six experimental chapters of this thesis deal with different aspects of antibiotic 
resistance, all of which are of relevance in the fight against this global healthcare problem. 
The development of successful alternative strategies to treat MDR infections requires a detailed 
understanding of all these different aspects. Molecular mechanisms involved in drug resistance 
need to be studied to understand the development of resistance. The resulting insights could 
provide us with new approaches and targets to counteract resistance, rendering resistant 
pathogens again sensitive to already developed antibiotics. Further, a better understanding of the 
differentiation processes in bacterial communities, by dissecting biological phenomena such as 
bacterial communication, formation of persister cells and biofilm formation, will be instrumental 
for combating chronic bacterial infections. Although the development and implementation of 
alternatives for antibiotics will be essential for stopping the rise of MDR superbugs, it is important 
to realize that for a long-term solution drastic changes are needed in the ways we produce and 
use our antibiotics. As demonstrated over the last decades, bacteria are very smart in finding 
ways by which they can counteract the effects of antibiotics. The fact that these antibiotics target 
a wide range of essential processes in the bacterial cells makes this feat even more impressive 
and clearly underscores the evolutionary adaptability of bacteria. Hence, the introduction of 
new therapeutic approaches will, most likely, eventually result in the development of resistance. 
It is therefore essential to invest in complementary preventive and therapeutic approaches that 
are then implemented under strict antibiotic stewardship. Combining all our knowledge and 
experience will most certainly help us find innovative solutions for controlling the antibiotic 
resistance problem, but this will require a concerted effort of researchers and clinicians and, 
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De ontdekking en introductie van de eerste antibiotica wordt nog steeds beschouwd als één 
van de grootste medische doorbraken van de 20ste eeuw. Toen penicilline algemeen beschikbaar 
kwam voor het grote publiek, werd gedacht dat dit wel eens het begin van het einde kon zijn 
van de moeilijke strijd tegen bacteriële infecties. In het pre-antibiotica tijdperk waren infecties 
veroorzaakt door bacteriën namelijk vaak onbehandelbaar en ernstige invasieve infecties 
resulteerden daarom veelal in de dood van de patiënt. Met behulp van antibiotica werden veel 
van deze infecties plotseling goed behandelbaar en konden patiënten volledig genezen. De 
introductie en het veelvuldige gebruik van antibiotica resulteerden echter al snel in de opkomst 
van de eerste resistente bacteriële ziekteverwekkers. Door de jaren heen is gebleken dat de 
introductie van een nieuwe antibioticum bijna altijd snel gevolgd werd door de opkomst van 
bacteriën die resistent waren tegen het nieuwe antibioticum. Helaas is de ontwikkeling van 
nieuwe antibiotica een lastig en vaak langdurig proces. Hierdoor is het moeilijk om voldoende 
tegenwicht te bieden aan de snelle evolutie van resistente bacteriën. De consequentie van deze 
onbalans is dat sommige bacteriële infecties de laatste jaren steeds moeilijker te behandelen zijn. 
De verontrustend snelle ontwikkeling van “meervoudig drug-resistente” bacteriën (MDR) en 
zelfs enkele “totaal drug-resistente” (TDR) bacteriën suggereert misschien zelfs het begin van 
een mogelijk post-antibiotica tijdperk.
In historisch opzicht wordt de ontwikkeling van antibioticumresistentie vaak gekoppeld aan het 
eerste klinische en grootschalige gebruik van antibiotica. De oorsprong van antibioticumresistentie 
gaat echter veel verder terug in de tijd. Bacteriën hebben al miljarden jaren een prominente 
plek onder de op aarde levende organismen, waarbij ze altijd met andere (micro-)organismen 
moesten concurreren voor nutriënten en de meest ideale leefomgeving. In de context van deze 
constante strijd moet het ontstaan van natuurlijke antibiotica als wapen tegen ongewenste 
concurrenten gezien worden. Een consequentie van deze wapenwedloop is de evolutie van een 
grote verscheidenheid aan antimicrobiële moleculen gericht op de remming van verschillende 
essentiële processen die nodig zijn voor bacterieel leven. Veel van de huidige antibiotica die 
in de kliniek worden gebruikt zijn dan ook ontwikkeld op basis van natuurlijke antimicrobiële 
moleculen. Belangrijk is dat de evolutie van antibiotica hand in hand ging met de ontwikkeling 
van efficiënte resistentiemechanismen. Dit was in de eerste plaats een noodzaak voor de 
antibiotica-producerende microorganismen die ongevoelig moesten zijn voor de effecten van 
hun eigen producten. Bovendien was de ontwikkeling van resistentie tegen de antimicrobiële 
producten van concurrerende organismen een efficiënte strategie in de evolutionaire strijd 
om de beste ecologische niches. Bewijs dat antibioticumresistentie een natuurlijk en oud 
fenomeen is werd recentelijk verkregen uit 30.000 jaar oude permafrost monsters, waarin 
antibiticumresistentiegenen geïdentificeerd werden (1).  Onderzoek wees uit dat deze oude genen 
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nog steeds functioneel zijn tegen  antibiotica die tegenwoordig in de kliniek worden gebruikt. 
Deze resultaten maken het aannemelijk, dat het veelvuldige gebruik van antibiotica heeft geleid 
tot een sterke selectie van bacteriën die over resistentiemechanismen beschikken die al sinds 
lange tijd aanwezig zijn in de natuurlijke genenpool. 
Resistentie tegen een bepaald antibioticum kan veroorzaakt worden door een natuurlijke 
eigenschap van een bacterie, maar de resistentie kan ook worden verworven door mutatie van 
bepaalde genen of door de opname van genetische elementen met resistentiegenen. De alzo 
verworven resistentie is in het algemeen te relateren aan drie verschillende mechanismen: 
(1) inactivatie van het antibioticum door afbraak dan wel chemische verandering van het 
antibioticummolecuul; (2) structurele aanpassing van het antibioticumdoelwit in de bacterie 
waardoor het antibioticum hier niet meer aan kan binden; en (3) verlaging van de intracellulaire 
concentratie van de antibiotica door aanpassingen die de opname van antibiotica remmen of die 
de actieve excretie van antibiotica verhogen (2). Verder kunnen bacteriën door verschillende 
aanpassingen in hun levenstijl minder gevoelig worden voor de effecten van antibiotica. Door 
bijvoorbeeld een multicellulaire biofilm te vormen kunnen bacteriën hun tolerantie voor antibiotica 
met wel 100 tot 1000 keer verhogen (3). Zo’n biofilm bestaat uit vele bacteriën die samenleven 
in een complexe structuur, vaak gehecht aan een vast oppervlak. De bacteriën vormen dan een 
soort van bacteriekoek, waarbij ze ingekapseld zijn in een beschermende buitenlaag. Doordat 
antibiotica moeilijk kunnen doordringen in een biofilm zijn de bacteriën relatief goed beschermd 
tegen de effecten van antibiotica. Verder is aangetoond dat er in een biofilm kleine populaties van 
zogenaamde persistente cellen aanwezig zijn. Dit zijn langzaam groeiende of niet delende cellen 
die door hun lage metabolische activiteit minder gevoelig zijn voor de effecten van antibiotica 
(4). Bacteriën beschikken alzo over verschillende effectieve manieren om zich te verweren tegen 
de toxische effecten van antibiotica. De kans is daarom groot, dat ook tegen nieuwe toekomstige 
antibiotica binnen de kortste keren resistentie zal optreden. Onderzoek naar de ontwikkeling van 
antibioticumresistentie en de verschillende aspecten die daarbij een rol spelen is daarom van 
essentieel belang voor de ontwikkeling van alternatieve en vooral duurzame strategieën voor de 
aanpak van het resistentieprobleem.     
Samenvatting en Discussie 
In dit proefschrift “over antibioticumresistentie” worden verschillende aspecten van het 
antibioticumresistentieprobleem beschreven. In het inleidende hoofdstuk 1 is dit probleem van 
verschillende kanten belicht en zijn de specifieke doelstellingen van het onderhavige onderzoek 
gepresenteerd. 
In hoofdstuk 2 wordt het mechanisme beschreven, dat zorgt voor de expressie van de multidrug 
transporter BmrC/BmrD in de bacterie Bacillus subtilis. BmrC and BmrD vormen samen een 
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zogenaamde ABC-transporter die in staat is verschillende toxische producten uit de cel te 
transporteren (5). Interessant is dat de expressie van de bmrC en bmrD genen wordt geïnduceerd 
door enkele klinisch relevante antibiotica. In hoofdstuk 2 wordt aangetoond dat expressie van 
deze genen wordt gereguleerd door een gespecialiseerd systeem, dat in staat is de aanwezigheid 
van antibiotica te detecteren die gericht zijn tegen het ribosoom en daardoor de eiwitsynthese 
remmen. De resultaten laten zien dat de transcriptie van bmrC en brmD wordt geregeld door 
een zogenaamd transcriptioneel attenuatie-mechanisme. Hievoor is het  bmrB gen nodig, een 
klein gen dat voor de twee ABC-transportergenen ligt. Het brmB gen wordt samen met de bmrC 
en bmrD ABC-transportergenen afgeschreven. Het bmrB messenger-RNA (mRNA) codeert 
voor een klein eiwit (BmrB) maar heeft daarnaast ook een specifieke structuur. Met behulp van 
verschillende puntmutaties kon aangetoond worden dat deze RNA-structuur essentieel is voor het 
reguleren van de expressie van de brmC en bmrD genen. Door de vorming van een zogenaamde 
transcriptionele terminatorstructuur of een anti-terminatorstructuur kan de transcriptie van 
bmrC en bmrD respectievelijk aan- of uitgezet worden. De vorming van de terminator of anti-
terminatorstructuur wordt bepaald door de efficiëntie van de omzetting van het bmrB mRNA 
naar eiwit. In afwezigheid van antibiotica kunnen ribosomen het bmrB mRNA efficiënt vertalen 
naar het BmrB eiwit. Onder deze omstandigheden wordt de vorming van de terminatorstructuur 
gestimuleerd en dit resulteert in een vroegtijdige terminatie van het transcriptieproces. Hierdoor 
worden de ABC-transportergenen bmrC en bmrD niet  afgeschreven en wordt de BmrC/BmrD 
transporter niet gevormd. In de aanwezigheid van antibiotica die gericht zijn tegen het ribosoom 
wordt de vertaling van het bmrB mRNA naar eiwit gehinderd. Dit levert een gunstige situatie 
op voor de vorming van de anti-terminatorstructuur in het mRNA. De vorming van deze anti-
terminator voorkomt de vorming van de terminator en stimuleert daarmee de transcriptie van 
de bmrC en bmrD genen. Een opmerkelijke waarneming was dat de expressie van de bmrC en 
bmrD genen strikt gebonden is aan de late fases van de groei van B. subtilis, de zogenaamde 
stationaire groeifase. Deze vertraagde expressie bleek bepaald te worden door AbrB, een 
belangrijke transcriptionele regulator die een grote rol speelt bij de overgang van exponeniële 
groei naar stationaire groei. 
Het onderzoek beschreven in hoofdstuk 3 betreft de regulatie van de AbrB regulator zelf. In 
individuele cellen van een bacteriepopulatie blijkt het expressieniveau van deze regulator grote 
variaties te vertonen. Deze zogenaamde expressieheterogeniteit wordt, zoals aangetoond in 
hoofdstuk 3, deels veroorzaakt door een klein regulatorisch RNA-molecuul met de naam RnaC/
S1022. De directe interactie van RnaC/S1022 met het abrB mRNA zorgt voor een grotere cel 
tot cel variatie in de AbrB-niveaus. Dit verschijnsel werd opgemerkt, doordat deletie van het 
RnaC/S1022-gen in een verbeterende groei van B. subtilis resulteerde. Dit effect bleek te worden 
veroorzaakt door verhoogde abrB mRNA- en ArbB eiwitniveaus. Verdere analyse liet zien, dat 
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RnaC/S1022 het abrB mRNA-niveau reguleert via een directe sequentie-afhankelijke interactie, 
waardoor vervolgens ruis in de expressie van het AbrB eiwit ontstaat. De alzo veroorzaakte 
heterogeniteit in AbrB-expressie binnen de bacteriepopulatie zorgt vervolgens voor de vorming 
van snel- en langzaam groeiende cellen. Deze diversiteit in groeisnelheden binnen een bacteriële 
populatie kan een significante rol spelen bij de ontwikkeling van antibioticumresistentie, omdat 
langzaam groeiende cellen immers minder gevoelig zijn voor de effecten van antibiotica dan 
snel groeiende cellen.  
Het onderzoek beschreven in hoofdstuk 4 was gericht op Staphylococcus aureus, een klinisch 
relevante bacterie. S. aureus is een belangrijke humane ziekteverwekker die vaak deel uit maakt 
van de humane microbiota. Hoewel het dragerschap van S. aureus over het algemeen weinig 
problemen veroorzaakt  kan S. aureus gevaarlijke invasieve infecties veroorzaken. Vooral voor 
mensen die kampen met een verminderde weerstand ten gevolge van een onderliggende ziekte 
kan deze bacterie een serieuze bedreiging vormen. Daarbij komt het feit, dat infecties met S. 
aureus soms moeilijk te behandelen zijn door het vermogen van deze bacterie resistentie te 
verwerven tegen verschillende soorten antibiotica. Hiervan is waarschijnlijk de meticilline 
resistente S. aureus (MRSA) het meest bekende voorbeeld. Bij de experimenten beschreven 
in hoofdstuk 4 werd S. aureus onder andere blootgesteld aan verschillende klinisch relevante 
antibiotica. De relatief lage antibioticumconcentraties die gebruikt werden in deze studie 
brachten verassend genoeg over het algemeen weinig veranderingen in de bacterie teweeg, zoals 
vastgesteld werd door genoomwijde transcriptieanalyses. De grootste veranderingen werden 
opgemerkt als S. aureus werd behandeld met de antibiotica ciprofloxacine of flucloxacilline. 
Deze antibiotica induceerden de expressie van bacteriofaaggenen en initieerden daarmee de 
activatie van de desbetreffende bacteriofagen. Bacteriofagen zijn bacteriële virussen die goed in 
staat zijn om genetisch materiaal tussen bacteriën uit te wisselen. De bevinding dat ciprofloxacine 
en flucloxacilline zorgen voor activatie van bacteriofagen suggereert dan ook dat het (verkeerde) 
gebruik van deze antibiotica de ontwikkeling en verspreiding van resistentiegenen door middel 
van bacteriofagen zou kunnen stimuleren.
Veel van de genen die coderen voor klinisch relevante resistentiemechanismen in S. aureus zijn 
gelegen op mobiele DNA-elementen die worden verspreid via horizontale gen-transfer (HGT). 
Deze HGT kan bijvoorbeeld gefaciliteerd worden door de hierboven besproken bacteriofagen. 
Een andere manier voor S. aureus om DNA op te nemen is de zogenaamde transformatie. 
Competente S. aureus cellen zijn in staat om vrij DNA te binden, op te nemen en vervolgens in 
te bouwen in het eigen DNA. Het is al een tijd bekend dat S. aureus natuurlijk competent kan 
worden, maar het mechanisme dat hieraan ten grondslag ligt was nog grotendeels onbekend bij 
aanvang van dit promotieonderzoek. De studie beschreven in hoofdstuk 5 is gefocust op de post-
translationele processing van ComGC, een belangrijk onderdeel van het competentiesysteem 
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van S. aureus. Dit competentiesysteem blijkt sterk verwant te zijn aan het competentiesysteem 
van de eerder besproken B. subtilis bacterie, dat uitgebreid in kaart is gebracht. In B. subtilis 
vormt ComGC een zogenaamde pseudopilus op het celoppervlak die een belangrijke rol in 
DNA-binding en -opname speelt. De resultaten in hoofdstuk 5 laten zien dat ook in S. aureus 
het ComGC-eiwit geassembleerd wordt op het celoppervlak. De stabiliteit van de ComGC 
pseudopilus wordt gereguleerd door een enzym, genaamd DsbA. Verder is ComGC afhankelijk 
van een ander enzym, ComC, voor de juiste plaatsing op het oppervlak van de cel. Naast het 
feit dat er voor het eerst een functie is beschreven voor DsbA en ComC laten de resultaten zien, 
dat het Com systeem van S. aureus waarschijnlijk, net als het verwante systeem van B. subtilis 
(6), betrokken is bij de ontwikkeling van competentie. Een meer gedetailleerde kennis over de 
competentieontwikkeling in S. aureus is van groot belang, omdat deze ziekteverwekker zich snel 
aan een veranderende omgeving kan aanpassen door middel van de opname van extern DNA.
De eigenschap van S. aureus en veel andere ziekteverwekkers om snel resistent te kunnen 
worden tegen antibiotica onderstreept de noodzaak om nieuwe antibiotica te ontwikkelen, 
maar laat ook duidelijk zien dat dit een moeilijk te winnen race is. Daarom is het belangrijk 
om onderzoek te doen naar alternatieve oplossingen die hopelijk het veelvuldige gebruik van 
antibiotica kunnen beperken. Eén van deze strategieën is de ontwikkeling van efficiënte vaccins 
die gevaarlijke invasieve infecties kunnen voorkomen of genezen. Voor S. aureus zijn er in de 
laatste jaren verschillende pogingen gedaan om tot de ontwikkeling van een goed beschermend 
vaccin te komen. Helaas bleek geen van deze strategieën een effectieve bescherming te bieden, 
alhoewel recente data suggereren dat dit niet onmogelijk is (7). In hoofdstuk 6 wordt een nieuwe 
strategie beschreven voor de identificatie van nieuwe potentiëlen doelwitten voor vaccinatie 
tegen S. aureus infecties. Verschillende nieuwe oppervlakteeiwitten werden geïdentificeerd met 
behulp van een combinatie van twee verschillende moleculaire methodes, waarbij uitstekende 
eiwitdelen als het ware van het celoppervlak afgeschoren werden. Vervolgens werden de 
afgeschoren delen verzameld en geïdentificeerd met behulp van massaspectrometrie (MS). 
Tevens werden deze eiwitten gescreend met het plasma van patiënten met de genetisch-bepaalde 
huidziekte epidermolysis bullosa (EB) om te onderzoeken of ze gemakkelijk herkend kunnen 
worden door het humane immuunsysteem. Omdat de patiënten met EB vaak chronische wonden 
hebben die in veel gevallen gekoloniseerd zijn met S. aureus vertonen ze vaak een sterke 
immuunreactie tegen eiwitten van deze bacterie. Door de screening met het plasma van deze 
patiënten konden immunodominante epitopen in S. aureus eiwitten worden geïdentificeerd die 
mogelijkerwijs gebruikt kunnen worden voor de ontwikkeling van nieuwe actieve of passieve 
vaccinatiestrategieën. 
Een andere effectieve oplossing om de opkomst en verspreiding van antibioticumresistente 
bacteriestammen tegen te gaan is de consequente implementatie van infectiepreventiemaatregelen. 
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Vooral in een ziekenhuisomgeving zijn strikte hygiëneprotocollen vaak buitengewoon effectief. 
Patiënten vormen namelijk een kwetsbare groep die erg bevattelijk kan zijn voor bacteriële 
infecties. Een van de grootste moeilijkheden bij de implementatie van dergelijke protocollen is 
echter de consequente opvolging van de opgestelde protocollen, met name bij het handenwassen. 
Dit heeft te maken met het feit dat het frequent wassen van de handen kan leiden tot een 
droge en geïrriteerde huid. Om deze reden is de ontwikkeling van alternatieve methoden en 
middelen die strikte hygiëneprotocollen ondersteunen van belang in de strijd tegen bacteriële 
ziekenhuisinfecties in het algemeen en tegen antibioticumresistente bacteriën in het bijzonder (8). 
Hoofdstuk 7 beschrijft onderzoek naar een nieuw soort antimicrobieel handreinigingsmiddel. In 
deze studie werd een dergelijk middel ontwikkeld met als doel verplegend personeel en patiënten 
voor de duur van de verzorgende handelingen – minuten tot uren - te beschermen tegen microbiële 
besmettingen. Het ontwikkelde middel is gebaseerd op een dunne film van een co-polymeer die 
als een soort microhandschoen achterblijft op de hand. Door de veelgebruikte antimicrobiële 
stof  benzalkonium chloride (BKC) toe te voegen aan de polymeeroplossing wordt de dunne 
polymeerfilm op de hand tevens bacteriedodend. De studie in hoofdstuk 7 suggereert dat een 
combinatie van polyvinylpyrrolidone (PVP) en een maleaat-derivaat met 0.9% BKC voldoet aan 
de primaire voorwaarden voor een antibacteriële microhandschoen. Verder toont een serie proof-
of-principle experimenten aan, dat deze polymeerformulering een paar uur bescherming biedt 
tegen microbiële besmetting van de hand, waarna de microhandschoen met water en zeep weer 
verwijderd kan worden. De bescherming die deze antibacteriële microhandschoen lijkt te bieden 
zou daarom wellicht van toegevoegde waarde kunnen zijn ter ondersteuning van bestaande 
infectiepreventiemaatregelen. Het is hierbij van belang te onderstrepen, dat een dergelijk product 
niet de strikte hygiëneprotocollen voor infectiepreventie kan vervangen, maar wellicht wel een 
zinvolle bijdrage kan leveren aan de verbeterde implementatie hiervan. 
De zes experimentele hoofdstukken van dit proefschrift behandelen verschillende aspecten 
van het antibioticumresistentieprobleem. In hoofdstuk 8 zijn deze resultaten kort in het Engels 
samengevat. Geconcludeerd kan worden, dat gedegen onderzoek naar de verschillende aspecten 
van het antibioticumresistentieprobleem van belang is voor de ontwikkeling van alternatieve 
strategieën voor de aanpak van deze wereldwijde bedreiging van de volksgezondheid. Het 
begrijpen van de moleculaire mechanismen die betrokken zijn bij antibioticumresistentie is 
belangrijk voor een algemeen begrip van de ontwikkeling van resistentie. Dit begrip is vervolgens 
van eminent belang voor de ontwikkeling van nieuwe benaderingen om het resistentieprobleem 
effectief te bestrijden. Met name voor de langere termijn is het belangrijk, dat er veranderingen 
komen in de manier waarop antibiotica worden ontwikkeld en gebuikt. In het recente verleden 
is duidelijk gebleken, dat bacteriën altijd snel met effectieve oplossingen komen om de effecten 
van antibiotica teniet te doen. Daarom is het van groot belang dat antibiotica verstandig worden 
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gebruikt, zodat er minimaal op resistente bacteriën geselecteerd wordt. Met al de aanwezige 
kennis en ervaring zullen op de middellange termijn zeker innovatieve oplossingen gevonden 
worden om het antibioticumresistentieprobleem succesvol tegemoet te treden, maar een 
duurzame aanpak van dit probleem vraagt met name om een verantwoordelijk gebruik van deze 
nieuwe oplossingen. 
  
Nederlandse samenvatting voor de leek 
211
Referenties
1. D'Costa,V.M., King,C.E., Kalan,L., Morar,M., Sung,W.W., Schwarz,C., Froese,D., Zazula,G., Calmels,F., 
Debruyne,R., Golding,G.B., Poinar,H.N., and Wright,G.D.  (2011) Antibiotic resistance is ancient. Nature, 477, 
457-461. 
2. Blair,J.M., Webber,M.A., Baylay,A.J., Ogbolu,D.O. and Piddock LJ (2015) Molecular mechanisms of antibiotic 
resistance. Nature Reviews Microbiology, 13, 42-51. 
3. Olsen,I. (2015) Biofilm-specific antibiotic tolerance and resistance. Eur. J.Clin.Microbiol. Infect. Dis.,[Epub 
ahead of print].
4.  Lewis,K. (2010) Persister cells. Annu. Rev. Microbiol., 64, 357-372. 
5. Torres,C., Galian,C., Freiberg,C., Fantino,J.R. and Jault,J.M. (2009) The YheI/YheH heterodimer from Bacillus 
subtilis is a multidrug ABC transporter. Biochim. Biophys. Acta, 1788, 615-622. 
6. Chung,Y.S. and Dubnau,D. (1995) ComC is required for the processing and translocation of comGC, a pilin-like 
competence protein of Bacillus subtilis. Mol. Microbiol., 15, 543-551.
7. Bagnoli,F., Fontana,M.R., Soldaini, E., Mishra,R.P., Fiaschi,L., Cartocci,E., Nardi-Dei,V., Ruggiero,P., Nosari,S., 
et al. (2015) Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad 
protection against Staphylococcus aureus.Proc. Natl. Acad. Sci. U.S.A, 112(12), 3680-3685.
8. Pittet,D. (2001) Compliance with hand disinfection and its impact on hospital-acquired infections. J. Hosp. 






Na iets meer dan vijf jaar is dit hem dan: mijn proefschrift! Uiteraard ging deze periode gepaard 
met de nodige ups en downs, wel bekend voor menig promovendus. Maar nu alles netjes 
opgeschreven en gebundeld is kan ik zeggen dat ik trots ben op het resultaat. Uiteraard was dit 
alles niet mogelijk geweest zonder de fantastische hulp van collega’s, vrienden en familie. Ik wil 
daarom deze ruimte gebruiken om een aantal belangrijke mensen te bedanken.
Om te beginnen wil ik graag mijn promotor Jan Maarten van Dijl bedanken voor het mogelijk 
maken van dit proefschrift. Allereerst voor de mogelijkheid die je me hebt gegeven om na mijn 
master aan te slag mogen als PhD-student in de MolBac groep. Ik vond het leuk en leerzaam 
om samen het traject te beginnen met het schrijven van de aanvraag voor het Ubbo Emmius 
fonds, die eindelijk heeft gezorgd voor de financiering van het PhD-project. Daarnaast wil ik je 
ook bedanken voor je onuitputtelijke enthousiasme voor de wetenschap en je positieve kijk op 
(bijna) alles. Regelmatig ben ik je kantoor uitgelopen met een positievere kijk op mijn resultaten. 
Ook de afgelopen maanden, nodig voor het afronden van dit proefschrift, heb ik als erg positief 
ervaren. Ik denk dat we er een leuk verhaal van hebben gemaakt!  Jan Maarten, heel erg bedankt 
voor alles! 
Emma, friend and co-supervisor, it was always lovely to work with you. Great to figure out one 
of the biggest mysteries of Bacillus: J. I really enjoyed the dinners you organized and cooked, 
they were great! I am happy that you got the opportunity to start the Denham group back in home 
sweet home England. I am sure we will keep in touch!
Dear Annette, too bad you cannot be there on the day of the defense. It would have been great 
to have you there, not only as a good friend, but also since you were the one that introduced me 
into MolBac lab during my internship. You learned me a lot of the skills needed for the work 
in a microbiology lab and I really enjoyed working with you. I am glad you have found a good 
position and are feeling at home in Austria. I think I will be passing by somewhere in the near 
future for a beer or two.
My two paranymphs Giorgio and Ruben, great that you guys will be my paranymphs on the big 
day. Thanks for the dinners/beers we had together! Ruben, it was a pleasure for me to distract 
you so every once in a while from your work. Thanks for your help on J, the theory of almost 
everything, is was fun to crack that baby. Giorgio, roomie, it was great sharing an office with 
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